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Abstract  
 
 
Globally, gastric cancer claims around 800,000 lives per year. As many 
patients present at an advanced stage of disease, prognosis remains poor for 
most patients, with five-year survival rates of less than 30%. As many 
patients show only limited short-term benefits from current therapeutic 
regimes, there is a clear need for improved understanding of the molecular 
mechanisms that drive the development and spread of gastric cancer. In this 
context, the role of the tumour microenvironment in cancer development and 
the potential for new forms of therapeutic intervention has become a field of 
increasing interest in many areas of cancer research. It is now well 
established that the development and progression of gastric tumours is 
facilitated by reciprocal communication between cancer cells, and cells within 
the surrounding tissue. In this study we focus our investigation on the 
mechanisms and consequences of paracrine communication between gastric 
cancer cells and different populations of stromal myofibroblasts, which are 
prevalent within the cancer microenvironment and form a significant 
proportion of many solid tumours.  
 
Previous studies show that myofibroblasts derived from gastric tumours 
(CAMs) have inherently different profiles of gene expression, compared to 
patient matched adjacent tissue myofibroblasts (ATMs), or normal tissue 
myofibroblasts (NTMs). Given these differences, we were interested to know 
if specific myofibroblast populations respond differently to signals from 
cancer cells; or conversely, if they exhibit differential ability to facilitate pro- 
tumourogenic changes in gastric cancer cells.  Using a combination of 
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bioinformatics and experimental techniques we demonstrate that CAM-
conditioned media induces distinct changes in the gene expression profiles 
and metabolic activity of AGS gastric cancer cells.  Significantly, these 
changes were not observed following exposure to conditioned media derived 
from either ATM or NTM cells.  Conversely, CAM cells were found to have 
higher levels of GLUT1 and MCT4 expression with a corresponding reduction 
in mitochondrial activity compared to NTM cell lines. Finally, initial analysis 
of CAM imposed changes in AGS gene-expression suggests changes may 
reflect patient prognosis or stage of tumour development, implying future 
potential for patient stratification.  In conclusion, data from this study shows 
that activated CAMs are robustly programmed by cancer cells to facilitate 
optimal conditions for tumour growth. Therefore, further analysis of this 
system may provide much needed options for improved therapeutic 
intervention and precision medicine. 
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1.0 Overview 
 
The most fundamental property of living cell systems is the ability to consume 
and transform energy, a process termed “metabolism” originating from the 
Greek word “metabolismos,” meaning, “to change.” Cellular metabolism 
consists of many individual chemical reactions, which occur throughout 
metabolic pathways. These pathways exist in a delicate balance between 
anabolic (energy consuming) or catabolic (energy producing).  Metabolic 
processes and pathways in cancer cells have been a subject of much interest 
since the observations of Otto Warburg and his contemporaries in the early 
20th century (Warburg et al., 1927 and Warburg 1956). Despite almost ninety 
years of research on this subject, there are still many unanswered questions 
regarding the role of metabolic change in cancers.  
 
 The field of cancer therapeutics has greatly progressed over the past decade; 
however, with increased incidence of chemotherapy resistance, and global 
increase in the prevalence of cancer, further understanding and new methods 
for therapeutic intervention are needed. Work presented in this thesis 
highlights the role of metabolism in gastric cancer and its tumour 
microenvironment, and the potential use as a therapeutic target in combatting 
this disease.  
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1.1 Gastric Cancer: An Overview 
 
Cancers are a large family of multifactorial diseases, characterised by 
abnormal cell growth and often the ability to metastasise and spread to other 
parts of the body.  There are many factors that contribute to the development 
and progression of cancer, including: genetics, environmental stress, diet and 
lifestyle choices. The progression of normal cells, which form a mass, to 
malignant cancer cells, is primarily due to accumulation of molecular changes 
in cells as a result of exposure to these genetic or environmental factors.  
There are two key papers by Hannahan and Weinburg, which have since 
become the sine qua non for cancer biologists. The ‘Hallmarks of Cancer’ were 
first published in 2000 and covered the main cellular capabilities that cells 
require when evolving from healthy cells to malignant tumours. More recently 
an updated and revised version of the paper was published, ‘Hallmarks of 
Cancer: the Next Generation’ (Hannahan and Weinburg., 2011) which 
reviewed the evidence supporting the importance of the tumour 
microenvironment and energy metabolism in the process of carcinogenesis. 
The relationship between tumour cells and the tumour microenvironment is 
closely linked to that of energy metabolism, however there is much conflict in 
the literature regarding the fundamentals of this relationship, this present 
thesis attempts to address these issues in using a gastric cancer model and 
primary gastric stromal cells.  
 
Gastric cancer is currently the fifth most common cancer in the world, with 
just under one million new cases diagnosed in 2012 alone (Wcrf.org, 2014). 
Despite the continuing research and some improvements in cancer 
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therapeutics, treatment of gastric cancer remains problematic and the 
prognosis for most patients remains poor.  
 
As with most cancers, early detection of gastric cancer correlates with good 
long-term survival rates for patients (Hohenberger et al., 2009), however, due 
to non-specific symptoms and lack of routine screening, early diagnosis is rare 
and only 1 in 5 people survive the disease for five years or more after diagnosis 
(Cancer Research UK, 2014). 
 
Late diagnosis inevitably results in patients requiring post or peri operative 
chemotherapy, or radiotherapy in combination with surgery, depending upon 
the localisation and spread of the tumour (Meyer and Wilke 2011). 
Unfortunately, for patients who present with advanced tumours, especially 
with spread to the lymph nodes and metastasis, there are limited treatment 
options available. Current strategies for treatment include using combinations 
of chemotherapy agents, mainly platinum and fluoropyrimidine based 
compounds, such as 5-fluorouracil (5-FU) and doxorubicin (Cunningham et 
al., 2008, Tetzlaff et al., 2008, and Van Cutsem et al., 2009).  Advances in 
identification of stage and sub-group specific biomarkers, will improve 
therapeutic prescription of drugs to patients most likely to show responses, 
thereby limiting unnecessary treatment or suffering in inappropriate patient 
cohorts.  
HER2 overexpression has been identified in nearly 25% of gastric cancer 
patients and is associated with a poor prognosis (Kunz et al., 2012 and Meyer 
and Wilke 2011).  Combining monoclonal antibody treatment with traditional 
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chemotherapeutic agents in patients overexpressing HER2 using trastuzumab 
is a current treatment strategy in both gastric and breast carcinomas 
(Jørgensen 2010 and Bose et al., 2013).  With the use of these 
chemotherapeutic agents for palliative treatment of gastric cancer resulting in 
median survival times of only 9 to 11 months, increasing t0 14 months in 
HER2 expressing patients treated with trastuzumab (Van Cutsem et al., 2009) 
and the problem of resistance to chemotherapy, there is a substantial need to 
establish new and improved therapeutic strategies.  
  
1.2 Epidemiology of Gastric Cancer  
 
Histologically, there are two distinct variants of gastric carcinoma which have 
been identified: diffuse-type gastric cancer, sometimes known as signet ring 
carcinoma (Otsuji 1998 and Li et al., 2007) which comprises of individual 
neoplastic cells that are infiltrating into the stomach wall tissue, but do not 
form glandular structures (Zhang et al., 2010 and Kim et al., 2004) and 
intestinal-type adenocarcinomas, which advance through a series of 
histological stages (gastric atrophy, followed by intestinal metaplasia, which in 
turn may lead to dysplasia) (Ming 1977, Dicken et al., 2005 and Wroblewski et 
al.,2010). There have been various classifications of gastric cancer over the 
years but the Lauren classification, first introduced in 1965 is the most 
common and widely used today.   This classification system is able to 
histologically distinguish, between gastric adenocarcinomas of diffuse origin 
(DGCA) and gastric adenocarcinomas intestinal (IGCA) subtypes (Vauhkonen 
et al., 2006).  The primary prognostic factors in gastric carcinoma are the size 
and location of the tumour, and if the patient has any accompanying diseases 
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(Meyer and Wilke 2011, Takahashi et al., 2013 and Tetzlaff et al., 2008). 
There are two main tumor sites of gastric adenocarcinoma, and these are 
classed as proximal and distal (Crew and Neugut, 2006). The majority of 
stomach cancers are attributed to environmental factors such as Helicobacter 
pylori (H. Pylori), gastritis, and lifestyle factors such as diet and smoking 
(Forman and Burley 2006 and Correa 2013). Indeed, occurrence of gastric 
cancer varies significantly between populations, with the highest number of 
cases occurring in East Asia (Leung et al., 2008), indicating that both 
environmental and genetic factors may contribute to occurrence and 
progression of the disease.  Other factors contributing to the progression of 
gastric cancer include over production of the gastric antral hormone, gastrin, 
which has been shown to alter a ranger of cellular processes including 
proliferation, apoptosis, migration and tissue remodelling (Burkitt et al., 2009 
and Dockray 2004).  
 
1.2.1 Helicobactor pylori 
 
H. pylori is a class I carcinogen, it was first isolated in 1982, during a study of 
100 patients, all of which were undergoing gastroscopies (Warren and 
Marshall, 1984). The bacterial strain was identified in all patients presenting 
with gastric ulcers, chronic gastritis and intestinal ulcer; ultimately leading to 
the general use of antibiotics as a treatment for gastric ulcers (Warren and 
Marshall, 1984). Since the discovery of H. pylori, the bacterium has become 
the focus of countless gastric studies and is now known to be one of the most 
common infections in humans (Cave, 1997, Fuccio et al., 2007 and Uemura et 
al., 2001). H. pylori infection, specifically cytotoxin-associated gene A (CAGA) 
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positive strains are known to be potentially carcinogenic, as this strain is 
known to be associated with peptic ulceration with different strains of 
H.pylori being associated with different clinical outcomes [figure 1.1]. 
 
 
Atrophic	Gastri s	
 
Figure 1. 1. Schematic adapted from Correa and Plazuelo (2012).  
Clinical outcomes of infection with CagA positive and negative H.Pylori infections. 
 
 
1.2.2 Diet and Gastric Cancer  
Gastric cancer is a multifactorial disease, and the type of diet an individual 
consumes may have an important role to play in increased risk of the disease. 
Nitrate – rich foods such as processed meats, salted fish and pickled 
vegetables have all been reported to contribute to an increased risk of gastric 
carcinoma (Lee et al., 1995 and Navarro Silvera 2008). The method of cooking 
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food may also be linked to increased risk, as frying or grilling foods produce 
greater quantities of heterocyclic amines (Jedrychowski et al., 1993, Liu et al., 
2009 and Correa 1992).  Equally, high dietary salt intake is also reported to be 
associated with a greater risk, as it may be linked to intestinal metaplasia and 
also could potentially increase the risk of infection with H.pylori (Correa 1992 
and Tsugane et al.,1994).  
 
1.2.3 Genetics and Gastric Cancer  
Gastric cancer is a multifactorial disease, characterised by abnormal cell 
proliferation and the ability to metastasise to other tissues of the body. There 
are well-documented genetic changes in gastric cancer including up-
regulation of NET1 (Bennett et al., 2011), which is associated with increased 
proliferation, and invasion of gastric cells into the surrounding stroma.  
HERG was also identified as being involved in the progression of gastric 
cancer (Shao et al., 2008), as it was found to be exclusively expressed in 
gastric cancer cells, it was also proposed to be a potential therapeutic target 
(Shao et al.,2008).  
Genome-wide association studies can also be used to further understand and 
elucidate genetic factors that make people more susceptible to polygenic 
diseases and cancers. A genome-wide association study carried out on diffuse 
type gastric carcinoma identified a prostate stem cell antigen and the Mucin 1 
(MUC1) genes, which were both associated with diffuse-type gastric cancer 
(Saeki et al., 2013). Further investigation into genetic factors contributing to 
gastric cancer and the tumour microenvironment may provide additional 
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opportunities for identification of better prognostic biomarkers and new 
methods of therapeutic intervention 
 
1.3 Targeting the Gastric Microenvironment  
 
Understanding the complex relationship between different cells within the 
tumour stroma is vital in understanding the true mechanism of tumour 
development and drug resistance.  As such, this is now an area of considerable 
interest for both patient stratification, and the identification of new targets for 
pharmacological inhibition. Indeed, many pharmaceutical companies and 
academic laboratories are focusing research on the development of new ways 
to inhibit tumour- associated stromal cells. Examples of these developments 
include; re-educating immune cells of the microenvironment through targets 
such as general control non-derepressible 2 (GCN2) (Yu et al., 2007 and Ye et 
al., 2010), targeting tumour associated macrophages (Mantovani et al., 2006) 
and also blocking the paracrine communication between myofibroblast cells 
and cancer cells through mechanisms such the wnt signalling pathway (Liu et 
al., 2013 and Yauch et al., 2008).   Despite these recent developments, there is 
still much we do not know about cells of the tumour stroma or reciprocal 
mechanisms of communication within the cancer microenvironment. 
 
1.4 Cells of the Gastric Stroma and The Tumour Microenvironment  
 
The gastric stroma is comprised of a range of cells, many of which make up 
the connective, supportive framework of the functional epithelium cells. These 
include; fibroblasts, mesenchymal stem cells (MSCs), myofibroblast cells and 
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immune cells.  The cancer microenvironment contains a dynamic mixture of 
these non-cancerous cells, both in and around the developing tumour, these 
stromal cells can transform to aid and support cancer cell growth (Albini and 
Sporn, 2007). 
1.4.1 Fibroblast Cells 
 
Fibroblast cells function as a part of normal connective tissue. They have a 
distinct morphology, with elongated cell bodies and extended cellular 
processes.  They are slow dividing cells with reduced motility and whilst 
structurally similar to myofibroblast cells, they do not express -SMA 
(Grotendorst et al., 2004). During normal wound healing, they migrate to the 
site of injury, where they establish a collagen rich extra-cellular matrix (ECM) 
(Gabbiani  et al., 1971).  
 
The literature often refers to myofibroblast cells as ‘fibroblast’ cells however it 
is important to note the distinction between the two cell subtypes. Fibroblast 
cells are a pre-cursor to myofibroblast cells (or ‘active’ fibroblasts) 
differentiating into myofibroblast cells upon exposure to inflammatory or 
oncogenic signalling (Tomasek et al., 2002).  
 
1.4.2 Mesenchymel Stem Cells  
 
Mesenchymel stem cells (MSCs) are multipotent adult cells that have been 
shown to differentiate into a range of connective tissue cell subsets, including 
myofibroblasts  (Haniffa et al., 2009). They are characterised by the 
expression of markers such as CD105, CD29 and CD90, which are associated 
with the stroma, and the absence of expression of haemotopoetic cells 
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markers (Lee et al., 2013). Literature on the role of MSCs is conflicting with 
reports showing they have the potential to exhibit both positive and negative 
effects on tumour growth (Martin et al., 2010, Prockop and Youn., 2012, Al 
Jumah and Abumaree., 2012 and Anton et al., 2012). However, as they are 
thought to home to the site of developing tumours there is significant interest 
in the use of programmed MSCs to inhibit tumour development. 
 
1.4.3 Myofibroblast Cells  
1.4.3.1 The Origin of The Myofibroblast Cell 
 
During the late 1970s, extensive studies were performed into the composition 
of granulation tissue, leading to the identification of myofibroblasts which 
were found to be fundamental to the process of wound healing (Gabbiani et 
al., 1971,). After further investigation it became apparent that myofibroblasts 
not only play a key role in wound healing, but also within the stroma of some 
neoplasms (Sobral et al., 2011, Tsujino et al., 2007 and Ishii et al., 2003). 
Despite the cells morphology, immunohistochemistry (Shimasaki et al., 2007) 
and biochemistry being more fully elucidated following their discovery, there 
is still much that is unclear about these cells.  
 
It is reported that myofibroblasts are derived from normal fibroblasts, which 
are activated when inflammation or injury occurs, often being stimulated by 
transforming growth factor (TGF)-β and endothelin-1 (EDN1) (Phan et al., 
2003). Current opinion is that fibroblasts firstly become protomyofibroblasts, 
expressing both beta and gamma cytoplasmic actins before finally 
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transforming to active myofibroblasts, which express smooth muscle actin 
fibres (Micallef et al., 2012).  It is known that urokinase plasminogen activator 
receptor (uPAR), which is an extracellular protease system involved in cell 
migration, the modelling of the extracellular matrix and growth factor 
activation is present on the surface of fibroblasts (Bernstein et al., 2007). This 
receptor is reported to regulate cell transition from fibroblasts to 
myofibroblasts. Studies show that down-regulation of uPAR is necessary for 
the differentiation of fibroblasts into active myofibroblasts. Thus, loss of uPAR 
can be used as a marker for some myofibroblast populations (Bernstein et al., 
2007). 
 
As the origin of tissue myofibroblasts appears to be heterogeneous, it is highly 
likely that not all myofibroblast cells will display identical properties 
(Chauhan et al., 2003).  There is further evidence to suggest that other cells 
can become “active” and display myofibroblast-like characteristics these 
include pericytes, MSCs (Kosinski et al., 2010) and fibrocytes (Mitcallef et al., 
2012). Also, it is possible that the origin of myofibroblasts may depend on the 
site of damage; for example, in pathological situations within the liver, 
myofibroblast-like cells expressing -SMA are thought to be derived from 
both hepatic stellate cells and local liver fibroblasts (Yin et al., 2013).  
 
1.4.3.2 Identifying Myofibroblast Cells 
Aside from -SMA, myofibroblast cells also express other muscle cell markers, 
such as myosin and desmin, they can also be characterised by expression of 
vimentin and reduced CAV-1 expression. They share a similar phenotype with 
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smooth muscle cells in the expression of actin microfilament bundles. This is 
why the most common myofibroblast marker is alpha-smooth muscle actin (α-
SMA)  (Hinz et al., 2003 and Hinz et al., 2001).  Although both 
myofibroblasts and smooth muscle cell types express smooth muscle actin at 
high levels, these cells have distinctive morphologies and gene expression 
profiles (Gan et al., 2007).  Significantly, the functional properties of 
myofibroblasts vary according to the initial cause or process of activation, 
such as tissue inflammation or proximity to a developing tumour.  
 
In light of these observations it is clear that myofibroblasts do not have simple 
unifying properties, their functional profiles and degree of activity is clearly 
influenced by the form and extent of niche-specific paracrine conditioning. As 
such, the mechanism and consequences of myofibroblast conditioning must 
be carefully defined in different tumours, at different stages of development 
and different tissue locations in order to define tumour specific signatures and 
unify mechanisms of cancer reprogramming.  
 
1.4.3.3 Myofibroblasts in Cancer  
The role of myofibroblasts in cancer is currently inconclusive but presence of 
-SMA  myofibroblasts has been used as a marker of poor prognosis 
(Fuyuhiro et al., 2011). Information relating to the role of myofibroblasts in 
tumour development varies considerably between tumour types. Recruitment 
and activation of myofibroblasts is known to correlate with tumour invasion, 
but not in the initiation of tumour formation (De-Assis et al., 2012).  It is well 
known that in prostate cancer the tumour microenvironment plays a role in 
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tumour progression and metastasis (Barron et al., 2012, Giannoni et al., 2013, 
Shaw et al., 2009,Giannoni et al., 2010). Studies have been carried out to 
elucidate the mechanisms behind the relationship between the stromal cells 
and prostate cancer progression. A study by Shaw et al (2009) examines the 
role of paracrine signalling between the tumour and it’s microenvironment via 
the sonic hedgehog pathway. Another, more recent study found that 
preventing differentiation of prostate myofibroblast cells by using DHA, 
reduced epithelial to mesenchymel transition and tumour invasion (Bianchini 
et al., 2012). These studies indicate that the ability to influence myofibroblast 
function may provide an effective means of indirectly regulating the 
proliferation and migration of the cancer cells.  
 
Studies in breast cancer again indicate that the presence of myofibroblasts 
often correlates with increased invasiveness and poor prognosis (Surowiak et 
al., 2006 and Yamashita et al., 2012). One study by (Yazhou et al., 2004) 
showed that loss of Hematopoietic progenitor cell antigen CD34 expression 
and increased expression of -SMA was associated with carcinomas and not 
with normal breast tissue containing CD34 expressing fibroblast cells. CD34 is 
linked to stem cell phenotypes and is associated with Another study by 
Surowiak et al (2006), reported a consistent positive correlation between the 
prevalence of myofibroblasts in the tumour stroma and expression of a 
marker of proliferation (Ki67) and the proto-oncogene HER-2 in breast cancer 
cells.  In lung adenocarcinoma, positive staining of active myofibroblast cells 
was associated with lymph node metastasis, high stage, high grade, vascular 
invasion and a reduced survival times (Zhu et al., 2007.) However, there is 
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conflicting evidence to the role of myofibroblast cells in lung cancer, as 
Matsubara et al (2009) reported that sub-epithelial myofibroblasts identified 
by -SMA expression in lung adenocarcinoma was a histological indicator of 
excellent prognosis in the patients they tested (Matsubara et al., 2009).  These 
varying reports on the role of myofibroblasts in cancer progression need to be 
further elucidated for a greater range of tumour types.  
1.4.3.4 Myofibroblasts in gastric cancer  
The role of the myofibroblast cell in gastric cancer is not very well 
documented; studies in scirrhous gastric cancer patients show that an 
increase in myofibroblast cells is correlated with a worse prognosis (Fuyuhiro 
et al., 2011). Also studies in mouse models of gastric cancer have shown that 
tumour associated myofibroblasts express VEGFA which contributes to the 
promotion of angiogenesis (Guo et al., 2008).  Work carried out in the 
laboratory of Professor A. Varro showed that gastric cancer associated 
myofibroblasts (CAMs) caused increased cancer cell migration and 
proliferation when compared to adjacent tissue myofibroblasts (ATMs) and 
normal tissue myofibroblasts (NTMs) (Holmberg et al., 2012). Also a 
comparative proteomic analysis of myofibroblast secretomes revealed a 
decrease in extracellular matrix adaptor protein like transforming growth 
factor-induced gene-h3 (TGFβig-h3) in the CAM secretome. This decrease was 
correlated with lymph node metastasis, worse prognosis and shorter patient 
survival (Holmberg et al., 2012).  It is therefore vital to further elucidate the 
role of the gastric CAMs in cancer progression and patient prognosis.  
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1.5 Signalling in the Gastric Cancer Environment  
 
Complex methods of cross-talk have been identified between cancer cells and 
cells in the tumour microenvironment, [figure 1.2]. Whilst the process itself is 
well documented, the molecular mechanisms that control these processes are 
not fully understood, and may vary according to the type of malignancy, the 
stage of tumour development and the dynamic composition of the 
surrounding tissue.  
 
 
 
Figure 1. 2. Schematic showing cellular cross-talk in the tumour 
microenvironment.  
The cancer microenvironment contains a dynamic mixture of cancerous cells and 
non-cancerous cells, both in and around the developing tumour including 
myofibroblast cells (CAMs) which act to recruit immune cells (TAMs), stem cells 
(MSCs) and form an environment supporting tumour growth. 
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Research in breast cancer models suggest that metastasis and chemo-
resistance are driven by molecular changes in both tumour cells and the 
surrounding stroma, (Acharyya et al., 2012), with up-regulation of TNF- in 
stromal cells conferring chemo-resistance in the cancer cells (Acharyya et al., 
2012). Cancer associated fibroblasts (CAFs) via TGF-beta signalling have 
shown to confer a more aggressive and metastatic phenotype due to induction 
of epithelial to mesenchmel transition in breast cancer cells (Yu et al., 2014).  
Up regulation of growth factors secreted by stromal cells (Turner et al., 2010), 
deregulation of endothelin-1 (Hinsley et al., 2012) and changes in hedgehog 
ligand and Wnt signalling (Yauch et al., 2008) are all examples of paracrine 
communication which enhance tumourigenesis. The dependency of cancer 
cells on the tumour microenvironment is well established, however, the 
molecular process that facilitates functional reprogramming in cancer or 
stromal cells has yet to be defined. In particular, which processes are transient 
reversible responses to external factors, or the consequences of longer term 
epigenetic programming, remain important unanswered questions.   
 
1.5.1 Transcription Factors  
 
Transcription factors are proteins that bind to specific DNA sequences in the 
promoter regions of target genes, thereby driving gene expression. 
Transcription factors are known to be key factors in cancer initiation and 
progression (Darnell 2002, Thorne et al., 2009 and Libermann 2006). For 
example, up-regulation of STAT-3 has a key role in many cancers including; 
metastasis in prostate cancer (Abdulghani et al., 2008), drug resistance in 
gastric cancer (Huang et al., 2011) and proliferation in ovarian and breast 
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cancers (Burke et al., 2001). Also, up-regulation of the SP family of 
transcription factors has been implicated in tumour development (Kong et al., 
2010 and Chuang et al., 2009), as they are reported to have a role in cell-cycle 
progression and cell differentiation. In addition, acting in conjunction with 
Akt they also play an important role in regulating tumour cell metabolism, 
(Archer 2009).  
 
More recently, the differential regulation of transcription factors in cancer 
stromal cells has also become an area of increased interest. Indeed, there is a 
growing body of evidence to show that regulation of transcription networks in 
stromal cells directly leads to the proliferation and migration of cancer cells 
(Hatiboglu et al., 2011 and Kim et al., 2011). In particular, the role of NRF2 
and NF-κB in hypoxia and the microenvironment is a vital process in the 
development and progression of tumour cells (Satoh et al., 2002).  
 
Dysregulation of transcription factors is thought to be a key factor in the 
instigation and development of gastric tumours, based on studies performed 
in gastric cell lines (Kang et al., 2011, Almedia et al., 2003, and Huang et al., 
2011), however currently there are no reports regarding the effects of 
paracrine communication on transcriptional regulation in the gastric cancer 
microenvironment.  Transcriptional analysis of co-culture, or conditioned 
media microarray studies from tumour – stroma interactions would provide 
deeper insight and understanding behind the molecular mechanisms driving 
cancer progression in the tumour stroma. 
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1.5.2 Epithelial to Mesenchymal Transition  
 
Epithelial to mesenchymal transition (EMT) is the process whereby epithelial 
cells lose their polarity and convert to a migratory mesenchymal phenotype 
(Jiang et al., 2011). EMT is critical for appropriate embryonic development, it 
also occurs during fibrosis, wound healing, tissue regeneration, organ fibrosis, 
cancer progression and metastasis, as well as diseases of chronic 
inflammation such as inflammatory bowel disease (Powell et al., 2011).  
Cancer cells utilise EMT to facilitate invasion of cells into surrounding tissues, 
crossing endothelial barriers and entering circulation; thus enabling 
metastasis to other organs in the body (Jiang et al., 2011). There is much 
evidence supporting the concept of hypoxia-associated factors inducing EMT 
through transcriptional regulation (Kang and Massagué.. 2004). It has been 
established that the most common and important inducers of EMT are 
transcription factors that suppress E-cadherin expression, such as TWIST and 
SNAIL (Kang and Massagué., 2004).  There have also been reports that EMT 
is induced by inflammatory chemokines and cytokines (Shirakihara et al., 
2011). TGF-β has been shown to have both pro and anti-tumour effects. It is 
associated in EMT in late-stage tumours, by enhancing production of growth 
factors that encourage migration and production of matrix molecules (Heldin 
et al., 2012). TGF-β has also been shown to alter normal epithelial cells in the 
tumour microenvironment, promoting EMT and encouraging invasion of 
cancer cells into surrounding tissue (Shirakihara et al., 2011).  The cytokine 
tumour necrosis factor alpha (TNF ) has also been reported to induce EMT 
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in human HCT116 cells, showing to promote invasion and metastasis of 
colorectal cancer cells (Wang et al., 2013).  
1.5.4 Hypoxia  
Hypoxia results when regions of the body are deprived of oxygen. It is well 
established that hypoxia is a critical factor in the regulation of wound healing, 
due to increasing blood supply to the damaged area, restoring homeostasis to 
the site of injury (Trabold et al., 2003). One of the many ways that cells adapt 
to a shortage of oxygen is production of angiogenic factors (Rofstad and 
Danielsen 1999, Shweiki et al., 1992 and Tamura et al., 2009), in order to 
increase local blood supply.  Despite hypoxia being important in wound 
healing (Oberringer et al., 2008), in carcinogenesis, sustained hypoxia can 
have severe implications on both the metabolism and migratory abilities of 
cells.  Indeed, hypoxia plays a critical role in tumour development and 
progression (Tamura et al., 2009, Hong et al., 2005 and Lee 2009).  The 
effects of hypoxia are mediated by a number of signalling molecules, such as 
the family of hypoxia inducible factors (HIFs) and their downstream effectors 
(Papandreou et al., 2006 and Du et al., 2011).  Transcription factor, nuclear 
factor-erythroid 2 (NRF2) is also a key component in the cellular response to 
oxidative stress, and is linked to increased levels of angiogenic factors and 
HIF1- expression (Kim et al., 2011). Blocking NRF2 was shown to supress 
tumour angiogenesis in colon cancer through inhibiting HIF1- (Kim et al., 
2011).   
 
HIF1 is a heterodimeric basic helix-loop-helix structure consisting of the alpha 
subunit (HIF1-) and the aryl hydrocarbon receptor nuclear translocator 
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which is the beta subunit HIF- (Ke and Costa 2006).  In normoxia HIF is 
usually down-regulated by the ubiquitin-proteosome pathway, however in 
hypoxic conditions, degradation of HIF is prevented by prolyl-hydroxylases 
that act to stablise the -subunit of HIF1-, enabling it to translocate to the 
nucleus and form a heterodimer with HIF- (Jiang et al,, 2010). When in the 
nucleus, HIF drives expression of a multitude of genes relating to cell survival 
and hypoxia, enabling the cell to adapt to a lack of oxygen, by switching 
metabolism to glycolysis from mitochondrial respiration (Lu et al., 2002).  In 
solid tumours it is well established that there are many regions of hypoxia due 
to the rapid growth of cancer cells, and poor vasculature. There have been 
various studies that show activation of HIF leads to increased cancer cell 
invasion (Koh et al., 2011, Manalo et al., 2005, Branco-Price et al., 2012, Li et 
al., 2009, Semenza 2011 and Maxwell 2005). HIF expression is strongly 
associated with the regulation of angiogenic factors such as vascular 
endothelial growth factors (VEGF) (Cao et al., 2009, Pugh and Ratcliff 2003 
and Park et al., 2007).  Indeed, loss of HIF-1 expression was linked to 
profound inhibition of blood vessel growth in solid tumours, due to decreased 
VEGF expression (Tang et al., 2004). Up–regulation of hypoxia-associated 
factors has also been linked to enhanced EMT (Misra et al., 2012) and there is 
a strong link between Akt mediated signal transduction (Elstrom et al.,2004) 
active HIF-1, and expression of enzymes involved in glycolysis (Koukourakis 
et al.,2006).  Breast cancer models have shown that hypoxia can induce a 
metabolic phenotype, in which cells up-regulate HIF1-, glucose transporter 1 
(GLUT-1) and carbonic anhydrase IX (CAIX), which confers resistance to the 
resulting decrease in extracellular pH (Chen et al.,2010).  The regulation of 
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metabolic transporter channels has also been linked with hypoxia, as HIF1- 
induces up regulation of the monocarboxylate transporter 4 (MCT4), which 
facilitates  the increased lactic acid produced during hypoxia to be promptly 
removed from the cell (Ullah et al., 2006).  
 
1.5.5 Cytokines  
 
Cytokines are small soluble secreted proteins that act as messengers between 
cells, especially cells of the immune system (Borish and Steinke, 2003). They 
can be released into the circulation to act on cellular receptors to initiate a 
downstream response cascade (Jiang et al,. 2013). The role of cytokines in 
cancer is varied, and depending on the cells of the tumor microenvironment, 
cytokines can initiate either a pro-tumour (Jiang et al,. 2013) or anti-tumour 
response (Banchereau et al., 2012).  Indeed TGF- is well documented to have 
an ambiguous role in cancer progression as it has been shown to display both 
tumour-suppressing and -enhancing effects (Buck et al., 2006 and 
Ranganathan et al.,  2007). 
 
 
In most cases of chronic inflammation, cytokines act to induce cellular 
transformation and initiate malignancy (Landskrone et al., 2014). For 
example in cases such as multiple myeloma and other B cell malignancies, 
cytokine CCL5 produced by stromal cells, leads to the up-regulation of 
immunoglobulin secretion by B cells and increased expression of IL-6 via 
activation of GLI2 (Elsawa et al., 2011). Factors such as IL-6 are reported to 
be implicated in migration and the invasive properties of tumour cells. 
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(Ashizawa et al., 2005). The immune system is known to play a key role in 
detecting and destroying cancer cells in the body. Indeed, immunotherapy is 
showing great promise for treatment of several forms of cancer (Mellman et 
al., 2011, Palucka and Banchereau, 2012 and Lesterhuis et al., 2011). 
However, the adaptability of cancer cells means that in some cases tumours 
evolve to overcome detection by the immune system. Tumour cells can down-
regulate expression of self-antigens and can produce specific cytokines and 
chemokines which act to desensitise immune cells causing immune cell anergy 
(Ben-Baruch et al., 2006 and Stewart and Smyth, 2011).  
 
1.6 .Metabolism and Cancer 
 
The word ‘metabolism’ is derived from the Greek word “Metabolismos” and 
means “to change”. In the early 20th century, Otto Warburg pioneered studies 
in respiration and metabolism, particularly in relation to cancer cell 
metabolism (Warburg et al., 1924 and Warburg 1956).  Hans Kreb worked as 
research assistant to Warburg, and later in his career pioneered work, in the 
field of metabolism, which lead to the discovery of the fundamentals in 
cellular metabolic processes; the urea cycle and the citric acid cycle (Krebs, 
1937, Krebs et al., 1938 and Krebs 1938). These key discoveries form the basis 
and understanding of most cellular metabolic processes today.  
 
1.6.1 The Warburg Effect 
 
As discussed above, Otto Warburg pioneered studies of cancer cell in the 
1920s that, demonstrating that even under aerobic conditions, tumour tissues 
metabolise glucose to lactate at a considerably increased rate compared to 
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normal tissues, a phenomenon termed the Warburg effect (Warburg et al., 
1927). Since this discovery there have been numerous studies acknowledging 
the switch of cancer cells to a more glycolytic phenotype (Schulze et al., 2011, 
Salminen et al., 2010 and Cai et al., 2010). However, what causes alterations 
in these metabolic processes in cancers is still relatively unknown. Indeed, 
changes in cancer cell metabolism have been linked to changes in the 
expression of oncogenes (Muñoz-Pinedo et al., 2012), disruption of circadian 
rhythm (Sahar et al., 2009) and also loss of tumour suppressor function 
(Lyssiotis et al., 2012). 
 
 
Figure 1. 3. Schematic to illustrate the Warburg type effect. 
Cancer cells switch from oxidative phosphorylation to glycolysis, a less energy 
efficient way of respiration. 
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The question of why cancer cells would switch to glycolysis, a less efficient way 
of energy production, is something which has puzzled many scientists. 
Warburg postulated that the switch to glycolysis was due to defective 
mitochondrial function in these cells (Warburg et al., 1927). More recently 
these metabolic changes have been further elucidated and in some cancer 
models it is reported that cells still maintain mitochondrial function but 
preferentially utilise glycolysis for ATP production (Futin et al., 2006 and 
Koppenol et al., 2011) however the reasons for this still remain unclear.  
 
1.6.2 The Reverse Warburg Effect  
More recently, there have been studies identifying the importance of 
metabolic changes in stromal cells, which then support the growth of cancer 
cells (Pavlides et al 2009, Bonuccelli  et al., 2010 and Sotgia et al., 2012). The 
reverse Warburg model suggests that tumour cells actively utilise their 
mitochondria and receive high-energy metabolites from surrounding stromal 
cells, which in turn have switched to glycolysis [figure 1.4]. Understanding the 
mechanisms behind changes in metabolism in both the tumour and its 
microenvironment is vital for progression and development of improved 
therapeutic strategies and identification of biomarkers for new approaches to 
precision medicine.  
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Figure 1. 4. Schematic to illustrate a reverse Warburg type effect. 
Cancer cells utilise high energy metabolites for oxidative phosphorylation 
which have been received from stromal cells, using glycolysis for respiration. 
 
 
 
There is increasing evidence for the important role of the tumour 
microenvironment in the regulation of energy metabolism in carcinogenesis, 
indeed these changes are now considered a hallmark of cancer (Hannahan 
and Weinburg., 2011). However, as there is much conflict in the literature 
regarding the fundamentals of this relationship, this thesis attempts to 
address these issues in the context of gastric cancer model and primary gastric 
stromal cells.  
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1.8 Hypotheses, Aims and Objectives 
 
The primary purpose of this work was to characterise functional changes 
induced by communication between gastric myofibroblasts and AGS gastric 
cancer cells.   
 
To address this issue we aimed: 
 
1. To test the hypothesis that there would be differences in AGS cell gene 
expression profiles after conditioning with CAM or ATM media 
compared to control media.  
 
2. To establish the inherent and reciprocally induced metabolic profiles of 
gastric cancer epithelial cells and primary gastric cancer associated 
myofibroblasts 
 
3. To determine the effects of cancer co-culture on re-programming of 
normal tissue myofibroblast cells (NTMs) 
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Gene Expression Profiling Of 
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2.0 Introduction 
 
 
Historically, a selection of primary myofibroblast cell lines were isolated from 
a cohort of 12 patients with gastric cancer or 8 tissue donors with no history 
of gastric cancer (Varro laboratory).  These cell lines included Cancer 
Associated Myofibroblasts (CAMs), isolated from tissue immediately 
juxtaposed to gastric tumours and matched tissue Adjacent Tissue 
Myofibroblasts (ATMs), myofibroblasts isolated from tissue neighbouring the 
site of gastric tumours [figure 2.1].  In contrast, primary myofibroblasts 
isolated from patients with no history of cancer are defined as Normal Tissue 
Myofibroblasts (NTMs).  
 
Figure 2. 1 Cells of the stroma. 
Schematic showing distinction between matched cancer associated (CAM) and 
adjacent tissue (ATM) myofibroblasts and epithelial cancer cells. 
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Previous analysis of gene expression profiles of all patient primary gastric 
myofibroblast cell-lines showed that each form of myofibroblast (CAM, ATM 
and NTM) has distinct and characteristic global gene expression profiles 
(Jones et al., unpublished data). In addition, statistical correlation analysis 
enabled CAMs derived from early and late stage tumours to be correctly 
clustered into prognostic groups based on trends in gene expression profiles.   
 
In this study we aimed to further investigate the functional differences 
between these cell populations by performing comparative analysis of 
differential gene expression profiles that result from exposure to 
differentially conditioned media.  Microarray analysis allows for a data driven 
approach to identify potential biomarkers or pathways for follow up analysis.  
In these studies, AGS cells were exposed to conditioned media, derived from 
five sets of primary CAM and ATM cells, for 24h before processing samples 
for global gene expression analysis (work carried out by the Varro 
Laboratory).  The work carried out in this chapter aimed to determine any 
trends or potential targets of interest in AGS cells that were induced upon 
conditioning with primary myofibroblast cell media. It was hypothesised that 
there would be differential gene expression profiles between AGS cells 
conditioned with media from myofibroblast cells, compared to AGS cells 
grown in non-conditioned media.  
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2.1 Aims and Hypotheses  
 
This chapter describes the analysis and interpretation of data from a series of 
conditioning microarray experiments, which were originally performed in the 
laboratory of Professor Andrea Varro, the collaborating laboratory in this 
study.  The primary purpose of this chapter was to establish trends in gene 
expression profiles between AGS cells conditioned with primary gastric 
myofibroblast cell media. We wanted to test the hypotheses that trends in 
AGS gene expression profiles would vary between CAMs and ATM 
conditioning versus controls. 
The aims this chapter were: 
 
1. To confirm that the cells used in these studies retain previously 
defined markers and functional characteristics of CAM, ATM 
and NTM cells  
2. To establish the quality of available microarray data and to 
assess cell-type specific trends in global gene expression 
profiles  
3. To validate primary microarray data by targeted qPCR analysis  
4. To confirm that gene expression profiles observed in primary 
microarray data are retained in primary myofibroblasts used in 
subsequent functional studies.   
5. To generate potential targets of interest from bioinformatics 
analysis, which may contribute to, observed functional 
properties of different myofibroblast populations.  
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2.2 Chapter Specific Materials and Methods  
 
Full details of materials and methods can be found in chapter VI.  
 
2.2.1 Microarray Sample Selection and Data Processing 
 
All microarray studies were performed on low passage (P4-P10) 
myofibroblast cell-lines [table 1]. In all conditioning experiments, the effects 
of AGS conditioned media were compared to corresponding molecular 
signatures and functional phenotypes observed in non-conditioned serum-
free media. Details of patient data are shown in table 1.  
 
Label Sample Sample Type 
 
Array Sample Name 
190 CAM Sz190/1 P4 Cancer AV 55. CEL 
190 ATM Sz190/2 P4 Adjacent  AV 56. CEL 
192 CAM Sz192/1 P5 Cancer AV 82. CEL 
192 ATM Sz192/2 P5 Adjacent  AV 83. CEL 
294 CAM Sz294/1 P4 Cancer AV 59. CEL 
294 ATM Sz294/2 P5 Adjacent 1 AV 60. CEL 
305 CAM Sz305/1 P5 Cancer AV 84. CEL 
305 ATM Sz305/22 P5 Adjacent 1 AV 86. CEL 
308 CAM Sz308/1 P5 Cancer AV 87. CEL 
308 ATM  Sz308/22 P6 Adjacent AV 88. CEL 
CONTROL N/A N/A AV 58. CEL 
CONTROL N/A N/A AV 57. CEL 
CONTROL N/A N/A AV 94. CEL 
 
Table 1. Primary myofibroblast cell-lines used in AGS conditioning 
microarray studies.  
 
Microarrays were carried out by the Varro laboratory and data was processed 
in Partek by Dr Jithesh Puthen (University of Liverpool). For grouped patient 
analysis an FDR cut of value of 0.25 was applied and ANOVA analysis was 
carried out, before gene lists were exported to excel for further analysis. 
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2.2.2 qPCR for Real Time Evaluation of Microarray Data 
 
Primary CAM myofibroblast cell-lines 190, 294 and 305 were selected for 
qPCR validation of induced gene expression profiles, as these represent 
different survival/prognosis patient subgroups, identified by previous 
informatics analysis of unconditioned CAM gene expression profiles (Jones et 
al., unpublished data).  Gene specific qPCR primers were designed for 
differentially regulated gene changes within each microarray data set.  
 
2.2.3 Proliferation and Migration Assays 
 
Proliferation and migration profiles of cell lines used in this study have been 
previously defined (Holmberg et al., 2012).  To confirm the validity of data 
presented in our current study, comparative proliferation and migration 
assays were performed on a selection of low-passage (P4-P9) CAM cells 190, 
308 294 and 305 which had also been used previously in microarray studies. 
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2.3 Results 
2.3.1 Characterisation of primary myofibroblast cell lines 
 
To confirm the cells were myofibroblast cell lines, cell phenotype, 
morphology, quantity and abundance were determined by the Varro 
Laboratory (Holmberg et al., 2012) [figure 2.2]. To confirm isolated primary 
CAMs, ATMs and NTMs retained their characteristic morphology and 
function, each cell line was stained to confirm the presence of a spindle or 
stellate morphology and expression of the two canonical myofibroblast 
markers, vimentin and α-SMA (Holmberg et al. 2012) [Figure 2.3]. Collated 
data from these experiments confirms that when RNA was prepared from 
primary gastric myofibroblasts for microarray analysis, cell lines maintained 
all of the hallmarks that have been used to define this cell type in other 
tissues. 
 
Figure 2. 2 Characterisation of myofibroblast cell types. 
 Representative images of tissues from which NTMs (A), CAMs (B) or ATMs (C) 
were isolated. Brown stain shows localization and relative abundance of 
myofibroblasts in each tissue. (D) Quantification of myofibroblast morphology, 
architecture and number in cancer, adjacent and normal tissues. Figure taken from 
Holmberg et al., Carcinogenesis 33:1553 (2012). 
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2.3.2 Microarray Processing  and Quality Analysis 
 
The primary purpose of the microarray analysis was to allow for a data 
driven, exploratory approach, to identify potential candidates of interest for 
follow up analysis.  In order to progress with the microarray data 
experiments, a series of quality control and normalisation steps were carried 
out. Firstly, the RNA extracted from AGS conditioned cells, passed quality 
(RQI) and purity thresholds and could therefore be used in subsequent 
microarray experiments (Varro Laboratory).  
  
Affymetrix array chips allowed for normalisation locally, as each gene is 
Figure 2. 3. Characterisation of myofibroblast cell types. 
 Immunofloruescnce to show strong coexpression of the myofibroblast markers 
vimentin and α -SMA in isolated primary human CAMs, ATMs and NTMs. Figure 
taken from Holmberg et al., Carcinogenesis 33:1553 (2012). 
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matched to 11 pairs of probes, which are evenly distributed throughout the 
chip to detect any noise within the genechip (as well as gene expression). 
Each chip also contains probes which measure non-specific binding of cRNA 
which also eliminates non-specific signals and enables the data to be 
normalised effectively. To ensure quality control between the 12 arrays, there 
is also a selection of normalisation probes on the gene chip, which have 
constant levels of expression, these are used to normalise signals across the 
multiple arrays.   
 
An array quality metrics report (AQMR) can also be generated to look more 
closely at batch effects and to identify any potential outliers or skewing in the 
data sets. These reports were carried out on our microarray datasets by Dr 
Helen Jones (University of Manchester).  Full details of AQMR generated for 
these microarrays can be found in the appendix [supplementary file IIII).  
Briefly, histograms showing density distribution of the microarrays were 
found to be highly comparable, showing consistent and comparable intensity 
ranges [Figure 2.4]. 
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Figure 2. 4 Density estimates (smoothed histograms) of AGS 
conditioned microarray data. 
Each array is indicated by a single blue line showing the density distributions 
between data from individual microarrays were found to be highly comparable. 
 
 
Distance between arrays were plotted using a false colour heatmap [figure 
2.5] to assess clustering of biologically related samples or experimental 
trends, which may indicate unwanted batch effects. Outlier detection was 
performed by looking for arrays for which the sum of the distances to all 
other arrays, Sa = Σb dab was exceptionally large. Three such arrays were 
detected as outliers in this analysis, marked by an asterisk in figure 2.5.  
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Figure 2. 5. False colour heat-map of arrays.  
The plot shows variation between data from individual arrays by clustering of 
related trends. Outliers in this analysis are indicated by the asterisk (*).  
 
 
As these three arrays were performed on the same day it is highly probable 
that this variation could be due to an experimental batch effect.  To establish 
if the three identified outliers were due to batch effect, a principle component 
analysis was also carried out both before (work carried out by Dr Helen 
Jones) [figure 2.10] and then after batch correction, using Partek©. software 
(work carried out by Dr Jithesh Puthen) to generate a 3D model of the global 
gene expression data [figure 2.11]. Significantly, data from this analysis 
shows that batch correction does effectively remove deleterious effects of 
batch processing. Therefore, batch corrected microarray data was considered 
to be suitable for use in all subsequent gene expression and bioinformatics 
studies. 
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Figure 2. 6 Principle component analysis of microarray data. 
The array quality metrics report plotted the PCA showing the global gene expression 
of the arrays  both before batch correction.  
 
 
.  
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Figure 2. 7 Principle component analysis of global gene expression 
profiles of AGS conditioning microarray data using PARTEK©. 
After RMA normalisation and batch correction data was plotted and global gene 
expression analysed by principle component analysis. 
 
 
As stated previously, RNA quality was determined before the microarray was 
carried out, however RNA quality can also be evaluated on the raw data set 
after the microarray was carried out using the AQMR.  Any arrays with a 
slope highly different from others arrays may indicate significant variation in 
RNA quality. Results shown in Figure 2.8 indicate that there was no 
significant difference between the mean intensities of the data; therefore we 
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can be confident that RNA the quality of RNA is consistent across all samples 
used in these studies.   
 
 
 
Figure 2. 5. Relative levels of RNA degradation across all microarray 
samples.  
All values were calculated from the pre-processed data after background correction 
and quantile normalisation. Each array is represented by a single line.  
 
 
2.3.3 Microarray Validation by qPCR 
 
Following quality analysis of microarray data, a series of targeted qPCR 
studies were performed to validate observed variations in gene expression 
profiles; and to demonstrate that cell stocks used in subsequent functional 
studies maintain the ability to induce comparable changes in patterns of AGS 
gene expression as observed in the original conditioned media microarray 
studies.  Therefore, targeted real time qPCR analysis was carried out on 
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cDNA derived from AGS cells treated with CAM conditioned media for 24h.  
In each case expression profiles were compared to AGS cells treated with 
unconditioned serum free media (consistent with conditions used in original 
microarray studies). Significantly, qPCR data from this analysis directly 
reflects differential trends in gene expression identified in primary 
microarray analysis across all cell lines tested [figure 2.9].  
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Figure 2. 6. qPCR validation of microarray gene targets from AGS treated with media from 294, 305 and 190 CAM.  
qPCR was carried in triplicate, all genes were normalised to beta-actin (housekeeping gene) and the serum free  control. 
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2.3.4 Microarray Data Analysis 
 
The purpose of the microarray data analysis was to generate potential 
interesting signatures, pathways or genes of interest to investigate further.  
Affymetrix arrays were normalised by Dr Jithesh Puthen  using Robust Multi-
array Average (RMA) and processed for batch correction (as previously 
described) using Partek statistical and visual data analysis software. Gene lists 
were generated for AGS treated with conditioned media for both CAM (n=5) 
and ATM (n=5) cell lines compared to controls [table 1] and also as individual 
patient data sets.  As the purpose of this analysis was hypothesis generating, 
fold change cut offs of 1.6 were used to filter the data to allow for maximum 
number of significant genes to be used in bioinformatics analysis.  Gene lists 
were analysed using Ingenuity software platform to identify statistical 
signatures and trends [figure 2.10]. Grouped analysis confers statistical 
significance within CAM and ATM conditioned subsets, whilst single patient 
analysis identifies patient specific trends within the data sets. Results were 
analysed using both approaches, to generate a thorough overview of the data 
set, to establish any differences between patient subgroups and to generate as 
much information as possible to from the microarray data sets. 
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Figure 2. 10.  Schematic showing sequential stages of microarray data 
analysis.  
Gene lists were ranked and analysed, then up-loaded into Ingenuity software 
platform to identify statistical signatures and trends in pathways, networks and 
transcription factors for both grouped and single patient data 
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2.3.4.1 Raw Data Analysis- Grouped Patient Data 
 
In order to investigate the hypothesis further, to determine if there were any 
differences in AGS gene expression following conditioning with primary 
myofibroblast cell media, raw gene-expression data analysis of microarray 
data was carried out. This analysis ranked genes according to fold change and 
p-value significance from the gene lists generated after initial processing 
(work carried out in Partek, by Dr Jithesh Puthen).  As previously stated, the 
work in this chapter was hypothesis generating, and used to investigate any 
potential trends within the data, therefore a p-value cut off of less than 0.5 
was applied to filter the data, and a fold change cut off of 1.6 was used as an 
arbitrary cut off for on all data sets.  Three gene lists were generated for 
further analysis: (1) AGS conditioned with CAM media vs control media; (2) 
AGS conditioned with ATM media vs control and (3) AGS conditioned with 
CAM media vs ATM media. Both CAM vs control and ATM vs control datasets 
had 200 genes, which significantly changed within the dataset after applying 
stringent cut offs (p<0.05, fc>1,6,<-1.6) compared to only 73 in the CAM vs 
ATM comparison. This result suggests that CAMs and ATMs have the ability 
to induced similar changes in AGS gene expression profiles.  
 
Table 2 shows the top ranking genes that are over expressed in CAM vs 
control dataset. Results show AGS treated with CAM conditioned media 
resulted in an up-regulation of cytoplasmic enzymes COQ3 and CYP1A1, 
kinase HK1 and enzyme CEACAM5 [table 2.]. Many of these differentially 
regulated genes have previously been reported to be associated with 
carcinogenesis; CEACAM5 expression has been correlated with worsened 
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prognosis of colon cancer, (Govindan et al., 2009 and Zheng et al., 2011) and 
also invasion and metastasis of cancer cells into surrounding tissue 
(Blumenthal et al., 2005).  IGFBP5 has also been associated with breast 
cancer progression and metastasis (Akkiprik et al., 2009. Interestingly, the 
most prominent down-regulated gene signatures were mostly from interferon 
or interferon-related pathways, including IFNL2, OAS2, IFIT3 and IFI44L 
[table 3].  
Chapter II; Results Chapter One 
 
 
 63 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symbol Entrez Gene Name p-value Fold Change Location Type(s) 
IGFBP5 insulin-like growth factor binding protein 5 2.11E-08 4.803 Extracellular Space other 
CEACAM5 carcinoembryonic antigen-related cell adhesion molecule 5 3.37E-04 2.758 Plasma Membrane other 
PGBD1 piggyBac transposable element derived 1 7.62E-04 2.612 Extracellular Space enzyme 
PRSS1 protease, serine, 1 (trypsin 1) 8.76E-04 2.435 Other peptidase 
CFI complement factor I 4.70E-05 2.33 Extracellular Space peptidase 
COQ3 coenzyme Q3 methyltransferase 1.52E-02 2.32 Cytoplasm enzyme 
CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1 3.52E-06 2.205 Cytoplasm enzyme 
AGK acylglycerol kinase 1.40E-03 2.187 Cytoplasm kinase 
MDP1 magnesium-dependent phosphatase 1 3.07E-03 2.124 Other phosphatase 
HK1 hexokinase 1 2.07E-05 2.114 Cytoplasm kinase 
Table 2. Top ranking differentially up-regulated significant genes in CAM vs Control AGS conditioning data set. Data was 
ranked by fold change. 
 
 Symbol Entrez Gene Name p-value Fold Change Location Type(s) 
IFNL2 interferon, lambda 2 1.14E-02 -2.451 Extracellular Space other 
OAS2 2'-5'-oligoadenylate synthetase 2, 69/71kDa 1.60E-07 -2.464 Cytoplasm enzyme 
USP18 ubiquitin specific peptidase 18 1.38E-04 -2.465 Cytoplasm peptidase 
IFIT3 interferon-induced protein with tetratricopeptide 
repeats 3 
1.59E-10 -2.506 Cytoplasm other 
IFI44L interferon-induced protein 44-like 5.84E-05 -2.587 Other other 
PMCH pro-melanin-concentrating hormone 8.15E-04 -3.01 Extracellular Space other 
RSAD2 radical S-adenosyl methionine domain containing 2 2.01E-07 -3.128 Cytoplasm enzyme 
ZNF114 zinc finger protein 114 3.43E-02 -3.267 Cytoplasm other 
MX2 myxovirus (influenza virus) resistance 2 (mouse) 2.28E-07 -3.488 Nucleus enzyme 
Table 3. Top ranking differentially down-regulated significant genes in CAM vs Control AGS conditioning data set.  Data 
was ranked by fold change. 
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Similar gene changes were observed in ATM vs Control data set, showing 
signatures of up-regulated genes such as CEACAM5 and IGFBP5, and with 
down-regulation of interferons and interferon associated proteins [table 4]. 
This trend differed in the CAM vs ATM dataset, where a different array of 
differentially regulated genes were present [table 5], interestingly showing up 
regulation of TGF-B which is strongly associated with poor prognosis 
(Bhowmick et al., 2004). DAAM2 was also up regulated, and is involved with 
the wnt signalling pathway in cancer, which may confer a more aggressive 
phenotype.  Further analysis of these data sets by transcriptional profiling 
may identify up and down–stream effectors and potential ‘hubs’, which 
control pathway signalling. Therefore, pathway and network mapping of 
differentially regulated gene signatures will provide more insight into relevant 
signalling and metabolic pathways, molecular networks, and biological 
functions, as well as predicting the direction of downstream effects on 
biological processes within the cell. 
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Symbol Entrez Gene Name p-value Fold Change Location Type(s) 
IGFBP5 insulin-like growth factor binding protein 5 1.29 E-08 5.213 Extracellular Space other 
CEACAM5 carcinoembryonic antigen-related cell adhesion molecule 
5 
2.59E-04 2.858 Plasma Membrane other 
PRSS1 protease, serine, 1 (trypsin 1) 6.27E-04 2.540 Other peptidase 
HEG1 Heart development protein  7.25E-03 2.373 Plasma other 
COQ3 coenzyme Q3 methyltransferase 2.65E-02 2.113 Cytoplasm enzyme 
RSAD2 radical S-adenosyl methionine domain containing 2 4.67E-08 -3.778 Cytoplasm enzyme 
OAS2 2'-5'-oligoadenylate synthetase 2, 69/71kDa 3.94E-09 -3.764 Cytoplasm enzyme 
MX2 myxovirus (influenza virus) resistance 2 (mouse) 2.28E-07 -3.488 Nucleus enzyme 
IFIT3 interferon-induced protein with tetratricopeptide repeats 
3 
1.59E-10 -2.506 Cytoplasm other 
PMCH pro-melanin-concentrating hormone 8.15E-04 -3.01 Extracellular Space other 
Table 4. Top ranking differentially up and down-regulated significant genes in ATM vs control AGS conditioning data set. 
Data was ranked by fold change.  
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Table 5. Top ranking differentially up and down-regulated significant genes in CAM vs ATM AGS conditioning data set. 
Data was ranked by fold change. 
 
Symbol Entrez Gene Name p-value Fold Change Location Type(s) 
PPP1R14A protein phosphatase 1, regulatory (inhibitor) subunit 14A 0.024 5.57 Cytoplasm phosphatase 
TGFB2 transforming growth factor, beta 2 0.025 5.33 Extracellular Space growth factor 
RGS5 regulator of G-protein signaling 5 0.042 4.94 Plasma Membrane other 
NDNF neuron-derived neurotrophic factor 0.013 4.38 Extracellular Space other 
DAAM2 dishevelled associated activator of morphogenesis 2 0.014 4.13 Other other 
PRSS3 protease, serine, 3 0.033 -3.93 Extracellular Space peptidase 
HPSE heparanase 0.041 -3.96 Plasma Membrane enzyme 
SDK1 sidekick cell adhesion molecule 1 0.047 -4.06 Plasma Membrane other 
STEAP1B STEAP family member 1B 0.041 -4.39 Other other 
DMKN dermokine 0.001 -5.28 Extracellular Space other 
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2.3.4.2 Pathway analysis 
Pathways analysis was performed using the Ingenuity software platform 
following application of a 1.6 fold change cut off and a p-value cut off of <0.5 
to the batch corrected RMA normalized microarray data set for CAM vs serum 
free control, ATM vs control and CAM vs ATM.  This analysis generated 
pathway reports containing information on differentially regulated canonical 
pathways, ranked by assignation of p-value within the data, as well as ratio of 
molecules within the data set to those in the pathway. Ingenuity uses Fisher's 
exact test right-tailed to calculate the significance (-log of p-value). The ratio 
is calculated as follows: 
Number of genes in a given pathway that meet your cutoff criteria 
Total number of genes that make up that pathway and that are in the 
reference gene set. 
 
Analysis showed a significant and marked increase in pathways associated 
with interferon signalling [figure 2.11], with the number of positive hits on this 
pathway being significantly down regulated.  These results also concur with 
the raw gene expression analysis.  Analysis also showed a significant and 
marked increase in load on pathways associated with immunoregulation 
within the cells, again correlating with a number of decreased gene signatures 
associated with these pathways in the raw dataset [table 6]. Pathways 
associated with antigen presenting, and also macrophages, fibroblasts and 
endothelial cells were also significant [table 6] implicating the immune 
response and t-cells as key processes affected by CAM conditioning. 
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Figure 2. 11. Table showing ranked canonical pathways from Ingenuity pathway analysis on CAM vs Control AGS treated 
microarray data set (p<0.05, fc >-1.6, >1.6).  
Data plotted shows the top ten ranked pathways in order of significance. 
  
Chapter II; Results Chapter One 
 
 
 69 
 
Ingenuity Canonical Pathways 
 -log(p-
value) Ratio Molecules 
      Role of Pattern Recognition Receptors in Recognition of Bacteria 
and Viruses 5.93E00 8.4E-02 IFIH1,CXCL8,OAS1,IRF7,OAS2,PIK3C2A,IL10,DDX58,IFNB1,OAS3 
Interferon Signaling 5.5E00 1.67E-01 IFIT3,IFIT1,OAS1,MX1,IFNB1,TAP1 
   Activation of IRF by Cytosolic Pattern Recognition Receptors 5.26E00 1.17E-01 IFIH1,IRF7,IL10,DDX58,IFNB1,IFIT2,ISG15 
   IL-17A Signaling in Gastric Cells 5.07E00 2.0E-01 CXCL10,CXCL8,FOS,CXCL11,EGFR 
   Hepatic Fibrosis / Hepatic Stellate Cell Activation 4.03E00 5.1E-02 CXCL8,COL4A1,IL10,LEPR,COL8A1,MMP13,TNFSF10,IGFBP5,COL28A1,EGFR 
Role of Hypercytokinemia/hyperchemokinemia in the 
Pathogenesis of Influenza 3.99E00 1.22E-01 CXCL10,CXCL8,IL15,IFNB1,IFNL1 
   Role of Cytokines in Mediating Communication between Immune 
Cells 3.49E00 9.62E-02 CXCL8,IL10,IL15,IFNB1,IFNL1 
    Role of Macrophages, Fibroblasts and Endothelial Cells in 
Rheumatoid Arthritis 3.3E00 3.83E-02 CXCL8,SOCS3,FOS,PIK3C2A,IL10,PRSS2,IL15,MMP13,CREB5,PRSS3,PRSS1 
Antigen Presentation Pathway 3.08E00 1.08E-01 PSMB9,NLRC5,TAP1,TAP2 
    ILK Signaling 2.92E00 4.42E-02 DOCK1,FOS,PIK3C2A,RHOB,MUC1,ITGB8,ITGB6,CREB5 
 
Table 6. Ranked canonical pathways from Ingenuity pathway analysis of CAM vs Control AGS treated microarray data (p<0.05, fc >-
1.6, >1.6). 
Plots shows ranked pathways, significance, ratio and differentially regulated molecules in the data set. 
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Analysis of ATM vs control conditioning data also showed a significant 
increase in pathways associated with the cytokine response, including 
pathways associated with IL-17A as well as a general cytokine signalling 
pathway being differentially regulated. Results also showed the interferon 
signalling pathway as being the most statistically significant changed pathway  
[figure 2.12]. Analysis again also showed a significant and marked increase in 
load on pathways associated with immunoregulation within the cells, 
implicating a critical role of the immune response in this system [table 7].  
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Figure 2. 12. Data to show ranked canonical pathways from Ingenuity network analysis on ATM vs Control AGS treated 
microarray data set (p<0.05, fc >-1.6, >1.6).  
Data plotted shows the top ten ranked pathways in order of significance. 
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Ingenuity Canonical Pathways -log(p-value) Ratio Molecule 
Interferon Signaling 7.62E00 1.94E-01 IFIT3,IFIT1,OAS1,MX1,IFNB1,IFI35,TAP1 
Activation of IRF by Cytosolic Pattern Recognition Receptors 6.03E00 1.17E-01 IFIH1,IRF7,IL10,DDX58,IFNB1,IFIT2,ISG15 
Role of Pattern Recognition Receptors in Recognition of 
Bacteria and Viruses 
5.97E00 7.56E-02 IFIH1,CXCL8,OAS1,IRF7,OAS2,IL10,DDX58,IFNB1,OAS3 
IL-17A Signaling in Gastric Cells 4.2E00 1.6E-01 CXCL10,CXCL8,CXCL11,EGFR 
Role of RIG1-like Receptors in Antiviral Innate Immunity 4.2E00 9.76E-02 IFIH1,IRF7,DDX58,IFNB1 
Role of Hypercytokinemia/hyperchemokinemia in the  
Pathogenesis of Influenza 3.34E00 9.76E-02 CXCL10,CXCL8,IFNB1,IFNL1 
Role of Cytokines in Mediating Communication between 
Immune Cells 3.34E00 7.69E-02 CXCL8,IL10,IFNB1,IFNL1 
Hepatic Fibrosis / Hepatic Stellate Cell Activation 2.95E00 3.57E-02 CXCL8,COL4A1,IL10,MMP13,TNFSF10,IGFBP5,EGFR 
Retinoic acid Mediated Apoptosis Signaling 2.75E00 6.78E-02 IFNB1,TNFSF10,PARP9,PARP14 
Pathogenesis of Multiple Sclerosis 2.74E00 2.22E-01 CXCL10,CXCL11 
 
Table 7. Ranked canonical pathways from Ingenuity pathway analysis of ATM vs Control AGS treated microarray data 
(p<0.05, fc >-1.6, >1.6).  
Plot shows ranked pathways, significance, ratio and differentially regulated molecules. 
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Analysis of CAM vs ATM conditioning data showed a distinct difference in 
gene signatures compared to the other analyses [figure 2.13], with no 
inflammatory pathways being reported. Differentially regulated pathways 
identified included MAPK signalling, PPAR- α and epithelial adherens 
junction signalling [table 8].  
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Figure 2. 13. Graph to show ranked canonical pathways from Ingenuity network analysis on CAM vs ATM AGS treated 
microarray data set (p<0.05, fc >-1.6, >1.6).  
Data plotted shows the top ten ranked pathways in order of significance.  
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Ingenuity Canonical Pathways  -log(p-value) Ratio Molecules 
Hepatic Fibrosis / Hepatic Stellate Cell 
Activation 4.41E00 3.57E-02 COL8A2,COL5A2,CYP2E1,HGF,TGFB2,TNFRSF1B,PDGFC 
Prostanoid Biosynthesis 3.11E00 2.22E- PTGES,PTGDS 
    
PPARα/RXRα Activation 2.11E00 
01 
2.42E-02 GHR,TGFB2,BMPR2,ABCA1 
Role of JAK2 in Hormone-like Cytokine 
Signaling 
 2E00 6.25E-02 GHR,SH2B3 
    Pancreatic Adenocarcinoma Signaling 
 1.86E00 2.83E-02 CYP2E1,TGFB2,PDGFC 
   Synaptic Long Term Potentiation 
 1.76E00 2.59E- ITPR3,PPP1R14A,GRIA3 
   
p38 MAPK Signaling 1.75E00 2.56E-02 DUSP1,TGFB2,TNFRSF1B 
Human Embryonic Stem Cell Pluripotency 1.62E00 2.29E-02 TGFB2,BMPR2,PDGFC 
   Pregnenolone Biosynthesis 1.55E00 1.67E-01 CYP2E1 
 Epithelial Adherens Junction Signaling 1.52E00 2.1E-02 HGF,TGFB2,BMPR2 
     
Table 8. Data to show ranked canonical pathways from Ingenuity network analysis on CAM vs ATM AGS treated microarray 
data set (p<0.05, fc >-1.6, >1.6).  
Data plotted shows the top ten ranked pathways in order of significance.
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2.3.4.3  Network Analysis  
 
In order to generate a thorough analysis of the data and generate as many 
potential interesting targets as possible, network mapping was performed on 
the data sets. Ingenuity Software suite was used to analyse batch corrected 
RMA normalized microarray data which passed both p-value and fold change 
cut-off criteria (<0.5 and 1.6 respectively) for the CAM vs serum free control 
data set. Ingenuity network reports were generated providing analysis of 
differentially regulated networks within the dataset that are mapped to 
specific diseases and functions, ranked according to significance. Networks 
identified by this analysis may explain gene expression changes, as novel 
upstream regulators control small hierarchical networks, which do not require 
all the molecules to have direct connection to the dataset. Scoring criteria 
provide a means to prioritise the most interesting and relevant trends 
associated with the phenotype of interest.  In this instance, for both CAM and 
ATM treated AGS gene expression profiles [table 9 and table 10], the 
inflammatory response was ranked as the most significant network. This 
result concurs with the raw data analysis, which showed down-regulation of 
genes corresponding to cytokines and proteins in the interferon pathway. 
Canonical pathway mapping also using Ingenuity showed significant pathway 
load of down-regulated genes on inflammation and infectious disease 
response.                             
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Rank Top Diseases and Functions         
  
1 Infectious Disease, Antimicrobial Response, Inflammatory Response     
  
2 Antimicrobial Response, Inflammatory Response, Dermatological Diseases and Conditions 
  
3 Infectious Disease, Cell Signalling, Cancer 
   
  
4 Cell-To-Cell Signalling and Interaction, Cell-mediated Immune Response, Cellular Movement 
  
5 Cell Death and Survival, Cancer, Cellular Development 
   
  
6 Lipid Metabolism, Small Molecule Biochemistry, Nervous System Development and Function 
  
7 Dermatological Diseases and Conditions, Cancer, Endocrine System Disorders 
 
  
8 Endocrine System Disorders, Gastrointestinal Disease, Inflammatory Disease 
 
  
9 
Cellular Development, Cellular Growth and Proliferation, Cardiovascular System Development and 
Function 
10 Cell Death and Survival, Cancer, Gastrointestinal Disease 
  
  
11 Drug Metabolism, Molecular Transport, Lipid Metabolism 
  
  
12 Infectious Disease, Cell Morphology, Cellular Assembly and Organisation 
 
  
       13     Cell-To-Cell Signalling and Interaction, Cellular Assembly and Organization, Tissue Development 
  
Table 9. Table to show ranked networks from Ingenuity network analysis on CAM vs Control 
AGS treated microarray data set (p<0.05, fc >-1.6, >1.6). Ingenuity network reports of all the 
differentially regulated networks within the dataset were generated.  These were then ranked according to 
significance with 1 being most significant network and 13 least significant network. 
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Network analysis in CAM vs control and CAM vs ATM conditioning data set 
showed multiple networks relating to cancer and cancer progression [table 9 
and table 11], which would perhaps be expected. However, it is interesting to 
note that these networks were not identified in ATM vs control comparisons 
[table 10]. This suggests that whilst there may be similar signatures in ATM 
conditioned AGS gene expression profiles, there are significantly more genes 
relating to carcinogenesis and cancer progression in the CAM conditioned 
media datasets.  
Gastrointestinal disease networks were also pulled out in this analysis, which 
again may be expected reflecting the origins of these cell lines.  Cell to cell 
signalling and interactions were also identified in the CAM datasets [table 9 
and table 11] with the majority of ATM networks being associated with 
inflammation and the immune response [table 10]. Networks associated with 
the cell cycle, cell death and survival were also identified. Evasion of cell death 
and deregulated cell cycle are all hallmarks of cancer and cancer progression, 
the presence of these networks was identified in all three groups, suggesting 
that both CAM and ATM conditioning experiments have the ability to induce 
changes associated with cell-cycle functioning. Networks connected with 
metabolism, molecular transport and lipid metabolism were also within the 
top ranking significant functions list for the CAM vs control datasets [table 9 ]. 
These networks were not identified in the ATM vs control dataset, suggesting 
these changes are unique to CAM conditioning.  
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Rank Top Diseases and Functions 
    1 Infectious Disease, Antimicrobial Response, Inflammatory Response 
  2 Dermatological Diseases and Conditions, Infectious Disease, Cell Cycle 
 3 Cell Cycle, Cell Death and Survival, Cellular Function and Maintenance 
 4 Dermatological Diseases and Conditions, Antimicrobial Response, Inflammatory Response 
5 Connective Tissue Disorders, Immunological Disease, Inflammatory Disease 
 6 Infectious Disease, Antimicrobial Response, Inflammatory Response 
  7 Organismal Injury and Abnormalities, Cellular Development, Cellular Growth and Proliferation 
8 Cell Cycle, Connective Tissue Disorders, Developmental Disorder 
  
Table 10. Table to show ranked networks from Ingenuity network analysis on ATM vs Control 
AGS treated microarray data set (p<0.05, fc >-1.6, >1.6). Ingenuity network reports of all the 
differentially regulated networks within the dataset were generated.  These were then ranked according to 
significance with 1 being most significant network and 8 least significant network. 
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Rank Top Diseases and Functions  
1 Tissue Morphology, Cellular Growth and Proliferation, Cellular Movement 
  
 
2 Cancer, Cell Cycle, Cell Death and Survival 
    
 
3 Protein Synthesis, Cellular Movement, Hematological System Development and Function 
 
 
4 Cancer, Cell Death and Survival, Cellular  Development  
5 Cardiovascular Disease, Organismal Injury and Abnormalities, Reproductive System Disease 
 
 
6 Developmental Disorder, Endocrine System Disorders, Gastrointestinal Disease 
  
 
7 
Cell-To-Cell Signaling and Interaction, Reproductive System Development and Function, Cell 
Morphology  
8 Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance 
 
 
9 Cancer, Cell Death and Survival, Embryonic Development 
   
 
Table 11. Table to show ranked networks from Ingenuity network analysis on CAM vs ATM 
AGS treated microarray data set (p<0.05, fc >-1.6, >1.6). Ingenuity network reports of all the 
differentially regulated networks within the dataset were generated.  These were then ranked according to 
significance with 1 being most significant network and 9 least significant network. 
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2.3.4.4  Transcription Factor Analysis  
 
Comparative microarray gene expression data was further analysed using the 
IngenuityTM data analysis software suite, after a fold change cut off of 1.6 and 
a p-value cut off of <0.5 was applied to batch corrected RMA normalized 
microarray data for: (1) CAM vs serum free controls, (2) ATM vs serum free 
controls  and  (3) CAM vs ATM comparisons.  An IngenuityTM 
transcription factor reports was generated for each dataset, providing 
information on differentially regulated transcription factors and ‘hub’ 
transcription factors, which controlled multiple differentially regulated genes 
within each dataset [figure 2.14]. 
‘Hub’	Transcrip on	Factor	
Pathway	Transcrip on	Factor	
Kinase	
Enzyme	
Pathway	
 
Figure 2. 7. Schematic to show transcriptional regulation in canonical 
pathways.  
‘Hub’ transcription factors control multiple down-stream effectors, which are 
differentially regulated in pathways. Pathways also contain modulated transcription 
factors that are up or down regulated.  
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CAM vs Control comparison generated data showing transcription factors 
ATF3, NUPR1 and HDAC8 as being significantly (p<0.05) up regulated 
[figure 2.15]. Activating transcription factor 3 (ATF3) is a member of the 
ATF/cyclic AMP response element-binding family (Yin et al., 2008) and has 
been reported to have both pro and anti-tumour effects (Yuan et al 2013 and 
Yin et al., 2012).  Four of the transcription factors identified in the CAM 
conditioning dataset were also identified in the ATM conditioning dataset 
[figure 2.16], showing down-regulation of NLRC5 and IRF7 and also up-
regulation of HDAC8 and NUPR1. No differentially regulated transcription 
factors were pulled out from the CAM vs ATM date set analysis due to the 
stringency of this analysis.   
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Figure 2.15. CAM induced changes in AGS transcription factor expression 
profiles.   
Six transcription factors involved in cellular processes were found to be differentially 
regulated from CAM vs Control AGS conditioned gene expression profiles. 
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Figure 2.16. ATM induced changes in AGS transcription factor expression 
profiles.   
Six transcription factors identified as differentially regulated from ATM vs Control 
AGS conditioned gene expression profiles. 
 
Following investigation of differentially regulated transcription factors, 
upstream analysis was carried out to identify any ‘hub’ transcription factors 
which are not themselves changed, but regulate a number of differentially 
expressed genes [as depicted in figure 2.14]. The outcomes of this analysis 
produced highly interesting results: firstly, interferon pathway transcription 
factors were pulled out in both CAM and ATM conditioning studies [table 12 
and table 13], a result which concurs with previous pathway and network 
analysis in this chapter, these include STAT3, STAT2, and IRF3, IRF1 and 
IRF7.  The TP53 (p53) gene was also identified as significant in the CAM 
conditioning dataset; tumour suppression by p53 occurs by transcription-
dependent activities in the nucleus where p53 regulates transcription of cell-
cycle related genes, DNA repair, apoptosis, signalling, transcription, and 
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metabolic genes. (Dai and Gu., 2010).  Results suggest down-stream dis-
regulation of p53 targets, or even p53 itself, which controls these targets, 
causing a knock-on effect on cell cycle regulation and evasion of apoptosis.   
Transcription factor SP1 was also identified as being a controlling 
transcription factor in the analysis, but only in the CAM vs control dataset, not 
in the ATM data sets [table 12].  
 
 
 
Transcription Factor             p-value  
IRF3 1.31E-11 
STAT2 2.53E-11 
IRF1 7.53E-09 
STAT1 3.05E-07 
CEBPA 3.59E-05 
IRF7 8.32E-05 
RELA 8.58E-05 
SMARCB1 9.99E-05 
SP1 1.21E-04 
TP53 1.22E-04 
 
Table 12. Significant ‘Hub’ transcription factors that control downstream 
differentially regulated effector genes within CAM vs control AGS 
conditioned data set. 
Transcription factors are ranked according to p-value, generated from total number 
of downstream effector molecules changed within the dataset.  
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Transcription Factor       p-value of overlap 
CNOT7 4.02E-26 
STAT2 5.50E-16 
IRF3 9.90E-13 
STAT1 9.78E-11 
IRF1 2.40E-08 
IRF9 2.77E-07 
CENPA 4.19E-07 
SMARCA4 6.43E-06 
IRF7 1.97E-05 
FOX03 2.65E-05 
 
Table 13. Significant ‘Hub’ transcription factors that control downstream 
differentially regulated effector genes within ATM vs control AGS 
conditioned data set.  
Transcription factors are ranked according to p-value, generated from total number 
of downstream effector molecules changed within the dataset.  
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2.3.4.5  Gene Set Enrichment Analysis  
 
The purpose of microarray experiments is to profile and compare the 
expression of thousands of genes across a number of samples. Ordinarily this 
involves detailed analysis, restricted to focusing on a smaller number of the 
most ‘interesting’ genes. The most common approach to this analysis is 
usually identifying the genes which are most up or down regulated then 
choosing a cut off value to shorten of the list to a handful of genes for further 
investigation, however there are other, more stringent approaches to 
analysing microarray data. Gene Set Enrichment Analysis (GSEA) is a 
computational method that determines whether an a priori defined set of 
genes shows statistically significant differences between two phenotypes.  In 
this instance, gene enrichment was carried out on AGS microarray data, which 
had been generated from AGS cells conditioned with media from CAM, ATM, 
or control media, it is essentially another, more stringent way of analysing this 
microarray dataset. GSEA focuses on cumulative changes in the expression of 
multiple genes as a group, which acts to shift the emphasis from individual 
genes to groups of genes. By looking at several genes at once, GSEA can 
identify pathways where several genes each change a small amount, but in a 
coordinated way, this can help elucidate the complexities of co-regulation.  
Gene enrichment analysis was carried out in collaboration with Dr Helen 
Smith (Manchester University), results generated 27 gene signatures in CAM 
vs control AGS conditioning data set, 83 signatures in ATM vs control data set 
and 46 signatures in the CAM vs ATM dataset.  Full details of GSEA data 
reports can be found in the appendix [supplementary file II, figure 2.0.] The 
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highest-ranking signatures for all data sets are shown below (table 14, table 15 
and table 16). Interestingly, the top hits of pathways which were generated 
using IngenuityTM were also identified using GSEA, such as immune response, 
cell cycle control and also metabolic pathways. Indeed, the CAM vs ATM data 
set included a number of gene signatures relating to metabolic regulation 
[supplementary file II, 2.0.] suggesting a high amount of gene changes 
produced by CAM conditioning lead induction in metabolically linked genes 
and pathways.  Identifying similar patterns in differentially regulated 
signatures using a more stringent analysis technique like GSEA gives more 
confidence in the results generated by bioinformatics analysis. 
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NAME SIZE ES NES NOM p-val FDR q-val FWER p-val 
REACTOME_REGULATION_OF_ _HIF_BY_OXYGEN 22 0.425 1.650 0 1.000 0.730 
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES 47 0.455 1.559 0 1.000 0.810 
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING 37 0.344 1.469 0 1.000 0.990 
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES 34 0.498 1.467 0 1.000 0.990 
PID_HIF2PATHWAY 30 0.548 1.445 0 1.000 1.000 
PID_BCR_5PATHWAY 64 0.391 1.443 0 1.000 1.000 
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION 84 0.339 1.438 0 1.000 1.000 
BIOCARTA_NDKDYNAMIN_PATHWAY 17 0.421 1.421 0 0.969 1.000 
PID_HES_HEYPATHWAY 44 0.383 1.405 0 0.941 1.000 
 
Table 14. Table to show ranked networks from Gene Set Enrichment Analysis on CAM vs control AGS treated microarray 
data set. 
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NAME SIZE ES NES NOM p-val FDR q-val FWER p-val 
BIOCARTA_FAS_PATHWAY 30 0.522 1.741 0 1.000 0.340 
TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX 28 0.495 1.706 0 0.719 0.490 
ST_GRANULE_CELL_SURVIVAL_PATHWAY 26 0.535 1.654 0 1.000 0.670 
BIOCARTA_TNFR1_PATHWAY 29 0.390 1.626 0 1.000 0.730 
KEGG_GLIOMA 63 0.454 1.616 0 0.961 0.760 
BIOCARTA_EGF_PATHWAY 30 0.574 1.579 0 0.820 0.980 
PID_P38_MK2PATHWAY 21 0.526 1.572 0 0.636 0.980 
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR 17 0.691 1.564 0 0.640 0.980 
BIOCARTA_BCR_PATHWAY 33 0.474 1.539 0 0.749 1.000 
 
Table 15. Table to show ranked networks from Gene Set Enrichment Analysis on ATM vs control AGS treated microarray 
data set.  
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NAME SIZE ES NES NOM p-val FDR q-val FWER p-val 
BIOCARTA_CTCF_PATHWAY 22 0.530 1.578 0 1 0.78 
REACTOME_GLYCOLYSIS 26 0.466 1.565 0 1 0.88 
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION 44 0.550 1.562 0 1 0.88 
ST_GRANULE_CELL_SURVIVAL_PATHWAY 26 0.421 1.531 0 1 0.92 
ST_ERK1_ERK2_MAPK_PATHWAY 31 0.489 1.525 0 1 0.94 
PID_PI3KCIPATHWAY 41 0.457 1.520 0 1 0.95 
PID_E2F_PATHWAY 65 0.334 1.494 0 1 0.95 
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION 43 0.628 1.494 0 1 0.95 
REACTOME_GLUCONEOGENESIS 30 0.476 1.492 0 1 0.95 
 
Table 16. Table to show ranked networks from Gene Set Enrichment Analysis on CAM vs ATM AGS treated microarray data 
set. 
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2.3.4.5  GeneVestigator  
GeneVestigator is a software platform that can be used to obtain information 
and insight into expression profiles of specific genes of interest, including; 
identifying cancers, diseases or conditions, which overexpress the target gene.  
The software can also cluster related genes to investigate co-expression 
Clustering related genes or multiple genes of interest to look at co-expression 
and down-stream targets.  In this instance a number of analyses were carried 
out, firstly observing gene expression across the gastric neoplasms database, 
and secondly analysing metabolic transporter genes of interest to determine 
expression in gastric cell lines and primary samples [figure 2.17].  A number of 
genes from the monocarboxylate transporter family (MCTs) were selected to 
determine expression across AGS gastric cancer cells in various experiments. 
GeneVestigator analysis showed up – regulation of SLC161 genes (MCT1) and 
SLC16A3 and A4 as most up-regulated.  Further interesting gene signatures in 
gastric samples established using the GeneVestigator software were also 
identified  [supplementary file II, figures 2.1, 2.2,and 2.3]. 
 
Figure 2. 17. Snapshot of GeneVestigator analysis in Gastric cancer cells.  
MCT family of small molecule transporters were selected for expression analysis in 
gastric cell lines. 
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2.3.5 Raw Data Analysis Of Single Patient Data 
 
Whilst grouped analysis is useful for detecting statistical trends within 
datasets, some signatures or unifying trends can be lost between patients. For 
example different changes, or different numbers of gene changes within a 
common pathway may be differentially affected in different patients. Previous 
analysis of CAM gene expression profiles (Jones et al., unpublished data) 
revealed distinct patient subgroups, so it was decided that single patient 
analysis would be performed on the individual CAM datasets to establish any 
potential differences in patient subgroup on conditioning experiments. 
Pathway and network analysis were also carried out, as for grouped patient 
data. In general signatures from these analyses were similar to those obtained 
from combined group data; with interferon and inflammatory signalling being 
key pathways down-regulated across patients within the datasets and 
significant networks relating to cell-cycle, inflammation and gastrointestinal 
disease being ranked highly [supplementary file II; figure 2.4].  
There were some differences in gene expression from AGS conditioned with 
294 CAM media (a “good” prognostic CAM) across single patient gene 
expression data including higher expression of ubiquitin enzymes COQ3 and 
UQCC3 [table 17]. 
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Patient 305 Fold Change    Patient 308 Fold Change    Patient 192 Fold Change    Patient 294 Fold Change    Patient 190 Fold Change   
CEACAM 5 3.764 CEACAM 5 2.578 CEACAM 5 2.57 
  
CEACAM 5 2.75 
PRSS1 3.2 PRSS1 2.395 PRSS1 2.44 
  
PRSS1 2.41 
PGBD1 2.6 PGBD1 2.458 PGBD1 2.49 PGBD1 3.03 PGBD1 2.66 
  
METTL10 2.358 METTL10 2.38 METTL10 3.02 METTL10 2.38 
MX2 -3.3 MX2 -3.51 MX2 -3.54 MX2 -3.57 MX2 -3.48 
PMCH -2.7 PMCH -3.398 PMCH -2.96 PMCH -3.002 PMCH -3.01 
IFI44L -3 
  
IFI44L -2.77 
  
IFI44L -2.58 
RSAD2 -2.7 RSAD2 -2.817 
    
RSAD2 -2.71 
    ZNF114 -2.69   ZNF114 -2.58 
TFF1 2.9 SPP1 -2.793 IDI 2.2 MIR5188 -3.14 
  FOSB 2.7    
 
MMP13 -3.23 
  IFIT1 -2.7    HK1 2.75 
      COQ3 2.57   
      UQCC3 2.55   
 
Table 17. Data to show top hits for up-regulated and down-regulated genes for single patient AGS conditioning data with 
CAM media. Commonly differentially regulated  genes between single patients are in the first part of the table, up-regulated genes are shown 
in red whilst down- regulated are shown in green. The second half of the table shows patient unique transcription factors 
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2.3.5.1. Transcription Factor Analysis of Single Patient Data   
 
To establish further trends and potential candidate genes of interest between 
the datasets, comparative gene expression data was analysed using 
IngenuityTM data analysis software, after a fold-change cut-off of 1.6 was 
applied to batch corrected RMA normalized single-patient CAM vs controls 
and ATM vs control datasets. IngenuityTM transcription factor reports were 
generated for each dataset, providing information relating to ‘hub’ 
transcription factors, which controlled multiple differentially regulated genes 
within each dataset [table 18]. Analysis showed FOS and NLRC5 transcription 
factors were common across the AGS samples. Data also showed some unique 
signatures in transcriptional regulation; IRF8 was identified in the 294-
conditioning sample, which was from a patient with good survival and 
prognostic scoring (Varro lab and Jones et al., unpublished data). FOSB was 
identified in the AGS treated with media from myofibroblast cells from the 
patients with the worst prognosis and survival scores (305 and 190).  Whilst 
differences in transcriptional profiling may be patient subgroup dependant, 
microarray profiling of AGS cells conditioned with media from a larger cohort 
of patient myofibroblasts in order to draw any firm conclusions on patient- 
specific trends.  
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Patient 305 Fold Change    Patient 308 Fold Change    Patient 192 Fold Change    Patient 294 Fold Change    Patient 190 Fold Change   
FOS 2.332 FOS 1.812 
  
FOS 1.707 FOS 1.94 
FOSB 2.776 
      
FOSB 1.926 
NLRC5 -2.099 NLRC5 -2.169 NLRC5 -2.329 NLRC5 -2.25 NLRC5 -2.21 
HDAC8 1.757   
 
HDAC8 1.657 HDAC8 1.875 HDAC8 1.715 
ATF3 2.007   
   
IRF8 -1.77 IRF7 -1.606 
NUPR1 1.973   
       
          Table 18. Data to show top hits for up-regulated and down-regulated transcription factors for single patient AGS 
conditioning data with CAM media.  
Common transcription factors between single patients are in the first part of the table, up-regulated transcription factors are shown in red 
whilst down- regulated are shown in green. The second half of the table shows patient unique transcription factors. 
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2.3.5 Phenotypic Effects of CAM conditioned media on AGS cells  
 
AGS cells were treated with CAM conditioned media from patient 
myofibroblast cells for 24h before performing EdU proliferation assay. Results 
showed an increase in AGS cell proliferation upon addition of CAM cell media, 
compared to the serum free control [figure 2.19 A]. This data was also 
expressed as an average across the AGS cells treated with conditioned media 
from a cohort of CAM cell lines [figure 2.19 B]. Results show a statistically 
significant increase in AGS cell proliferation compared to the serum free 
control.   
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Figure 2. 19. Effects of CAM conditioned media on AGS cell proliferation.  
AGS cells were conditioned with CAM media for 24h. Results were quantified as 
percentage of cells stained positive for EDU, out of total cell population, and 
expressed as either as single patient data [A] or as an average across CAMs [B]. 
ANOVA analysis of single patient data showed a significant increase (indicated by an 
asterisk (*) in proliferation of AGS cells upon treatment with CAM media across all 
cell lines (p<0.05). Students T-Test analysis of combined data, also showed statistical 
significance in AGS cell proliferation of (indicated by an asterisk (*), N=3, error bars 
represent standard deviation. 
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To investigate effect on AGS cell migration, AGS cells were seeded in boydon 
chamber plates together with CAM conditioned media from three 
representative patient primary myofibroblast cells lines for 24h before 
performing migration assays. Results showed an increase in AGS cell 
migration upon addition of CAM cell media, compared to the serum free 
control [figure 2.20]. 
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Figure 2. 20. Effects of CAM conditioned media on AGS cell migration.  
AGS cells were conditioned with CAM media for 24h. Results are expressed as single 
patient data. ANOVA analysis of single patient data showed a significant increase 
(indicated by an asterisk (***) in proliferation of AGS cells upon treatment with 
CAM media across all cell lines (p<0.05), N=3, error bars represent standard 
deviation.  
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2.4 Discussion  
 
This purpose of this chapter was to establish any differential effects that 
CAM-conditioned, ATM-conditioned, or control media have on AGS gene 
expression profiles. Preliminary analysis confirmed that stocks of primary 
myofibroblasts used in these studies exhibit previously defined properties, 
including differential induction of AGS/cancer cell migration and 
proliferation (Holmberg et al., 2012). In addition, the quality of microarray 
data was confirmed using standard microarray quality analysis software prior 
to subsequent data processing and analysis. Trends observed in primary 
microarray data were also experimentally verified by targeted qPCR studies, 
thereby confirming the validity of differential gene expression profiles and 
demonstrating the retention of differential properties in each myofibroblast 
population.  Having established the validity of primary gene expression 
profiles, bioinformatics tools were then used to further investigate consistent 
trends in gene expression profiles. This analysis generated interesting trends 
in metabolic gene signatures and pathways, however trends based on patient 
subgrouping could not be made due to the small samples size (n=5, with 
patients from different subgroups). A larger scale microarray study using 
AGS conditioned with a greater number of myofibroblast patient media 
would be needed to be carried out to make conclusions about sub-group 
specific trends.   
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The purpose of the microarray data analysis was exploratory and hypothesis 
generating; it was used to establish any trends within the conditioning data 
set and to look at together with previous microarray analysis (Dr Helen 
Jones, unpublished data).  Initial comparison of gene expression profiles 
identified interesting trends within grouped patient data. CEACAM5 up 
regulation has been reported in many cancers and has been shown to be a 
major target for Smad3-mediated TGF- β signalling (Blumenthal et al., 
2007). IGFBP5 has been shown to aid cell survival in low nutrient conditions, 
which has implications in cancer progression and survival (Akkiprik et al, 
2009). The gene CYP1A1 was also identified up regulated in the CAM 
conditioning dataset. Significantly, this gene is known to be involved in 
metabolism and causes bioactivation of benzo[a]pyrene, which forms DNA 
adducts resulting in enhanced levels of mutagenesis (Costa et al., 2010). 
 
In this instance, for both CAM and ATM treated AGS gene expression 
profiles, the inflammatory and immune response were ranked as the most 
significant networks. Interferon proteins are part of the cytokine family, 
involved in numerous functions, including antiviral and antimicrobial 
response, apoptosis, cell-cycle control and facilitating other cytokines 
(Slattery et al, 2011). Down-regulation of these proteins may have numerous 
implications including the cancer cell’s ability to evade the immune response 
and apoptosis. This result concurs with the raw data analysis, which showed 
down-regulation of genes corresponding to cytokines and proteins in the 
interferon pathway. Canonical pathway mapping also using Ingenuity, 
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showed significant pathway load of down-regulated genes on inflammation 
and infectious disease response.  
 
Results from Ingenuity transcriptional analysis of grouped patient data 
showed a significant increase of ATF3 in the CAM conditioning dataset, 
which was not present in ATM vs control conditioning dataset.  Transcription 
factor ATF3 has been reported to have pro-tumour effects, increasing 
metastatic potential in breast cancer and the inflammatory response 
(Wolford et al., 2013,  Hai et al ., 2010). More recently ATF3 has been linked 
to metabolic regulation and energy metabolism (Lee et al., 2013).  
Interestingly, other transcription factors associated with metabolic activity in 
the cell were also identified as up- regulated, SP1 and p53, both ‘hub’ 
transcription factors. SP1 is known to regulate a number of genes, but 
particularly those associated with metabolism, specifically pyruvate kinase 
and fatty acid synthase (Archer et al., 2011). Dis-regulation of P53 is 
associated with enabling cells to resist the shift to glycolysis (Cheung et al., 
2010). The identification of p53 as a hub transcription factor is interesting, as 
this acts to regulate transcription of cell-cycle related genes, DNA repair, 
apoptosis, signalling, transcription, and metabolic genes. In addition, p53 
can also induce apoptosis and autophagy in the cytoplasm through 
transcription independent activities (Dai and Gu., 2010).  The presence of 
p53 in this analysis is interesting taken in context of the cell-cycle networks 
identified in the previous analysis. Results suggest down-stream dis-
regulation of p53 targets, or even p53 itself, which controls these targets, 
causing a knock-on effect on cell cycle regulation and evasion of apoptosis.   
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The most interesting and striking data generated from the microarray gene 
analysis performed in this chapter were the variations seen across a number 
of metabolic genes and transcription factors associated with metabolic 
regulation. The metabolic signatures generated from both grouped and single 
patient CAM data are particularly relevant when considered in the context of 
previous work  (Jones et al., unpublished data) carried out on the 
myofibroblast cell lines, which were used to provide the conditioned media in 
this study.   
 
Briefly, differential gene expression profiles of CAMs, ATMs or NTMs were 
analysed to generate microarray data, which was investigated by several 
methods including multivariate and correspondence analysis (Jones et al., 
2012, unpublished data). These studies allowed differentially affected genes 
and pathways to be considered at the same time with both corresponding 
changes being plotted on the 3D graph to generate functionally related 
clusters.  These clusters were then analysed systematically using odds ratios 
to define not only pathways containing the greatest number of differential 
gene expression but more importantly, differentially expressed genes that 
form an intersection between multiple canonical pathways. As such, these 
genes potentially represent a key subset of differentially expressed genes that 
have the potential to impose maximal impact on the system, or to confer 
specific functional or prognostic phenotypes (Jones et al., unpublished data). 
Overall, these results show that the CAM vs. NTM comparison produced the 
greatest number of differentially regulated genes relating to fatty acid--
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oxidation and metabolic pathways. The expression of genes within these 
pathways were generally found to be significantly up–regulated in CAMs 
compared to NTMs [table 19].  
 
 
 
 
Gene name Over-represented pathway Fold change 
SLC2A11 Facilitative Na+-independent glucose transporters 1.75 
SLC2A10 Facilitative Na+-independent glucose transporters 1.41 
SLC16A3 Bile salt and organic anion SLC transporters 5.43 
SLC16A7 Bile salt and organic anion SLC transporters -1.49 
SLC27A1 Transport of fatty acids 1.42 
 
Table 19. Pathways identified in CAM vs NTM myofibroblast analysis.  
Over-represented transporter pathways (odds ratios >2) identified within the 
Reactome database and associated with differentially regulated transporters 
(p≤0.05), for the CAM vs. NTM data set. (Jones et al., unpublished data). 
 
 
 
 
Combined analysis of CAM gene-expression profiles and myofibroblast 
conditioning studies, provides the basis for a proposed model of energy 
metabolism in gastric cancer [figure 2.26].  Signatures from these collective 
studies were further investigated to establish if these trends could be 
functionally validated in available primary myofibroblast cell lines.  
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Figure 2. 8. Schematic representing predictive model of paracrine 
communication between myofibroblast cells and AGS epithelial gastric 
cancer.  
This was based on microarray data analysis of primary gastric myofibroblast cell 
lines and AGS cancer cells conditioned with CAM media to investigate paracrine 
signalling. 
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Chapter Three 
 
Metabolic Reprogramming in the 
Gastric Cancer 
Microenvironment 
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3.0  Introduction  
 
Paracrine communication between cancer cells and the tumour 
microenvironment has become an area of increasing interest in recent years, 
with the focus of academia and industry alike looking to target the cells 
supporting tumour growth, as well as tumour cells alone. The immune 
response of the tumour microenvironment (Zhou et al., 2014): the role of 
cytokines (Wilson et al., 2002): and activation of transcription factors (Yu et 
al., 2007), are all well established areas of therapeutic interest within the 
tumour-microenvironment’s paracrine system, however, little is understood 
regarding reciprocal communication in the field of cell metabolism and 
cancer development. Despite this fact, the concept of paracrine 
communication in relation to cellular metabolism is not entirely a new one; 
as early as the 1950s, the work of McIlwain showed lactate as an energy 
substrate for cells in brain tissue. Subsequently, reciprocal communication 
has been shown between astrocytes and neurone cells, with astrocytes 
supplying substrates to neurons from their glycogen stores and from 
glycolysis (Genc et al., 2011, Allaman et al., 2011). The parallels of this 
relationship can be seen in the ‘Reverse Warburg Effect’, first postulated by 
the Lisanti research group (Pavlides et al., 2009). This model shows a 
metabolic switch of stromal myofibroblasts to a glycolytic phenotype, which 
acts to support and enhance tumour growth via transport of high-energy 
metabolic products (Pavlides et al., 2009, Bonuccelli  et al., 2010 and Sotgia 
et al., 2012).  
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The complexities of energy metabolism in the tumour and its stroma have not 
yet been presented in a gastric cancer model. The goal of this chapter was to 
determine the metabolic status of gastric cancer cell lines and primary gastric 
myofibroblasts, based on the previous microarray data analysis of both 
myofibroblast and AGS co-cultured experiments, to provide a thorough 
representation of energy metabolism in the microenvironment of gastric 
cancer. 
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3.1 Aims and Hypotheses  
 
This chapter addresses induced metabolic changes that occur in primary 
human gastric myofibroblasts and AGS gastric cancer cells under co-culture 
conditions. We aimed to test the hypothesis that CAM and AGS cells have 
distinct metabolic profiles and to see if co-culture and conditioned media 
experiments would induce reciprocal metabolic changes in each cell type. 
Briefly, the primary aims of the chapter were: 
 
1. To analyse and compare the basal levels of mitochondrial activity in 
primary gastric myofibroblasts and AGS cells. 
 
2. To determine if CAM and NTM cell-lines retain innate metabolic 
properties, which are maintained in low passage cultures. 
 
 
3. To use co-culture and conditioned media experiments to investigate 
imposed reciprocal changes in each cell type.  
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3.2 Chapter Specific Materials and Methods. 
 
Full and extensive details of materials and methods used in this chapter can 
be found in Chapter VI.  
 
3.2.1  XF-Extracellular Flux Analyser  
 
3.2.1.1 Myofibroblast Cells 
 
To investigate the glycolytic capacity and oxygen consumption rate of 
Myofibroblasts, low passage (P5-P10) primary CAM cell lines (308, 305, 294, 
42 and 45) and primary NTM cell lines (334, 196 and 241), were each seeded 
into 24-well XF seahorse Flux analyser cell dishes, which were pre-treated 
with Cell-Tak.  Cellular glycolytic function and oxygen consumption rate 
testing was carried out in n=5 replica. Control wells were not treated with any 
drugs or compounds. 
 
3.2.1.2 AGS Cancer Cells  
 
To determine the range of metabolic changes imposed in AGS gastric cancer 
cells following exposure to CAM conditioned media; AGS cells were seeded at 
a density of 80,000 cells/well, in n=5 replica format in Cell-Tak treated 24 
well XF Seahorse Flux analyser cell dishes. Adherent cells were cultured for 
24 hours in full media before being washed three times in DPBS. Cells were 
then cultured overnight in CAM 308, or CAM 294 conditioned media or in 
serum free control media. In each case, the cellular glycolytic capacity and 
oxygen consumption rate were recorded.  
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3.2.2  Mitotracker® Staining 
 
Low passage (P5-P10) CAM and NTM cell lines and AGS cells were cultured 
to ≈ 80% confluence prior to performing assays and Mitotracker® staining 
was carried out. For each assay twenty images were taken using a 63X oil 
objective on a Ziess multiphoton 2 confocal microscope. Whole cell image 
intensity levels were quantified using ImageJ software. Results were analysed 
as both single patient/cell-line specific data and as combined CAMs vs NTMs 
comparisons.  
 
3.2.3 Immunofluorescence for GLUT1 Transporter Channel 
 
Low passage (P5-P10) CAM and NTM cell lines between were grown on glass 
coverslips in DMEM full-media for 24 hours to achieve ≈ 80% cell confluence.  
Cells were processed for immunofluorescence as previously described and 
stained with GLUT1 antibody.  
 
3.2.4 Real Time PCR for CAM Conditioning Experiments 
 
AGS cells grown to 60-70 % confluence in 10cm dishes were washed three 
times in PBS before adding 10ml of conditioned media from CAMs (190, 192, 
305, 308 or 294) or NTM 334. After a 24h incubation cells were prepared for 
RNA extraction.  
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3.2.5 Western Blotting for CAM, NTM and AGS Conditioning 
Experiments 
 
 
CAM cell lines 308 and 294, and NTM cell line 334 (P5-P10) were grown to 
80% confluence. In each case cells were harvested and processed for western 
blotting as previously described. Membranes were probed for MCT4 and 
tubulin for loading. AGS cell lines were split and grown until 80% confluent 
before being treated for 24 hours with CAM or NTM conditioned media. Cells 
were harvested and processed for western blotting.  Membranes were 
incubated with MCT1, CD147 and tubulin antibodies.  
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3.3 Results 
 
3.3.1 Comparison of mitochondrial activity in CAMs, NTMs and 
AGS gastric cancer cells 
 
It is well established that cancer cells modify their metabolic pathways in 
order to provide sufficient energy to drive enhanced cell proliferation, 
invasion into surrounding tissue and migration (Yi et al., 2012, Bonuccelli et 
al., 2010 and Schulz et al., 2006).  Warburg first proposed the hypothesis 
that cancer cells undergo a change in mitochondrial function, such that they 
become more dependent on glycolysis, than mitochondrial respiration to 
generate ATP (Warburg, 1956). Since the proposal of this hypothesis there 
have been many publications supporting the concept that tumour cells have 
altered mechanisms of ATP production (Christofk et al., 2008, Harjes et al., 
2012 and Heiden, 2012).  However, more recently the role of the tumour 
microenvironment has been re-evaluated in relation to paracrine 
communication between tumour cells and cells within the adjacent stroma, 
or tissue.  This concept of reciprocal paracrine communication within the 
tumour microenvironment is a complex issue, which remains poorly 
characterised for many forms of tumour.  Several issues currently limit a full 
understanding of the molecular processes that drive, or facilitate, metabolic 
balance within the microenvironment of gastric tumours. Different metabolic 
states may operate at different stages of tumour development and at different 
sites within a tumour; depending on local levels of acidity, hypoxia, 
inflammation and nutrient availability. Therefore, to provide improved 
insight into this process, it is important to first define the inherent metabolic 
properties of both gastric cancer cells and gastric stromal myofibroblasts. 
Armed with this information it is then possible to define changes imposed on 
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each cell type as a result of paracrine communication under different 
conditions. To address these questions, experiments were designed to define 
basal and imposed metabolic activity in gastric cancer cells and primary 
gastric myofibroblast cell lines.  
 
The Seahorse XF Flux analyser provides a gold standard method for 
measuring cellular respiratory metabolism, In brief; mitochondrial function 
(oxygen consumption rate or: ‘OCR’ levels) is determined by measuring the 
level of dissolved oxygen in the seahorse cell media (minimal media without 
serum or glucose). The Seahorse also measures extracellular acidification 
rates (‘ECAR’), produced by levels of secreted protons, which are indicative of 
levels of cellular glycolytic capacity. While these measurements are being 
taken, three substrates are sequentially injected into the cell media: (1) 
glucose to act as a substrate for glycolysis, (2) oligomycin to inhibit ATP 
synthase and (3) 2-deoxyglucose (2DG), to inhibit glycolysis. Due to the 
inherent complexity of these assays a representative selection of available 
CAMs and NTMs were selected for detailed analysis, in order to assess the 
validity of preliminary semi-qualitative live-cell Mitotracker analysis 
performed in conjunction with these experiments. Seahorse data was derived 
from AGS cells or primary CAM cell lines that are representative of sub-
groups of CAMs isolated from patients with either early or late-stage 
tumours; each of which was compared to a representative gastric NTM cell 
line. The oxygen consumption rate of AGS cells, CAMs and NTMs was 
measured and recorded [Figure 3.1]. Results showed an overall increase in 
the rate of oxygen consumption in AGS cells compared to all selected CAM or 
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NTM cell-lines. Inhibition of ATP synthesis by oligomycin A, significantly 
reduces electron flow through the electron transport chain, therefore cells 
dependent on mitochondrial respiration, rather than glycolysis, will be more 
dramatically affected by addition of this drug. This can been seen in figure 
3.1, where upon injection of oligomycin there is a significant drop in OCR 
reading in AGS cells, compared to that observed in either CAM or NTM cells. 
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Figure 3. 1. Oxygen Consumption Rate of AGS, CAM and NTM cells.  
The extracellular acidification rate and oxygen consumption rate of AGS (red) CAMs 
308 (blue) CAM 294 (yellow) and NTM 334 (grey) cells was recorded using the 
seahorse XF flux analyser. n=5, error bars represent standard deviation. Data was 
normalised to DNA concentration.  
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Mitotracker® mitochondrial dye was used to further confirm the results from 
the Seahorse, utilising the same myofibroblast cell lines as in the Seahorse, 
and keeping the cell passage numbers consistent in both experiments. 
Results showed a statistically significant (students t-test, p<0.0001) increase 
in Mitotracker®  staining in AGS cells compared to CAMs 308 and CAM 294 
and NTM 334 [figure 3.2].  
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Figure 3. 2. Mitochondrial intensity of AGS, CAM and NTM cells.  
Mitotracker  Red CM Ros stain was incubated with cells, prior to live-cell imaging. 
The relative intensity of mitochondrial staining was measured (n=20) as a semi 
qualitative measure of mitochondrial activity using ImageJ intensity quantification 
of pixels function. ANOVA analysis of data showed AGS cells had a significant 
(p<0.001) increase (indicated by asterisks (****) in mitochondrial stain compared to 
CAM or NTM cell-lines (n=3).  
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Mitochondrial activity was also measured using Mitotracker® stain across an 
additional panel of three CAM and three NTM cell lines to further investigate 
trends seen in cell lines chosen for use in seahorse studies. Image analysis of 
mitochondrial staining [figure 3.3A] showed a consistent reduction in 
mitochondrial activity across eight CAM and NTM cell lines compared to 
levels observed in AGS cells [figure 3.3B].  Due to the intense fluorescent 
signal detected from the AGS cells it was difficult to discern comparatively 
subtle differences in mitochondrial staining between myofibroblast subsets. 
Therefore, a further set of independent experiments were performed to 
examine the innate properties of these myofibroblasts using more sensitive 
settings on the multiphoton 2 microscope, which will be described later in 
this chapter.  
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Figure 3. 3. Mitochondrial intensity of AGS cells and a panel of primary 
NTM and CAM cell-lines.  
Mitotracker Red CM Ros stain was added to AGS, CAM and NTM cells before live-
cell imaging. Mitochondrial intensity was measured (n=20) using ImageJ, intensity 
quantification of pixels function.  A one-way ANOVA was performed to determine 
significance between cell lines. AGS cells showed a statically significant increase in 
mitochondrial stain compared to all CAM or NTM cells tested (p<0.001, indicated 
by an asterisk (***)). 
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3.3.2 Regulation of Transporter Channels in CAM and NTM 
Primary Cell Lines 
 
A series of reciprocal conditioning experiments was performed to investigate 
the effects of paracrine communication between AGS cells and 
myofibroblasts, as described previously [results chapter one], microarray 
studies were carried out to establish the effects that CAM conditioned media 
have on global gene expression profiles in gastric AGS cancer cells. Following 
normalisation and batch correction, lists of genes showing significant 
imposed changes in expression were used to perform gene and pathway 
enrichment studies to provide new insight into the spectrum of functional 
changes resulting from paracrine communication between gastric cancer cells 
and associated stromal CAMs. Selected targets were chosen from this analysis 
for validation and further analysis.  
 
As discussed previously, microarray analysis of primary CAM cell-lines 
showed an up regulation of various transporter channels involved in cellular 
metabolic pathways compared to control primary NTM cell-lines (Jones et 
al., unpublished data).  It has also been reported in the literature that glucose 
transporter one (GLUT1) is up regulated in cells and cell-lines that 
predominantly rely on glycolysis, rather than mitochondrial respiration 
(Young et al; 2011, Liu et al; 2012). The primary CAM, ATM and NTM raw 
data was re-analysed as single patient data. This was done using mas5 
normalisation, then R computer programming to calculate average probe 
expression for each gene, to establish patient based trends. GLUT1 was 
selected for further investigation, as it was identified as being a target of 
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interest by previous work carried out in the lab (Jones et al., unpublished 
data). Interestingly, this was one of the differentially regulated genes 
identified in the analysis of single patient gene expression profiles performed 
in this study [Figure 3.4]. 
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Figure 3. 4. Relative GLUT1 gene expression levels in 14 gastric CAM cell-
lines.  
Microarray gene expression profiling was carried out across a panel of 14 primary 
gastric CAM cell-lines.  In each case expression levels were normalised to average 
levels of GLUT1 expression detected across a panel of primary gastric NTM cell-
lines.  
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A panel of CAMs and NTMs was selected to assess relative levels of GLUT1 
expression in tumour or normal tissue derived myofibroblasts.  CAM cell-
lines 305, 308 and 294 and NTM cell lines 334, 241 and 196 were fixed and 
stained for GLUT1. Relative staining intensity was then quantified using 
ImageJ software (n=20 for each cell line). Variance analysis of this data 
showed a statistically significant difference between levels of GLUT1 
expression observed in CAM and NTM cell-lines [figure 3.5A]. A Tukey’s 
multiple comparisons test was also carried out [figure 3.5B] to examine the 
differences between means of intensity for a selection of patient 
myofibroblasts. However, results from this analysis showed no significant 
difference (with the exception of CAM 308) between the means observed for 
each CAM cell-line. Equally, no difference was observed between the mean 
values of the three NTM cell lines  (NTM 196, NTM 334 and NTM 241). There 
was however, statistical significance (p<0.05) between the means of all CAM 
and NTM cell-lines studied [figure 3.5B]. Immunofluorescence images show 
distinct differences in GLUT1 staining between CAM and NTM cell-lines 
[Figure 3.5C]. Finally, when the average single-patient intensity values for 
both CAMs and NTMs was combined (n=3) and a t-test carried out between 
the two groups, a statistically significant difference (p<0.05) in GLUT1 stain 
was observed between the two groups, [Figure 3.5D]. 
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A B
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Significant? Summary
351 NTM vs. 241 NTM -17.83 -44.15 to 8.485 No ns
351 NTM vs. 334 NTM -16.79 -43.11 to 9.523 No ns
351 NTM vs. 294 CAM -86.58 -112.9 to -60.27 Yes ****
351 NTM vs. 305 CAM -97.02 -123.3 to -70.71 Yes ****
351 NTM vs. 308 CAM -44.57 -70.89 to -18.26 Yes ****
241 NTM vs. 334 NTM 1.039 -25.28 to 27.35 No ns
241 NTM vs. 294 CAM -68.75 -95.07 to -42.44 Yes ****
241 NTM vs. 305 CAM -79.19 -105.5 to -52.87 Yes ****
241 NTM vs. 308 CAM -26.74 -53.06 to -0.4237Yes *
334 NTM vs. 294 CAM -69.79 -96.11 to -43.47 Yes ****
334 NTM vs. 305 CAM -80.23 -106.5 to -53.91 Yes ****
334 NTM vs. 308 CAM -27.78 -54.09 to -1.462 Yes *
294 CAM vs. 305 CAM -10.44 -36.75 to 15.88 No ns
294 CAM vs. 308 CAM 42.01 15.70 to 68.33 Yes ***
305 CAM vs. 308 CAM 52.45 26.13 to 78.77 Yes ****35
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Figure 3. 5. GLUT1 expression in CAMs and NTMs.  
Cells were fixed and stained with Rb anti-GLUT1. Relative levels of GLUT1 
expression were assessed by measuring fluorescence intensity across a 
representative selection of myofibroblasts (n=20) using ImageJ intensity 
quantification of pixels function. Results are shown for individual patients. A one-
way ANOVA (p<0.05, indicated by an asterisk (*)) (A) and a Tukey’s Multiple 
Comparison Test (B) were performed to establish statistical significance of observed 
differences in GLUT1 expression. Representative images of GLUT1 expression in 
NTMs and CAMs are shown in panels (C) and (D) respectively. The students t-test 
was also performed on average expression values across NTMs and CAMs, showing 
a statistically significant difference in GLUT1 stain between the two groups (p<0.05, 
indicated by an asterisk (*)). 
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Monocarboxylate transporter 4 (MCT4) was also identified to be up-regulated 
across CAMs, following analysis of single-patient gene-expression data  
[Figure 3.6]. This trend was also identified in a previous correspondence 
analysis of CAM specific gene expression profiles (Jones et al., unpublished 
data). Studies in breast and prostate cancer have also identified MCT4 as an 
important indicator of metabolic status (Bonuccelli et al.,  2010, Sotgia  et al., 
2012). Therefore, MCT4 was selected as a potential marker of altered 
metabolic status.  
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Figure 3. 6. Relative MCT4 gene expression levels in 14 gastric CAM cell-
lines.  
Microarray gene expression profiling was carried out across a panel of 14 primary 
gastric CAM cell-lines.  In each case expression levels were normalised to average 
levels of MCT4 expression detected in a panel of 8 primary gastric NTM cell-lines. 
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Relative levels of MCT4 protein expression were analysed in a selection of 
primary CAM and NTM cell lines by semi-quantitative western blotting 
[Figure 3.7A]. These cell-lines were selected for this study as they represent 
primary CAMs derived from the site of both early and late stage tumours. In 
addition, they were also the cell-lines used in previous AGS conditioning 
microarray studies that have been discussed in results chapter one.  
Results from western blot analysis show a clear increase in expression of 
MCT4 in CAM 308 and CAM 294 cells compared to control NTM 334 cells. In 
this analysis protein levels were quantified using ImageJ and normalised to 
the tubulin loading control [figure 3.7B].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter III; Results Chapter Two  
 124 
 
A 
MCT4 
3
0
8
 C
A
M
2
9
4
 C
A
M
3
3
4
 N
TM
Tubulin 
MCT4 
Tubulin 
7 Day Co-Culture with AGS Cells (2%FBS)
7 Day Culture  Alone (2%FBS)
49 kDa
49 kDa
49 kDa
49 kDa
  
B 
30
8 
C
A
M
29
4 
C
A
M
33
4 
N
TM
0.0
0.5
1.0
1.5
2.0
2.5
M
C
T
4
 E
x
p
re
s
s
io
n
 
Figure 3. 7. Relative levels of MCT4 expression in CAM and NTM cells.  
Western blots were performed on equivalent samples of whole cell lysates prepared 
from CAM or NTM cell-lines. Blots were probed with mouse monoclonal anti-MCT4  
to assess levels of MCT4 protein in each cell line (A). Intensity values were quantified 
using Image J intensity quantification of pixels function and normalised to 
corresponding levels of tubulin detected in each sample (B). 
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3.3.3 Analysis of changes in transporter channel expression in AGS 
cells following exposure to CAM conditioned media 
 
Monocarboxylate transporter channel one (MCT1) was selected as a candidate 
for further investigation. Analysis from the CAM microarray data set (Jones et 
al., unpublished data) identified this as a potential gene of interest, predicted 
by reciprocal patterns in gene changes such as MCT4 and ketone biosynthesis. 
MCT1 has also been identified in numerous published studies (Le Floch et al 
2011, Zhao et al 2014) whereby it has been established as a marker indicative 
of altered metabolic status. This has also been reported in other solid-
tumours, including breast (Whitaker-Menezes et al 2011), and prostate cancer 
(Sanità et al 2014) therefore determining the MCT1 status of AGS gastric 
cancer cell lines was important for the purposes of this study.  CD147 is a 
glycoprotein which exists on the plasma membrane; it contains a single 
transmembrane domain and also two immunoglobulin-like domains (Kirk et 
al., 2000). It known to form a complex with MCT1 and is reported to be 
responsible to the localisation and regulation of MCT1 with the cell, therefore 
CD147 was also selected for analysis by western blotting in these experiments.  
Firstly qPCR analysis was carried out after 24h conditioning of AGS cells with 
CAM conditioned media, results were normalised to beta-actin and expressed 
relative to control media. Results showed statistically significant increase 
(students t-test, p<0.001) of MCT1 transporter channel in AGS cells following 
incubation with CAM media, compared to control media [figure 3.8]. 
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Figure 3. 8. Relative changes in levels of MCT1 gene expression 
following exposure to of AGS cells to CAM conditioned media.  
Relative levels of MCT1 expression were quantified by qPCR following exposure of 
AGS cells to either serum free or CAM conditioned media for 24 hours. In each case 
expression levels were normalised to both beta actin and serum free expression 
levels. Students t-test showed significance (p<0.001, indicated by asterisk (****)) 
between control and CAM MCT1 gene expression. 
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After preliminary qPCR was performed to investigate regulation at mRNA 
level, further analysis was carried out using western blotting to determine the 
protein levels of MCT1 and CD147 following conditioning with CAM media.  
24h conditioning of AGS cells with media from CAM 308 and 294 showed an 
increase in CD147 and also MCT1 expression [figure 3.9]. MCT1 expression 
was already detected at a protein level in AGS cells which would be expected, 
as this suggests the AGS cells already have high levels of mitochondrial 
function; however CD147 was clearly up regulated in CAM conditioned media.  
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Figure 3. 9. Relative induction of MCT1 protein expression levels in AGS 
cells following exposure to CAM conditioned media.  
AGS cells were incubated for 24 hours with conditioned media from either CAM-308 
and CAM-294 or serum free media (CTL). Western blots of whole cell lysates were 
probed with mouse monoclonal anti-MCT1 and rabbit polyclonal anti-CD147 
antibodies and mouse monoclonal ant-tubulin as a loading control (A). Relative 
levels of protein expression were measured by ImageJ using the intensity 
quantification of pixels function, and values for MCT1 expression were normalised to 
respective levels of tubulin expression, panels (B) and (C) respectively. 
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3.3.4 Analysis of glycolytic capacity and oxygen consumption in 
AGS cells following exposure to CAM conditioned media 
 
Results presented in this chapter show for the first time that isolated gastric 
primary CAM cell lines, retain inherently modified metabolic signatures, 
however the effect that CAM conditioned media may have on the metabolic 
status of gastric AGS cancer cells has not yet been established. To investigate 
this question, two primary gastric CAM cell-lines were selected to generate 
CAM-conditioned media. Again CAMs used in these studies were selected to 
correspond with available microarray data, and secondly to investigate any 
potential variability that may exist between CAMs derived from earlier or later 
stage tumours. In this analysis, AGS cells were treated with conditioned media 
for 24h before the Seahorse XF analyser was used to generate a metabolic 
profile of treated AGS cells. Control conditions for these experiments were 
designed to directly match control conditioned used in the preparation of 
samples for microarray gene expression profiling (Varro lab). Interestingly, 
data showed that following 24 hours incubation with media from CAM 308, 
AGS cells show an overall increase in ATP production. Most importantly, CAM 
308 conditioned media imposed a significant increase in oxygen consumption 
rate, indicating a clear potential for CAM induced changes in AGS cell 
metabolism, potentially effecting levels of both glycolysis [supplementary file 
3; figure 3.1] and mitochondrial respiration [figure 3.10].   
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Figure 3. 10. Oxygen consumption rate of AGS cells treated with control 
or CAM conditioned media.  
The oxygen consumption rate of AGS cells treated with CAM conditioned media from 
patient 308 (red) or serum free media (dark red) was measured using the Seahorse 
XF Flux analyser. n=5, error bars represent standard deviation. Data was normalised 
to DNA concentration.  
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In contrast, conditioned media from CAM 294, a primary cell-line isolated 
from a less advanced tumour compared to CAM 308, showed no difference in 
glycolytic function [supplementary file 3; figure 3.2], and a slight decrease in 
oxygen consumption rate of AGS cells [figure 3.11]. This result suggests that 
the ability of CAMs to influence cancer-cell metabolism may be linked to the 
stage of tumour development.  Given that myofibroblasts may themselves be 
programmed by exposure to signals from cancer cells it is logical that longer 
exposure may confer a greater ability to drive paracrine reprogramming of 
cancer cells, thereby satisfying the growing need for energy production in late-
stage tumour development. However, to establish the broader significance of 
this observation similar, or complementary studies would need to be 
performed on AGS cells treated with a broader selection of CAM conditioned 
media. Despite the different induced metabolic changes observed by Seahorse 
analysis after 24 hours, both CAM 308 and CAM 294 cell-lines were found to 
induce up-regulation of MCT1 and CD147 in AGS cancer cells as demonstrated 
previously in this chapter. Therefore, expression of protein markers such as 
MCT1 may be an indication of metabolic potential rather than an accurate 
indication of functional balance between glycolytic activity and oxidative 
respiration. To look more closely at metabolic regulation in these cells 
Mitotracker® cell stain was used to look at this phenotype across a panel of 
CAMs.   
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Figure 3. 11. Oxygen consumption rate of AGS cells.   
The oxygen consumption rate of AGS cells treated with CAM-294 conditioned media 
(dark blue) or serum-free media (light blue) was measured using the Seahorse XF 
Flux analyser. n=5, error bars represent standard deviation. Data was normalised to 
DNA concentration.  
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3.3.5 Comparison of mitochondria activity of primary gastric CAM 
and NTM cells 
 
As stated earlier in this chapter, in order to look more closely at the 
mitochondrial activity in myofibroblast cells, a sensitive experiment was set 
up which was specifically designed to examine and compare any potential 
differences in mitochondrial function by live-cell imaging. A panel of CAM 
cell-lines isolated from patients from the worst patient prognosis sub-group 
(CAM 308, CAM 305 and CAM 45) and NTMs (NTM 334, NTM 241 and NTM 
196) were incubated with Mitotracker mitochondrial stain and representative 
images of live-cells (n=20) were recorded and fluorescence intensity was 
quantified using ImageJ software. Results from this analysis show interesting 
patient subgroup-related trends (Figure 3.12A) and an average percentage 
decrease in mitochondrial activity in CAMs compared to NTMs (p<0.01) 
(Figure 3.12B).  Representative images are shown (Figure 3.12C). This data 
shows that CAM cell-lines consistently exhibit lower mitochondrial staining, 
implying reduced levels of mitochondrial activity and oxidative respiration, 
than observed for comparative NTM cell-lines.  
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Figure 3. 12. Analysis of relative levels of mitochondrial activity in 
primary gastric NTM or CAM cells.  
Live NTM (334, 241 and 196) and CAM (305, 308 and 45) cells were stained with 
Mitotracker Red CM Ros using ImageJ intensity quantification of pixels function. 
Trends observed across individual cell-lines are shown in panel (A). A one-way 
ANOVA (p<0.05, indicated by asterisk (*)) and a Tukey’s Multiple Comparison Test 
(B) were performed to establish statistical significance of variability between 
observed activity in CAM and NTM cells. Representative images of levels of staining 
are shown in panel (C).  Average differences in levels of mitochondrial staining 
between NTMs and CAMs (n=3) are shown in panel (D) (t-test showed significance of 
p<0.05, indicated by asterisk (*)). 
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3.3.4 Comparing inherent glycolytic capacity and oxygen 
consumption rate of gastric CAMs and NTMs 
 
To look more closely at the metabolic trends indicated by Mitotracker staining 
analysis, the seahorse XF flux analyser was also used to perform a more 
detailed metabolic profiling of these cell-types.   Again, due to the inherent 
complexity of these experiments, representative CAM and NTM cell-lines 
were selected for comparison. Results presented in figure 3.13 show 
comparative data for CAM 308 and NTM 334, which have been used 
consistently throughout this results chapter. However, replicate experiments 
show these trends are also representative of values detected in other CAM and 
NTM cell-lines [supplementary file 3; figure 3.3]. Seahorse experiments were 
performed as described previously, and myofibroblast cell-lines were treated 
in the Mitotracker experiments, in order to minimise variability and keep 
comparisons as similar as possible. Results showed that the representative 
CAM cell line had an increased level of extracellular acidification compared to 
the control ‘NTM’ cell line. There is a statistically significant difference 
between the two cell lines, with a decrease in acidification much more 
pronounced in the CAM than the NTM cell line after addition of 2-
deoxyglucose [figure 3.13].  
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Figure 3. 13. Glycolytic capacity of CAMs and NTM cells.  
ECAR rates were measured for bad prognostic patient CAM-308 (red) and NTM-334 
(grey) using the Seahorse XF analyser. Results were normalized to DNA 
concentration. ANOVA analysis was carried out between conditions and showed 
there was a significant difference (p<0.01) between glycolytic capacity of 308 CAM 
and 334 NTM cells indicated by asterisk (***). Error bars represent standard 
deviation, n=5)   
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3.4 Discussion  
 
Energy metabolism is a key factor in tumour development, as cancer cells 
require a constant supply of energy and biosynthetic nutrients to support 
proliferation (Rossignol, et al., 2004 and Moreno-Sánchez et al.,2011). Data 
presented in this chapter provide new insight into the inherent and induced 
metabolic status of primary gastric myofibroblasts and AGS cells. To date, 
there is little information relating to the metabolic properties of gastric cancer 
cells or their effect on the metabolism of cells within the surrounding stroma.  
While data from other cancer models, have described characteristic changes in 
metabolic transporters, results remain incomplete with different models of 
classical and reverse Warburg effects being reported in different studies and 
tumour types (Cai et al., 2010, and Martinez-Outschoorn et al., 2011). There is 
also still very little known about the mechanisms of induction or regulation of 
these metabolic changes in cancer models.   
 
This chapter aimed to test the hypothesis that CAM and AGS cells have 
distinct metabolic profiles. Data presented in this chapter show that AGS 
gastric cancer cells have a much greater rate of oxygen consumption than that 
observed in stromal myofibroblasts.  Addition of Oligomycin A to inhibit ATP 
synthesis (Symersky et al,. 2012) in Seahorse metabolic profiling experiments, 
showed that AGS cells predominantly utilise mitochondrial respiration, rather 
than glycolysis as a primary mechanism of energy production. This signature 
of high-level mitochondrial activity is supported by Mitotracker data showing 
higher levels of mitochondrial activity in AGS cells compared to stromal 
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myofibroblasts. Collectively, this data is indicative of a reverse Warburg effect, 
in which cancer cells utilise oxidative phosphorylation as a primary source of 
energy. Interestingly, this is in contrast to the classical Warburg effect, which 
continues to be described in many publications (Schulze et al., 2011, Salminen 
et al., 2010 and Cai et al., 2010); stating that cancer cells rely on glycolysis, 
not mitochondria for respiration as a primary source of energy.  
 
We also aimed to test the hypothesis that co-culture of AGS and myofibroblast 
cells, and conditioned media experiments would cause paracrine induced 
metabolic changes in each cell type. Our data clearly demonstrates that AGS 
cells treated with CAM conditioned media leads to induction of MCT1 and 
CD147 expression, which is associated with a corresponding increase in the 
rate of oxygen consumption. In agreement with our findings, the Lisanti group 
have shown that treatment of MCF-7 breast cancer cells with high-energy 
metabolites showed an increase in both mitochondrial activity and 
mitochondrial biogenesis (Martinez-Outschoorn et al., 2011).  In our model 
we predict that CAMs become programmed by cancer cells to produce a range 
of nutrients and high-energy metabolites, which are then supplied to the 
cancer cells to support proliferation and tumour development.  
 
Although characteristic markers such as smooth muscle actin (SMA) and 
vimentin have been identified for myofibroblasts (Sharon et al., 2013), CD44 
for mesenchymel stem cells (Spaeth et al., 2013) and E-cadherin as a marker 
for epithelial cells (Kuphal and Bosserhoff, 2006), there are still very few 
markers recognised for metabolic status among cells of the stroma. In this 
study, a panel of CAMs and NTMs were selected to look more closely at 
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GLUT1 activity within different populations (CAM, ATM or NTM) of 
myofibroblasts. Results from immunofluorescence experiments performed in 
this study reveal consistent differences in GLUT1 staining between CAM and 
NTM cell lines; with the average intensity for CAMs and NTMs combined 
showed an overall statistically significant difference (p<0.05) in GLUT1 stain 
between the two groups. Therefore, we would propose that the presence of 
GLUT1 in stromal cells could be used as a potential marker for more 
aggressive/late-stage tumours that have succeeded in transforming the 
surrounding stromal myofibroblast cells to support and enhance growth.  This 
information may aid more appropriate therapeutic stratification of patients, 
or inform development of improved forms of ‘Precision Medicine’.  Results 
from our studies strongly support the concept of a ‘reverse Warburg’ effect, in 
which stromal cells, instead of cancer cells, up regulate transporter channels 
associated with export of the products of glycolysis. Interestingly, although 
most reports in the literature associate GLUT1 over-expression with tumour 
development, most studies report increased GLUT1 in cancer cells, not 
stromal cells (Amann., et al 2009, Chandler et al., 2006 and Young et al., 
2011). This pattern of expression is typical of the classical Warburg effect, 
whereby cancer cells up regulate GLUT1 as the tumour cells switch to 
glycolysis rather than oxidative phosphorylation. This suggests that different 
metabolic states or mechanisms may operate in different tumours, at different 
stages or development or even in different regions of a solid tumour. Our data 
strongly suggests that gastric cancer cells may favour mitochondrial 
respiration over aerobic glycolysis. Seahorse oxidative stress tests showed that 
the observed drop in oxygen consumption in NTM and CAM cells after the 
addition of oligomycin A was much more reduced than that observed with 
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AGS cells (0.055 pMoles/min/ngDNA compared to 0.15 pMoles/min/ngDNA 
in AGS cells), indicating that myofibroblasts in general are actually 
programmed to rely less on mitochondria for energy metabolism. Significantly 
we also observed that the extracellular acidification rate was also higher in 
CAMs compared to NTMs, which is consistent with an increase in the 
production and secretion of ketone bodies or lactate in myofibroblasts from 
cancer stroma, rather than normal tissue, and indicate high glycolytic activity. 
This result was again reflected in correlated Mitotracker studies, which show a 
consistent increase in Mitotracker staining in NTMs compared to CAMs, 
thereby indicating that they have more active mitochondria. This data again 
suggests fundamental differences in metabolic activity between these two 
forms of activated myofibroblasts., which are retained even after isolation and 
restricted passage in culture.  Relative levels of MCT4 expression were also 
investigated in primary myofibroblasts (308 CAM, 294 CAM and 334 NTM). 
As previously stated, these cells lines were chosen as they represent CAMs 
from both ‘good’ and ‘bad’ patient prognostic groups. In addition, these CAMs 
were also used in AGS conditioning studies previously described (results 
chapter II). Western blotting results showed an increase in expression of 
MCT4 in CAM cells 308 and 294 compared to the control NTM 334 cells. 
Indicating that CAMs maintain a metabolic phenotype that is distinct from 
NTMs. Interestingly, these results concur with microarray data, which shows 
increased levels of MCT4 compared to NTM controls.  MCT4 over-expression 
is synonymous with an increase in ketone and lactate transport, particularly in 
relation to cancer. Studies by Lisanti et al., also show an increase in MCT4 
expression in histological analysis of breast cancer stroma (Witkiewicz et al., 
2010). Moreover, in these studies the presence of MCT4 staining was 
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associated with a poor prognosis and a decrease in patient survival, which 
suggests the potential prognostic value of MCT4 detection in gastric cancer 
models.  A recent study in head and neck squamous carcinoma (HNSCC) also 
found MCT4 positive staining in stromal fibroblasts, and the presence of this 
was also found to be associated with a late stage tumours (Curry et al., 2013). 
Results therefore identify a potential prognostic value for GLUT1 and MCT4 
as  prognostic markers in gastric cancer stroma.  
 
Findings presented in this work show CAM conditioning of AGS cells for 24 
hours led to an increased rate of AGS cell proliferation and migration. Short 
term CAM conditioning of AGS cells also induced increased expression of 
MCT1, when analysed by qPCR, in addition, western blot results showed 
increased levels of both MCT1 transporter channels and CD147, which co-
localises with MCT1 and is required for its functional regulation and location. 
The observed elevation of MCT1 and CD147 expression is indicative of 
increased up regulation of the transport of ketone bodies and other high-
energy metabolites into the cancer cells.  Whilst there are publications 
supporting the concept of paracrine communication, and the ‘feeding’ of 
cancer cells with high energy building blocks for ATP generation (Pavlides et 
al 2009, and Sotgia et al., 2012), there are also conflicting reports in the 
literature.  Data published by Fine et al (2009) showed that ketone bodies 
actually act to inhibit cell growth, via over expression of uncoupling protein 2 
(UCP2). This data is discussed in the context of a modified version of the 
‘Randle Cycle’, which was first proposed in 1963 as ground breaking work in 
the field of metabolism in diabetes (Randle et al., 1963). The Randle cycle 
shows that ketone bodies and fatty acids act to inhibit glycolysis to ensure the 
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stable production of ATP, however in an adapted cancer cell model, 
production of ATP is not stable, due to dis-regulation of UCP2. Data produced 
by Fine et al., suggests that ketone bodies metabolised in cancers that over 
express uncoupling proteins, may inhibit glycolysis. Without the ability to 
produce ATP via oxidative phosphorylation, cell growth would be impaired.  It 
has been proposed that exposure to reactive oxygen species (ROS) and 
induction of HIF-1 may regulate UCPs, potentially leading to their over 
expression (Fine et al., 2009 and Nishio et al., 2005), thereby linking hypoxia 
and oxidative stress to the inhibition of cancer cell proliferation, due to dis-
regulation of mitochondrial electron transport proteins.  
Data presented in this chapter show high levels of mitochondrial respiration 
in AGS cancer cells after conditioning with media from associated CAMs. 
Analysis of microarray data from conditioning experiments show statistically 
significant (p<0.05) down regulation of UCP1 and UCP3 with no statistical 
change in UCP2 [supplementary file III; figure 3.4]. Taken together with 
phenotypic assays of CAM conditioning experiments, whereby we noted a 
corresponding change in AGS cell proliferation, suggesting that without UCP 
over-expression, CAM media rich in ketones and other high energy 
metabolites serves to drive AGS cancer growth.  This lack of over-expression 
of UPCs together with up regulation of ketone bodies in the CAM media is 
consistent with a model of pseudo-hypoxia, rather than hypoxia itself. In this 
model cancer cells maintain their mitochondrial function yet enforce or ‘trick’ 
stromal cells to switch to a more glycolytic phenotype via secretion of factors 
that induce oxidative stress.  To further understand the paracrine 
communication between tumour cells and stroma myofibroblasts, more 
experiments are needed to investigate the differential effects of hypoxia. 
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Performing proliferation assays on co-cultured cells exposed to conditions 
mimicking hypoxia such as treatment with hydrogen peroxide, or incubation 
in a hypoxic chamber, would establish whether there is an inhibition of 
growth in these conditions, as well as determining levels of UCPs by qPCR.   
Up regulation of MCT1 observed in these co-culture experiments also concurs 
with data in the previous chapter, whereby pathway analysis of conditioning 
data showed activation of the PPAR- α pathway in CAM cells compared to 
ATM conditioning.  Whilst there is still much to learn about the complex 
regulation of MCT1, it is known that activation of transcription factor 
peroxisome proliferator-activated receptor (PPAR)-α causes up-regulation of 
genes involved in ketone body synthesis (Kersten et al., 2001). Further work 
in this area in vivo provided data showing that activation of PPAR- α  was 
directly linked to increased mRNA levels of MCT1 (Konig et al., 2008).  This is 
interesting in context of data from co-culture microarrays and supportive co-
culture lab work carried out in this study.  These results provide indications of 
the potential pathways by which MCT1 is activated and regulated, however 
currently this knowledge is very limited, and there is much more to elucidate 
concerning the conditional regulation of transporter channels within different 
cell types. 
 
Elevated MCT1 expression has also been linked to increased invasion in lung 
cancer, colorectal cancer and also in malignant pleural mesothelioma, 
whereby siRNA silencing of MCT1 expression led to decreased invasion (Mogi 
et al., 2012, Pinheiro et al., 2008 and Izumi et al., 2011). Little is known about 
the mechanisms of this phenotype, however our data supports this concept. As 
previously discussed, CD147 is responsible for regulation of MCT1 expression 
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and subcellular localisation (Walters et al., 2013). Our data shows that CD147 
expression is highly up regulated in AGS cells after CAM conditioning. As 
CD147 is known to form a complex with MCT1, (Kirk et al., 2000) it is not 
surprising that its expression pattern closely mimics that of MCT1 in these 
cells. Interestingly, CD147 is also known to regulate and induce MMP 
expression in neighbouring myofibroblast cells (Gabison et al., 2005 and 
Jouneau et al., 2011). It is possible that the invasive properties linked to 
MCT1, could actually be facilitated by the MCT1-CD147 complex, and the 
induction of MMPs by CD147, which would contribute to degradation of the 
extracellular matrix, thereby enhancing tumour cell invasion. 
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4.0  Introduction  
 
Myofibroblasts play an important role in the normal wound–healing process, 
however they are not usually found in healthy uninjured tissues (Eyden, 
2005). Current dogma suggests that prolonged exposure to inflammatory 
signals, or tissue injury may drive a two-phase process in which fibroblasts are 
first converted into protomyofibroblasts, expressing both β and γ actin, before 
progressing to ‘activated myofibroblasts’, which express -smooth muscle 
actin (-SMA) (Micallef et al., 2012). Two factors, which contribute to this 
process, are transforming growth factor (TGF)-β and endothelin-1 (ET-1) 
(Phan et al., 2003).   
 
The microenvironment of gastric tissue is unique as even under healthy 
‘normal’ conditions both epithelia and underlying tissues may be exposed to 
environmental stress, inflammation, and signals that drive constant tissue 
regeneration [figure 4.1].  As cells within the gastric environment are in 
constant contact with these inflammatory signals, activated myofibroblast 
cells make up part of the natural cell population of gastric tissue. These cells, 
however, are functionally different to cancer-associated myofibroblasts taken 
from the site of a tumour or from tissue adjacent to developing tumours. 
These distinctions in gene expression profiles have been previously reported 
(Jones et al,. unpublished data) and have also been discussed in chapters II 
and III in this thesis.   
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In normal gastric tissue, balanced paracrine communication exists between myofibroblasts and epithelial cells. In cancer, cross–talk between 
CAMs and cancer cells leads to changes and activation of cancer promoting cytokines, chemokines and recruitment of adapted immune cells 
such as cancer associates macrophages and mesenchymel stem cells to the tumour site, creating an environment supportive of tumour growth. 
Figure 4. 1. Schematic representing differences between communication in normal ‘healthy’ gastric tissue and gastric 
cancer tissue.  
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The metabolic properties of healthy “normal” primary stromal cells has not 
yet been reported in the literature, nor have primary gastric myofibroblast 
cells taken from healthy tissue been used to resolve questions regarding 
metabolic re-programming within a cancer model.  As myofibroblast cells are 
vital for the wound healing process (Li and Wang, 2011) and cancer is often 
described as ‘the wound, which does not heal’ (Dvorak., 1986), using healthy 
myofibroblast cells to investigate the model of gastric cancer and cell 
reprogramming is potentially more clinically relevant than using an 
immortalised or primary fibroblast cell lines.  Data presented in this chapter is 
novel work in the field, and aims to provide a more comprehensive and 
clinically relevant model of tumour – stroma interactions.  
 Chapter IV; Results Chapter Three  
 149 
 
 
4.1 Aims and Hypothesis 
 
This chapter aimed to test the hypothesis that conditioned media from AGS 
cancer cells is able to induce CAM related functional and metabolic 
reprogramming of NTMs. The primary aim of work described in this chapter 
is to further examine inherent properties of gastric NTMs, and assess the 
potential for cancer cell mediated metabolic reprogramming into CAM like 
‘feeder cells’.  
 
1. To assess the inherent metabolic status of NTMs including analysing 
relative expression of CAM related markers of metabolic status  
 
2. To perform co-culture and cancer-cell conditioned-media studies to 
assess induced changes in NTM metabolic status. 
 
 
3. To establish if NTM cells can be functionally reprogrammed to adopt 
CAM-like metabolic properties. 
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4.2 Chapter Specific Materials and Methods  
Detailed materials and methods can be found in chapter six, however, below is 
a brief outline: 
 
4.2.1 Proliferation and Migration Assays 
EdU proliferation assays and boydon chamber migration assays were carried 
out as described previously. Low passage (P4-P9) NTM cells lines 334, 351 
and 241 were used in both proliferation and migration assays. In each case, 
serum-free media was used as a control, to ensure consistency with growth 
and cell maintenance conditions used in preparation of samples for associated 
microarray studies.  
 
4.2.2 Transwell Co-Cultures  
Long-term transwell co-cultures were set up in 10cm dishes using 2% serum 
media with AGS and NTM 334 cells seeded on the bottom and top 
compartments of the transwell culture units respectively at a density of 
300,000 cells/ml. Cells were fed every 72 hours, before being processed for 
RNA extraction or western blotting on day seven. AGS cells cultured at the 
same density for equivalent time in un-conditioned 2% serum media were 
used to define control levels of RNA and protein expression.  
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4.3 Results  
 
4.3.1 Phenotypic Effects of NTM conditioned media on AGS cells  
 
As previously discussed, there are distinct and definite differences in gene 
expression profiles between normal ‘healthy’ myofibroblasts and 
myofibroblasts taken from the cancer microenvironment.  Microarray analysis 
of CAM, NTM and NTM data, showed distinct and highly dissimilar gene 
expression patterns between NTMs, and CAM and ATM cell lines (Jones et al., 
unpublished data).  Principle component analysis of microarray data showed 
segregation of cell types, and NTMs were shown to have unique global gene 
expression patterns compared to CAMs and ATMs [figure 4.2].  
 
Figure 4. 2. Principal component analysis of all CAM (RED), ATM (BLUE) 
and NTM (GREEN) patient samples.  
PCA shows distinct segregation of myofibroblast cell types. Figure taken from Jones 
et al., unpublished data.  
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To examine more closely the inherent properties of gastric NTMs and to 
establish the potential for cancer cell mediated metabolic reprogramming into 
CAM like ‘feeder cells,’ a series of experiments were carried out.  Firstly, to 
establish the phenotypic effects of exposing AGS cells to NTM conditioned 
media, short term conditioned media proliferation and migration assays were 
performed as previously described (Holmberg et al, 2012). Results from these 
experiments show a significant and consistent increase in AGS cell 
proliferation and migration after treatment with conditioned media from 
NTM cell lines [figure 4.3]. Thereby demonstrating that non-cancer associated 
NTMs secrete factors that promote or encourage proliferation and migration 
of AGS cells. Observed NTM mediated increase in AGS cell proliferation was 
not, however, as high as that induced by equivalent CAM conditioned media 
[chapter III].  
 
The total number of migrated and proliferating AGS cells was variable 
between NTM patients, for example media from patient 334 induced less 
migration than patient 351; however the increase in migrated and dividing 
cells was still significant across all patients compared to the control media. 
Data from migration and proliferation assays were expressed across the three 
individual NTM cell lines [figures 4.3A and B], and as an average across all 
three cell lines [figures 4.3C and D] to illustrate both relative trends in each 
individual primary cell line as well as the overall NTM patient trend. 
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Figure 4. 3. EdU proliferation and boydon chamber migration assays 
representing NTM-conditioning effects on AGS cells.  
Boydon chamber assays showed increase in AGS cell migration, results were 
expressed as both single patient NTM data [A] and [C] combined average numbers of 
migrating cells.  ANOVA analysis of single patient data showed a significant increase 
(indicated by an asterisk (**))  in migration of AGS cells upon treatment with NTM 
media across cell lines (p<0.01). Students T-Test analysis of combined data, also 
showed statistical significance in AGS cell migration after treatment with conditioned 
media (indicated by an asterisk (*), N=3, error bars represent standard deviation. For 
proliferation assays, EdU dye was incorporated into AGS cells treated with NTM 
conditioned media, before FACS analysis was performed to determine % of 
proliferating cells. Results show [B] single patient NTM and [D] combined average 
numbers of proliferating cells following conditioning with either serum free or 
conditioned media (n=3) error bars represent standard deviation.  ANOVA analysis 
of single patient data showed a significant increase (indicated by an asterisk (****) in 
proliferation of AGS cells upon treatment with NTM media across all cell lines 
(p<0.001). Students T-Test analysis of combined data, also showed statistical 
significance in AGS cell proliferation after treatment with conditioned media 
(indicated by an asterisk (**), N=3, error bars represent standard deviation. 
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4.3.2 Validation of Microarray Targets in AGS cells co-cultured 
with NTM cell lines by qPCR 
 
24h conditioning was carried out as previously described to investigate NTM 
mediated changes in AGS gene expression. A series of qPCR experiments were 
designed to compare the top differentially regulated genes observed in the 
CAM conditioning experiments set with the NTM conditioning set. 
 
Data shows that the highest ranking up regulated genes in CAM conditioning 
data sets; HK1, CEACAM5 and GLUT1 were down regulated in NTM 
conditioning data sets [figure 4.4]. OAS1, one of the most greatly down 
regulated genes in the CAM conditioning data set, was only down regulated 
marginally, not significantly, in the NTM data sets. This confirms the 
microarray analysis and principle component analysis showing differences in 
gene expression between CAM and NTM cell lines [figure 4.5]. Whilst NTM 
conditioning has been shown to induce AGS proliferation and migration, it is 
apparent that there are many differences between the genes induced by 
conditioning, suggesting fundamental genetic differences between a CAM and 
NTM conditioning phenotype.  
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Figure 4. 4. qPCR to determine NTM-conditioning effects on AGS cells. 
Data presented shows gene expression in AGS cells following 24 hour conditioning 
with NTM 334  cell media, n=3, error bars represent standard deviation. In each case 
expression levels were normalised to both beta actin and serum free expression 
levels. 
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Figure 4. 5. qPCR shows NTM-conditioning effects on AGS cells. 
Data presented shows gene expression in AGS cells following 24 hour conditioning 
with CAMs 190, 294 and 305 and NTM 334 cell media, n=3. In each case expression 
levels were normalised to both beta actin and serum free expression levels. 
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4.3.3 Short Term NTM conditioning of AGS cells induced changes 
in AGS related gene expression profiles and protein expression 
 
AGS cells were conditioned with NTM media for 24 hours then qPCR was 
carried out to determine the levels of MCT1. Results showed there was a 
significant increase in MCT1 in AGS treated with NTM cell media, compared 
to AGS cells treated with control cell media [figure 4.6].  AGS cells treated 
with CAM conditioned media for 24 hours was also included for comparison.  
Following qPCR data analysis, western blot experiments were also carried out 
to determine the protein levels of MCT1 and CD147 in AGS cells following 
conditioning with NTM media. Western blotting analysis showed NTM cells 
induced expression of MCT1 and CD147 in AGS cells after 24 hour 
conditioning [figure 4.7], this was comparable to the induction of these 
transporter channels by CAM media.  
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Figure 4. 6. Relative changes in levels of MCT1 gene expression following 
exposure to of AGS cells to NTM conditioned media.  
Relative levels of MCT1 expression were quantified by qPCR following exposure of 
AGS cells to either serum free or NTM conditioned media for 24 hours, n=3, error 
bar represent standard deviation. In each case expression levels were normalised to 
both beta actin and serum free expression levels. 
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Figure 4. 7. Western blot to show MCT1 and CD147 protein levels  
following exposure of AGS cells to NTM conditioned media. 
Western blots were carried out following exposure of AGS cells to either serum free, 
CAM or NTM conditioned media for 24 hours. Tubulin was used as a loading control 
to check for equal loading.  
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4.3.4 Long Term AGS cells conditioning induced changes in NTM 
related gene expression profiles  
 
Following 24hr AGS conditioning with NTM media, a series of experiments 
were designed to test the hypothesis that AGS cells grown in co-culture with 
NTM cells could induce ‘CAM like’ changes in gene expression in NTM cells. 
Previous data from CAM, ATM and NTM microarrays showed primary gastric 
NTM cells have uniquely different gene expression profiles compared to 
gastric CAMs (Jones et al,. unpublished data). Specifically, NTM cell lines 
appear to have little to no expression of metabolic related transporter 
channels, such as GLUT1 and MCT4. In addition, results from seahorse 
metabolic profiling experiments and Mitotracker cell staining performed in 
this study, also show a marked difference in metabolic status between NTM 
and CAM cell lines [chapter III]. This data infers that in normal ‘healthy’ 
myofibroblast cells, mitochondria mediated oxidative respiration is 
predominantly used to generate ATP. Given the inherent differences observed 
between NTM and CAM metabolism, a series of experiments were designed to 
investigate whether it was possible to re-programme NTMs with cancer cell 
media, to determine if they acquire CAM-like metabolic feeder properties.  
This information would be advantageous in generating a more realistic model 
for tumour–stroma interactions in the early stages of tumours, particularly in 
relation to metabolic changes within the tumour microenvironment.  
 
To investigate changes in NTM gene expression profiles following exposure to 
AGS cells or AGS-conditioned media, long-term co-cultures were carried out 
in 10cm transwell plates. Transwell plates allow for the movement of small 
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molecules such as cytokines through the 0.4uM membrane, but do not allow 
for the movement of cells, thus ensuring two separate monolayers in each 
compartment, but the free exchange of media and components between cells.  
This allows for the understanding of effects of paracrine communication 
between these two cell subsets.  
 
Firstly, as GLUT1 was previously identified as being up regulated in CAMs but 
not in NTM cell lines [chapter III] it was selected as a target for further 
investigating in long- term NTM conditioning experiments.  qPCR 
experiments were carried out on transwell lysates to investigate the changes  
in induction of GLUT1 in NTM cells. Previous data presented in this work 
showed that expression of GLUT1 is inherently low in these cell types.  
After 7 day co-culture with AGS cancer cells, GLUT1 was up regulated 15 fold 
compared to cells cultured alone [figure 4.8]. For both cancer treated and 
control transwell plates, the seeding densities and the cell culture media used 
was consistent, and cells were fed every 72 hours. This data illustrates how 
rapidly and robustly paracrine communication between cell types can act, and 
how within just seven days, NTM cell line 334 is showing changes at the 
mRNA level in GLUT1, which has been previously demonstrated in CAM cell 
lines.   
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Figure 4. 8. Relative changes in levels of GLUT1 gene expression 
following co-culture of AGS cells with NTM cells. 
qPCR  was carried out on NTM cells line 334 after 7 days of co-culture with AGS cell 
to investigate levels of GLUT1. Co-cultured cells were compared to the non-treated 
control cells. Results represent n=3, data was normalised to beta actin as a stable 
housekeeping gene, error bars represent standard deviation. 
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4.3.5 Long Term AGS cells conditioning induced changes in NTM 
related protein expression profiles  
 
Due to the nature of these studies, for determining protein expression, 
comparative profiling was performed on one representative cell line from the 
‘normal’ myofibroblast cell bank, NTM 334, plus cancer associated 
myofibroblast cell lines from both ‘good’ and ‘bad’ prognostic patients, CAM 
308 and CAM 294. Results showed that after 7-day co-culture with AGS cells, 
NTM 334 up-regulated MCT4 transporter channel to a comparable level to 
that observed in CAM cells [figure 4.9A]. No up-regulation of MCT4 was 
observed in control myofibroblast cells, which had not been co-cultured with 
AGS cells [figure 4.9B].  This data indicates paracrine communication exists 
between AGS cancer cells and primary NTM cells, which is sufficient to induce 
MCT4 expression in theses “normal” myofibroblast cells after just 7 days of 
co-culture. 
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Figure 4. 9. Western blot to show comparison of CAM and NTM cells after 
co-culture.   
Myofibroblast cell lines were cultured for 7 days alone in media containing 2% FBS 
[A], or together with AGS cells in media containing 2% FBS [B]. Following cell lysis, 
BCA was carried out for protein normalisation and then samples were processed for 
western blotting. Membranes were probed for MCT4 and tubulin was used as a 
loading control. 
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4.3.6 NTM induced changes in AGS Cell Protein Expression 
 
To investigate the reciprocal responses induced in AGS cells co-cultured with 
NTM cell lines, lysates were collected from corresponding AGS cells grown in 
transwell units for analysis of corresponding markers MCT1 transporter and 
CD147 expression by western blotting.  MCT1 was selected as this was 
observed previously in the CAM induced phenotype [chapter III], as well as 
being reported in the literature (Pavlides et al 2009, Bonuccelli  et al., 2010 
and Sotgia et al., 2012), it is known to be up-regulated in response to 
transport of small high energy metabolites such as ketone bodies (Cuff et al., 
2002).  
Results showed levels of MCT1 transporter expression in AGS cells increased 
in response to both CAM and NTM conditioned media following 7 days co-
culture [figure 4.10], MCT1 was also present in the control treated cells (AGS 
cells grown for 7 days in 2% FBS media), this would be expected as this 
transporter channel is reported to be differentially regulated in some cancers 
(Curry et al., 2012, Zhao et al., 2014 and Pinheiro et al., 2011) and analysis 
using Genevestigator software also showed this gene has been pulled out of 
microarray analysis from the gastric cancer database [chapter II]. MCT1 up-
regulation is usually observed when oxidative cancer cells increase 
importation of lactate or ketone bodies to fuel their mitochondrial respiration, 
results showing increased MCT1 in AGS cells co-cultured with NTM cell line 
therefore suggests increased rate of mitochondrial respiration. CD147, 
otherwise known as Emmpirin is a member of the immunoglobulin 
superfamily and is expressed on many cells (Iacono et al., 2007).  
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It is reported to be essential for maintaining protein expression levels of 
monocarboxylate transporter channels (Kirk et al., 2000), as well as its 
primary function of regulating other processes such as MMPs (Chen et al., 
2011 and Sun et al., 2001), hence the name, Emmpirin (extracellular matrix 
metalloproteinase inducer). 
 
Results by western blot showed an increase in CD147 expression, which was 
detected in its mature, fully glycosylated form in the AGS cells co-cultured 
with CAM or NTM conditioned media. In contrast, when AGS cells were 
cultured in control unconditioned 2% FBS media, very little high molecular 
weight, un-glycosylated CD147 was detected, with the majority of expressed 
CD147 being detected as the lower molecular weight immature/core 
glycosylated form [figure 4.10] The observed difference in ratios of mature 
and immature forms of CD147 is consistent with MCT1 being required for 
CD147 maturation (from core to a complex form of glycosylation). This data 
suggests that after co-culture for 7 days, both CAM and NTM cell lines are 
capable of inducing maturation of CD147, which is consistent with detected 
increased levels of MCT1.   
 
MCT1 was still observed in the control cells as can be seen by the band in 
figure 4.10, however it was clear that CD147 levels were different in the CAM 
and NTM co-culture data, showing a distinct band at 64kDa and a fainter 
band at 82kDa. This data clearly suggests that overall the CAM and NTM cells 
have increased turnover and up regulation of MCT1/CD147 levels. 
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Figure 4. 10. Comparative levels of MCT1 and CD147 expression in AGS 
cells cultured in the presence or absence of CAM or NTM cells. 
AGS cells were cultured for 7 days with myofibroblast cell lines 308, 294 or 334 in 
media containing 2% FBS, control cells were grown alone in media containing 2% 
FBS. Following cell lysis of AGS cells, BCA was carried out for protein normalisation 
and then samples were processed for western blotting. Membranes were probed for 
MCT1, CD147 and tubulin was used as a loading control. 
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4.4 Discussion  
 
It is well established that tumour development is driven by reciprocal 
paracrine communication between cancer cells and cells in the neighbouring 
tissue or stroma. During this process, cancer cells produce oncogenic and 
signals, which enhance the growth and invasion into the surrounding stromal 
cells.  Whilst there is supporting evidence for the role of cancer associated 
fibroblasts (CAFs) in tumour progression, there are also many reports 
demonstrating that fibroblasts can restrict and contain cancer cells (Alkasalias 
et al., 2014 and Bisell et al., 2011), in part by preventing EMT and metastasis. 
  
Conversion of fibroblasts to myofibroblasts is hypothesied to be driven by 
exposure to inflammatory signals, which also attract differentiated 
myofibroblasts to the site of damage (Cai et al., 2010). Active myofibroblasts 
secrete ECM degrading proteases, thereby promoting changes in ECM 
composition and turnover (DeClerck et al., 2004).  In addition, 
myofibroblasts can also modulate immune responses at the site of injury and 
secrete various growth factors (Kim et al., 2010).  Using primary 
myofibroblast populations, to investigate cancer induced reprogramming is 
therefore more clinically relevant than using immortalised fibroblast cell lines  
when investigating molecular processes that drive the development and 
progression of gastric tumours.  
 
Previous data has shown that NTMs have similar inflammatory properties to 
CAMs, such as secretion of cytokines and interferon responses (Jones et al., 
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unpublished data). Also, NTMs are able to stimulate migration and 
proliferation of AGS cells in vitro. Comparison of metabolic profiles in the 
previous results chapter however, illustrated fundamental differences in 
primary NTM and CAM cells. In our studies NTMs exhibited much higher 
mitochondrial activity and significantly less GLUT1 expression, compared to 
CAMs. Glycolytic stress tests performed using the Seahorse show that CAM 
cells have increased extra-cellular acidification rates compared to NTM cells. 
In light of this observation we decided to examine the effects of co-culturing 
NTM cells with AGS cancer cells, in order to establish if CAM like metabolic 
profiles could be induced in NTMs, Thereby mimicking processes that may 
take place during cancer progression.   
 
Data presented in this chapter provides evidence that NTMs can be 
reprogrammed to adopt CAM like metabolic properties, which would support 
tumour growth. These changes include the up-regulation of MCT4, GLUT1 
with a converse induction of MCT1 and CD147 in AGS cells.   Collectively, 
these results show that prolonged reciprocal paracrine communication 
between gastric cancer cells and stromal myofibroblasts results in metabolic 
reprogramming to a pro-tumorigenic phenotype [figure 4.11]. 
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Figure 4. 11. Schematic to show the predicted model of NTM cells 
transition to a more ‘CAM’ like phenotype.  
Cross–talk between NTMs and cancer cells leads to changes and activation of cancer 
promoting cytokines, chemokines to the tumour site, driving mutual changes in both 
cell subsets. NTMs develop CAM- like properties, undergoing changes in metabolism, 
creating an environment supportive of tumour cell growth. 
 
 
 
Currently, there is limited work in the field of cancer related myofibroblast re-
programming, especially in the field of gastric cancer.  Data from studies on 
prostate cancer (Ishii et al., 2011) supported the findings presented in this 
work. Results demonstrated that co-culture of “normal” human prostate 
stromal cells with prostate cancer cell lines led to the induction of biochemical 
 Chapter IV; Results Chapter Three  
 170 
 
properties of “cancer associated” stromal cells, such as up regulation of TGF-
β. Conditioning of immortalised fibroblast cell lines with media from cancer 
cell lines has also been previously shown to induce an increased rate of 
aerobic glycolysis and energy transfer in the fibroblast cells (Guido et al., 2012 
and Martinez-Outschoorn et al., 2012).  
 
Similar work has also been performed in breast cancer models, whereby co-
culture of breast cancer cells with ‘normal breast fibroblasts’ cells promoted 
cancer cell invasion through up regulation of ADAM metallopeptidases (Tyan 
et al.,2012). Results showed cancer cells are capable of inducing normal 
stromal fibroblasts to secrete ADAMTS1 after co-culture (Tyan et al.,2012). 
Significantly, this study also highlights the induced change from a ‘normal’ to 
‘cancer promoting’ myofibroblast phenotype was not a transient process, but 
were retained after multiple passages, suggesting these changes were in some 
way epigenetically programmed.   In the field of gastric cancer, further work is 
required to establish whether the induced metabolic phenotype in ‘normal 
myofibroblast’ cells is retained after co-culture with AGS cancer cells is 
stopped. This would provide a more thorough picture to establish if these 
changes are epigenetic and offer further insight into this model.  Additionally, 
further work establishing the phenotypic effects of these metabolic changes, 
such as invasion, migration and responses to therapeutic drugs would provide 
new insight into the molecular mechanisms of tumour progression and novel 
therapeutic options. 
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5.0 Discussion  
 
5.1 Summary and Conclusions  
 
This study provides novel insight into mechanisms of paracrine 
communication and stromal cell programming in gastric cancer. Initial 
analysis of differential gene expression profiles resulting from exposure of AGS 
cells to conditioned media derived from different populations of primary 
myofibroblasts demonstrated that cancer derived myofibroblasts have unique 
properties that are retained in purified low-passage primary cultures.  
Comparative analysis of differential changes in gene expression profiles also 
provided new insight into molecular mechanisms, pathways and 
transcriptional networks, which operate in different classes of stromal 
myofibroblasts. In particular, we identified a clear pattern of imposed 
metabolic changes, which may well play a key role in the progression and 
prognosis of gastric cancer.  
 
5.2 Bioinformatic Analysis of Co-Culture Data  
 
In terms of CAM-to-AGS communication, pathways associated with 
inflammation and immune evasion were found to be most differentially 
regulated following exposure of AGS cells to CAM and ATM myofibroblast 
conditioned media. As chronic inflammation, gastritis and infection, are 
known to be causative factors in many cases of gastric cancer, this observation 
is in agreement with currently accepted models of gastric tumour development 
(Fox et al.,2007 and Bornschein et al., 2010). 
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Previous collaborative work in our laboratories (Varro and Sanderson) 
identified retained metabolic signatures in primary CAMs (Jones et al., 
unpublished data). In this study, we wanted to determine whether these 
changes confirmed reciprocal CAM-specific changes in the metabolic status of 
AGS cells. Subsequent pathway enrichment analysis showed that CAM 
conditioned media induced changes in the PPAR– pathway, which is 
associated with the regulation of the transporter channel MCT1. Activation of 
specific metabolically linked transcription factors, such as SP1 (Archer et al 
2011) were identified in CAM conditioned AGS cells. Interestingly, similar 
reciprocal changes in metabolic regulation have also been observed in other 
cancer models, and these changes are often associated with a more aggressive 
phenotype (Martinez-Outschoorn et al., 2011) and poor patient prognosis. This 
study suggests that markers of this form of reprogramming may also have 
utility in diagnosis and prognostic prediction in gastric cancer. 
 
5.3 Metabolic Signatures in CAM cells  
 
Following analysis of data from CAM conditioning of AGS cells, a series of 
experiments were planned to investigate the metabolic signatures identified 
from previous microarray analysis (Jones et al., unpublished data). Results 
from these studies show that CAMs and NTMs retained functional and 
phenotypic differences both at protein and mRNA levels. In particular, CAM 
cells showed up-regulation of GLUT1 and MCT4 channels, both metabolic 
markers that are synonymous with active glycolysis. These cell-types also 
exhibited low levels of staining with MitotrackerTM, indicating predominantly 
of less ‘active’ aerobic respiration takes place. Whilst these changes were 
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consistently observed across a selection of primary CAM cell lines, further 
investigations would need to be carried out to establish if there are more subtle 
differences between CAMs derived from early or late stage patient subgroups 
(Varro lab, Jones et al., unpublished data).  It may be expected that greater 
changes in metabolic signatures observed in CAM cell lines might correlate 
with a worse patient survival and prognosis score, as these metabolic changes 
feed the cancer cells, supplying more ATP for tumour growth and metastasis.  
Further analysis of CAM cell lines using other biochemical assays such as 
ketone and lactate kits would provide further information to quantify the 
production of Ketone bodies or pyruvate in different myofibroblast 
populations 
 
 
5.4 Re-programming of Normal Tissue Myofibroblasts  
 
Gastric tissue is relatively unique as activated myofiboroblasts are also found 
in normal healthy gastric tissues. These cells, however, are functionally 
different to CAMs taken from the site of a tumour, or from tissue adjacent to 
developing tumours, showing differences in microarray gene expression 
profiles, transcription factor expression and metabolic gene expression. 
However, data presented in this thesis show that NTMs can be re-
programmed in vitro by co-culture with AGS gastric cancer cells. 
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5.5 Future work and the potential for therapeutic intervention  
 
Data presented in this thesis reveal the therapeutic potential of MCTs in the 
treatment of gastric cancer. The use of MCT inhibitors in the treatment of 
solid tumors is relatively new; currently an MCT1 inhibitor is undergoing 
phase 1 clinical trials for the treatment of solid tumours, whilst MCT4 
inhibitors are currently undergoing development, but as yet there is no 
available data on the success of these drugs in the clinic. In general, MCTs 
offer an attractive option for intervention in the development of aggressive 
forms of gastric cancer,  which are not responding to conventional treatment. 
Potentially MCT inhibitors could be used after primary patient treatment, to 
disrupt the paracrine communication between the tumour and it’s stroma, 
and to prevent micro-metastasis and secondary cancer growth.   
Intervention using MCT1 inhibitors may however, pose a number of problems; 
firstly there is an assumption that tumours either rely on mitochondrial 
respiration or switch to glycolysis. However, this may be a very simplistic view 
as many late stage tumours may have areas of hypoxia, where cells would 
preferentially rely on glycolysis. As such, they will have areas of pseudo-
hypoxia and they may also have areas of high oxidative phosphorylation. 
Therefore, inhibition of MCT1 may not be successful in cases where there 
exists a mixture of tumour niches. Also, where it is effective, blocking intake of 
high-energy metabolites (by inhibition of MCT1) may cause further evolution 
of the cell to rely on alternative means of ATP production, such as fatty acid 
pathways  or activation of GCN2, which can act to induce ATF4 which can act 
to drive cell proliferation, evasion of apoptosis and adapt a metabolic response 
(Ye et al., 2010). 
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MCT1 is proposed to be the major regulator of bidirectional monocarboxylic 
acid transport between the brain and the blood (Smith et al., 2006). As 
discussed previously, the tumour stroma relationship mirrors the paracrine 
communication that exists between astrocytes and neurones within the brain. 
As lactate does not cross the blood-brain barrier easily, neurons obtain lactate 
from neighboring astrocytes via monocarboxylate transporter channels 
(Pellerin et al., 1998).  Interfering with this natural lactate shuttle in the brain 
could have serious deleterious effects on neuronal survival and brain function.  
 
The mechanisms by which MCT1 is regulated are still poorly characterised. 
Whilst its expression varies in response to external environmental stimuli, the 
controlling pathways and molecular regulation up-stream of this is not well 
elucidated. In this study we show that the PPAR- pathway is differentially 
regulated in response to CAM conditioning of AGS cells. Also, PPAR- is 
known to regulate MCT1 expression in cells (König et al., 2008). 
 
Further knowledge and understanding of other pathways controlling the 
regulation of MCTs would be beneficial and could provide additional 
therapeutic options; for example, selecting a molecular target up-stream of 
MCT1, which induces over-expression via a cancer specific pathway could be 
one way of specifically targeting MCT1 in cancer cells, whilst avoiding 
detrimental effects in healthy cells.  Data presented in this thesis show that 
CD147 expression is induced in AGS cells treated with CAM media, in the 
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same pattern as MCT1 expression. CD147 is known to form a complex with 
MCT1 and MCT4, and could offer further options for therapeutic intervention. 
 
5.6 Concluding Remarks  
 
Since the initial postulation of the ‘Warburg Effect’, there have been numerous 
studies that have concluded that cancer cells switch to aerobic glycolysis over 
mitochondrial respiration (Schulze et al., 2011, Salminen et al., 2010 and Cai 
et al., 2010). However, many of these studies do not take into account the 
complex nature of the cancer microenvironment. Results presented in this 
thesis support a reverse Warburg type effect in gastric cancer, whereby cancer 
cells program surrounding cells to provide nutrients, thus enabling cancer 
cells to maintain an increased rate of mitochondrial respiration. Interestingly, 
we also found that AGS cells also exhibited some markers of glycolysis, such 
as, up regulation of GLUT1 and HK1. This suggests that cancer cells may 
either be utilising both forms of respiration, switching from one form to the 
other, or that different cells within the total population exhibit different 
profiles. Further studies utilising quantitative in vitro and in vivo models are 
required to differentiate between these possibilities.   
 
The dynamic tumour microenvironment, involves a combination of immune 
cells, stem cells, fibroblasts and proliferative tumour cells ultimately the 
complex patterns of combinatorial crosstalk between all of these cell types will 
determine the efficiency of tumour growth. In this context it will be important 
to develop improved multi cell co-culture systems in which the relative 
contribution and proportions of each cell type can be studies and quantified in 
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order to develop mathematical models, which allow the consequences of 
sequential and combined perturbations to be modelled in order to guide 
development of optimal therapeutic strategies.   
 
Therefore in conclusion it is important to take into consideration the various 
factors in the processes of tumour growth and development, and to recognise 
that tumour cells do not rely on glycolysis or mitochondrial respiration as 
mutually exclusive events. Work from this thesis has demonstrated that in a 
gastric cancer model, there can be a switch of stromal cells to become ‘feeder’ 
cells, which support the growth of neighbouring cancer cells, and these 
changes could be exploited to develop novel therapeutic agents to work in 
conjunction with chemotherapy.   
 
Our data supports the hypothesis that the microenvironment does have an 
important role to play in energy metabolism and thus the growth of tumour 
cells. Our results support the concept of tumour compartmentalisation in 
energy metabolism and the metabolic shunting of high energy metabolites, 
depending on the needs of the cancer cells. It is evident clear that the tumour 
microenvironment is a dynamic and evolving system, in which both tumour 
and stromal cells continually adapt to provide an environment that is 
supportive of sustained but regulated tumour growth, and continued work in 
this area will provide more understanding of the complexities of this 
relationship.  
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6.1 Materials  
 
6.1.1 Reagents and Materials 
 
AGS gastric cancer cell line was obtained from the American Type Culture 
Collection (VA, USA)  
Antibiotic-antimycotic solution (Sigma, Poole, Dorset, UK)   
BCA Protein Assay (Thermo Scientific, UK) 
 BD Control Cell Culture Inserts and BD BioCoat Matrigel Invasion Chambers 
(BD Biosciences, Massachusetts, USA)   
Blocking Reagent (Biorad UK) 
 Bovine serum albumin (BSA; Jackson Immuno Research Laboratories, 
Suffolk, UK)  
Cell-Tak Cell Solution (BD Biosciences, UK) 
Clarity™ Western ECL Blotting Substrate (Biorad, UK) 
Click-iT® EDU proliferation Assay (Life Technologies, UK) 
Dulbecco's Modified Eagle's Medium (Sigma, Poole, Dorset, UK)   
Fetal bovine serum (FBS; Perbio, Cheshire, UK)   
GeneChip©Human Genome U133 Plus 2.0 arrays (Affymetrix, Santa Clara, 
CA, USA)   
Kodak X-Omat XAR-5 film  (Sigma, Poole, Dorset, UK) 
Mini-PROTEAN pre-cast gels (Biorad, UK)  
Mitotracker CMXRos dye (Life Technologies, UK) 
Nitrocellulose Membrane (Life Technologies, UK) 
Non-essential amino acid solution (Sigma, Poole, Dorset, UK)   
PageRulerTM Plus Prestained Protein Ladder (Fermentas, York, UK)  
Penicillin-streptomycin solution (Sigma, Poole, Dorset, UK)   
Phosphatase Inhibitor Cocktail set II, EDTA-Free (Calbiochem, USA)   
Protease Inhibitor Cocktail Set III, EDTA-Free (Calbiochem, USA) 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Quant-iT PicoGreen ds DNA kit (Life Technologies, UK) 
Quick Diff Kit for cell stain (IBG Immucor Limited) 
RNeasy kit (Qiagen, West Sussex, UK)   
Sequencing-grade modified trypsin (Promega, WI, USA)   
TWEEN20 (Sigma, Poole, Dorset, UK) 
Water (H20) used in all experiments was Millipore double filtered water. 
Whatman 3mm paper, Z763187 (Sigma, Poole, Dorset, UK) 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6.1.2 Solutions and Equipment 
The antibodies used for the work carried out in this thesis are listed below 
[table 20], together with the species of antibody (M= Mouse and Rb=Rabbit) 
and dilution used. Antibodies were used for both western blotting (WB) and 
Immunofluorescence (IF) techniques. Antibodies for western blotting were 
diluted in 5% blocking buffer [table 22], antibodies for immunofluorescence 
were diluted using 3% BSA [table 20].  
 
 
Antibody 
 
Antigen 
 
Dilution 
Factor  
 
Buffer 
 
Company and 
lot number 
 
Rb α MCT1 
 
Rb α MCT4 
 
Rb α GLUT1 
M α Tubulin 
Rb α CD147 
 
Donkey α 
Rb HRP 
 
Donkey α M 
HRP 
 
Human MCT1 
 
Human MCT4 
 
Human GLUT1 
Human Tubulin 
Human CD147 
 
IgG 
 
IgG 
 
1:500 
 
1:500 
 
1:1000 
1:1000 
1:500 
 
1:10,000 
 
 
 
1:10,000 
 
 
 
 
 
5 % milk 
in 
PBST/ 
 
3% BSA 
 
 
Santa Cruz (sc-
14916)   
Santa Cruz  (sc-
50329 
Abcam(ab40084) 
Abcam(ab6046) 
Abcam(ab64616) 
 
Jackson(715-001-
003) 
 
 
Jackson(711-001-
003) 
Table 20.  Antibodies and dilutions used in the work presented in this thesis.  
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Equipment 
 
Manufacturer and Model 
 
Seahorse  metabolic analyser 
 
 
Benchtop centrifuge 
 
qPCR machine  
 
Semi dry blotter 
 
Wet transfer blotter 
 
Live cell microscope 
 
Fixed cell microscope 
 
Nanodrop 2000 
 
 
Seahorse XFe  24 Flux Analyser, 
Seahorse Biosciences 
 
Eppendorf centrifuge  
 
Biorad CFX Connect 
 
Biorad Trans- Blot 
 
Biorad Protean 
 
Multiphoton two  
 
Olympus 1x81 
 
Thermo Scientific 
Table 21. Equipment used to carry out the work presented in this thesis.  
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The compositions of all buffers used within this thesis are described in the 
table below [table 22]. Water was the standard solvent used unless otherwise 
stated. 
 
Buffer 
 
Composition 
 
 
3 x sample buffer 
 
 
 
 
 
Mammalian cell lysis buffer 
 
 
 
Ponceau 
 
     SDS-PAGE stacking buffer 
 
 
 
SDS-PAGE separating buffer 
 
 
 
       SDS-PAGE running buffer 
 
 
 
 
Transfer buffer  
 
 
 
                        MOPS Buffer 
 
Blocking buffer 
 
 
Wash Buffer 
 
For 100 ml: 2.3 g Tris base, 9.0 g 
SDS, 30 ml glycerol, adjust volume to 
90 ml with dH2O,  50 mg 
bromophenol blue, add 10% β-
mercaptoethanol  
100μl RIPA buffer containing 1% 
protease and 1% phosphatase 
inhibitors 
0.2% Ponceau red in 1% acetic acid 
Acrylamide/Bis, ddH2O, 1.5M Tris-
HCl pH 8.8, 10% SDS, 10% APS, 
TEMED 
Acrylamide/Bis, ddH2O, 1.5 M Tris-
HCl pH 8.8,  10% SDS, 10% APS, 
TEMED 
0.2 g/l Tris base, 188 g/l glycine, 10 
g/l SDS 
 
14.4 g Glycine, 3.03 g Tris, 800 ml 
Water and 200 ml methanol 
 
Dilute 20x MOPS buffer in ddH2O 
5% blocking reagent in 50ml 1XPBS 
plus 1% tween 
1XPBS plus 1% tween 
Table 22. Buffers used to carry out the work presented in this thesis 
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6.2  Methods 
 
6.2.1 Primary Myofibroblast Cell Extraction (Varro Laboratory) 
 
Biopsies were taken from 14 patients with gastric cancer in Szeged hospital, 
Hungary. Myofibroblast cells taken from tissue in the tumour stroma are 
referred to as cancer associated myofibroblasts (CAMs) in 12 of the patients, 
biopsies were also taken from the tissue adjacent to the tumour site, these 
myofibroblast cells are referred to as adjacent tissue myofibroblasts (ATMs). 
As a control, myofibroblasts from normal tissues were extracted from 12 post 
mortem organ donors who had no known underlying medical conditions, 
these cells are referred to as normal tissue myofibroblasts (NTMs). These 
patient samples are shown in table 23. All work was approved by the Ethics 
Committees of the University of Szeged, Hungary. 
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Label Sample Sample type 
1-CAM Sz42/1 P5 Cancer 
1-ATM Sz42/2 P5 Adjacent 
2-CAM Sz45/1 P5 Cancer 
2-ATMA Sz45/2 P5 Adjacent 1 
2-ATMB Sz45/22 P7 Adjacent 2 
3-CAM Sz190/1 P4 Cancer 
3-ATM Sz190/2 P4 Adjacent  
4-CAM Sz192/1 P5 Cancer 
4-ATM Sz192/2 P5 Adjacent  
5-CAM Sz194/1 P5 Cancer  
5-ATM Sz194/2 P5 Adjacent 
7-CAM Sz198/1 P5 Cancer 
7-ATM Sz198/2 P5 Adjacent   
8-CAM Sz268/1 P5 Cancer 
8-ATMA Sz268/2 P5 Adjacent 1 
8-ATMB Sz268/22 P5 Adjacent 2 
9-CAM Sz271/1 P5 Cancer 
9-ATM Sz271/2 P5 Adjacent 
10-CAM Sz294/1 P4 Cancer 
10-ATMA Sz294/2 P5 Adjacent 1 
10-ATMB Sz294/22 P4 Adjacent 2 
11-CAM Sz305/1 P5 Cancer 
11-ATMB Sz305/22 P5 Adjacent 1 
12-CAM Sz308/1 P5 Cancer 
12-ATM Sz308/22 P6 Adjacent 
13-CAM Sz187/1 P8 Cancer 
14-CAM Sz197/1 P5 Cancer 
15-CAM Sz389/1 P7 Cancer 
15-ATM Sz389/2 P7 Adjacent 
21-ANMA Sz196/2 P5 Normal Tissue Myofibroblast  
22-ANMA Sz241/2 P6 Normal Tissue Myofibroblast  
22-ANMB Sz241/22 P6 Normal Tissue Myofibroblast  
23-ANMA Sz246/2 P6 Normal Tissue Myofibroblast  
23-ANMB Sz246/22 P6 Normal Tissue Myofibroblast  
24-ANMA Sz261/2 P6 Normal Tissue Myofibroblast  
24-ANMB Sz261/22 P6 Normal Tissue Myofibroblast  
25-ANMA Sz279/22 P4 Normal Tissue Myofibroblast  
26-ANMA Sz334/2 P5 Normal Tissue Myofibroblast  
26-ANMB Sz334/22 P5 Normal Tissue Myofibroblast  
27-ANMA Sz351/2 P5 Normal Tissue Myofibroblast  
27-ANMB Sz351/22 P5 Normal Tissue Myofibroblast  
28-ANMB 845P7 Normal Tissue Myofibroblast  
Table 23. Table detailing full list and labelling of primary patient myofibroblasts 
with passage number and sample type 
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Sz187 Sz197 Sz389 Sz192 Sz45 Sz195 Sz294 Sz268 Sz271 Sz194 Sz308 Sz305 Sz190 Sz198 Sz42 Patient code 
CagA 
+ve 
CagA 
+v None 
CagA 
+ve None 
CagA 
+ve None 
CagA 
+ve None H.pylori H.pylori 
CagA 
+ve None H.pylori None 
H.pylori status. 
H.pylori = infected 
CagA +ve =cagA strain detected 
None = No H.pylori infection  
F M M F M F F M M M M M F M M Gender 
39 54 67 49 82 85 84 76 72 76 51 59 65 77 72 Age 
TOTAL TOTAL DISTAL TOTAL DISTAL DISTAL TOTAL TOTAL TOTAL DISTAL TOTAL TOTAL TOTAL DISTAL TOTAL Type of resection 
0 0 1 0 1 1 1 0 0 1 0 0 0 1 0 
Anaemia HGB<100G/L or Blood 
Transfusion 
0 0 0 1 0 0 0 1 1 0 0 1 1 1 0 BMI <19 or Bodyweight loss >10KG 
4 2 3 3 3 1 3 4 4 1 1 3 4 2 1 
pTNM 
T 
2 0 1 2 2 1 0 2 1 0 2 2 0 0 0 N 
0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 M 
3 3 2 3 3 3 3 3 3 1 3 3 3 2 3 Grade 
0 1 0 1 0 1 0 0 1 0 1 1 1 0 0 Histological type: Intestinal or diffuse 
0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 Lymphatic vessel invasion 
1 0 0 0 0 0 0 1 1 0 0 0 0 0 0 Vascular invasion 
1 0 0 0 1 0 0 0 0 0 1 1 0 0 0 Positive margins of resection 
0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 Serological tumour marker-elevation 
0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 Tumour recurrence 
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
Synchron 
or 
metachron 
tumour 
With surgical 
intervention 
0 0 0 0 0 1 0 0 1 0 0 0 0 1 1 
Without surgical 
intervention 
15.5.07 16.8.07 2.7.06 21.5.07 26.6.06 7.8.07 5.12.07 6.11.07 13.11.07 6.8.07 8.1.08 3.1.08 18.5.07 27.8.07 16.6.06 Date of operative 
42 62 50 22 2 13 51 15 24 60 9 17 5 60 75 Survival (months) 
   29.3.09 8.06 14.9.07 12.3.12 2.09  1.9.12 19.10.08 1.8.09 14.10.07 10.9.12  Exit 
11 6 7 11 11 9 7 11 12 4 12 12 13 7 5 Total 
6 6 6 4 6 6 6 6 5 6 3 6 6 4 6 Myoscore 
Table 24. Patient information relating to the scoring details . Row displaying the total represents the prognosis score and is calculated based on 
the sum of all the variables. If the value is left blank the patient is not deceased. 
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6.2.2 Myofibroblast Cell Line Generation and Culture 
 
Primary myofibroblast cells were isolated from tissue samples and cultured by 
Peter Hegyi, (Department of Medicine, University of Szeged, Hungary), as 
previously described (McCaig et al., 2006). Primary myofibroblasts were 
cultured in Dulbecco’s   Modified   Eagles   Medium   supplemented with 10% 
Fetal Bovine Serum, 2% Antibiotic-Antimycotic solution, 1% Penicillin-
Streptomycin Solution, and 1% Non- essential amino acid solution. Cells were 
maintained at 37 ̊C and 5% CO2 and media was changed approximately every 
60 hours. When the cells reached 70 – 80 % confluence the cells were split by 
washing in Dulbecco’s Phosphate Buffered Saline before adding 0.25% trypsin 
for 4 to 5 minutes and cell passage number was noted. In all experiments cells 
were not passaged beyond passage 14 as it has been documented previously 
that primary cells may become senescent and stop proliferating after this 
point.  
6.2.3 AGS Cell Culture 
 
AGS cells were grown in Dulbecco’s   Modified   Eagles   Medium 
supplemented with 10% Fetal Bovine Serum 1% Antibiotic-Antimycotic and 
1% Penicillin-Streptomycin Solution. Cells were maintained at 37 ̊C and 
5%  CO2 and cells were passaged or media was changed approximately every 
46-72 hours. 
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6.2.4 Generation of Conditioned Media 
CAM cells were seeded at a density of 1,000 cells/ml, and left to grown for 24 
hours. After being washed three times in Dulbecco’s Phosphate Buffered 
Saline, Dulbecco’s   Modified   Eagles   Medium without fetal bovine 
serum was added to the cells, and they were left to grown for 24 hours.  The 
following day media was collected and centrifuged for 7 minutes at 800g, the 
supernatant was removed and this was used for the conditioning experiments. 
6.2.5 AGS Cell Conditioning for Microarray Analysis (Varro 
Laboratory) 
AGS cells were cultured onto 10 cm dishes and left to grow for 24 hours at a 
density of 1 million cells per ml. After being washed three times in Dulbecco’s 
Phosphate Buffered Saline, the conditioned media from cancer associated 
myofibroblasts and adjacent tissue myofibroblasts was added to a confluent 
monolayer of AGS cells. Dulbecco’s   Modified   Eagles   Medium without fetal 
bovine serum added to AGS cells was used as the control.  After 24 hours the 
cells were ready to be used for RNA extraction and subsequent microarray 
analysis. 
6.2.6 RNA Extractions, Gene Microarray and Normalisation (Varro 
Laboratory in Collaboration with Dr Jithesh Puthen,  Liverpool 
University Statistician)  
AGS Cells were cultured in conditioned media (as previously described) and 
RNA was extracted using an RNeasy Kit from Qiagen according to 
manufacturer’s protocol. This work was carried out by Dr I. Steele (Varro 
Lab). RNA quantity and quality was determined before microarrays were 
carried out. Gene microarrays were conducted on AGS cells cultured with 
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media from five patient CAM cell lines, plus their paired ATMs, with serum 
free media is used as the control [table 25]. The samples were processed using 
the GeneChip® Human Genome U133 Plus 2.0 Array at the Liverpool 
Genome Research Facility by Dr Lucille Rainbow.  
 
The Human Genome U133 plus 2.0 Array allows analyses of 38,700 genes.   
Affymetrix Genechips are designed so that each gene is matched to 11 pairs of 
probes, which are used to measure the level of expression. These probes are 
evenly distributed throughout the chip to detect any noise within the genechip 
and to allow for effective normalisation of the datasets. The probes consist of 
perfect and mis-match probes; mis-match probes are subtracted from perfect 
match probes to give the true signal value. Each chip also contains probes 
which measure non-specific binding of cRNA which is another way to 
eliminate non-specific signals and to normalise the data effectively.  To ensure 
quality control between different arrays, there is also a selection of 
normalisation probes, which have constant levels of expression. These are 
therefore used to normalise signals across multiple arrays.   
The GeneChip® Scanner 3000 was used for imaging the arrays, and quality 
control was performed using Affymetrix micro-array 5 QC metrics by Dr 
Helen Smith (The University of Manchester). The statistical analysis of gene 
expression profiles was performed in GeneSpring GX.10 and experiments 
were normalized by RMA analysis using PARTEK© software (Jithesh Puthen, 
University of Liverpool). The gene lists were then analysed for differential 
regulation. 
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Label Sample Sample type 
3-CAM Sz190/1 P4 Cancer 
3-ATM Sz190/2 P4 Adjacent  
4-CAM Sz192/1 P5 Cancer 
4-ATM Sz192/2 P5 Adjacent  
10-CAM Sz294/1 P4 Cancer 
10-ATMA Sz294/2 P5 Adjacent 1 
11-CAM Sz305/1 P5 Cancer 
11-ATMB Sz305/22 P5 Adjacent 1 
12-CAM Sz308/1 P5 Cancer 
12-ATM Sz308/22 P6 Adjacent 
CONTROL 
  CONTROL 
  CONTROL 
  Table 25. Table detailing full list and labelling of ASG microarray data generated 
from conditioning with primary patient myofibroblasts media. Table highlights cells 
passage number and sample type. 
 
6.2.7 Differentially regulated oligonucleotide lists 
 
Microarray data was analysed using Partek© and the data was normalized by 
RMA and then batch corrected by Jithesh Puthen (The University of 
Liverpool) as the microarrays were carried out across different days. ANOVA 
analysis was performed to generate p-values across the data sets. Gene lists 
were processed and a cut off value of p<0.05 and a fold change cut off of 1.6 
was applied as an arbitrary value to filter the gene sets. 
For single patient data, log fold changes were calculated for individual 
patients from intensity values and the averages from the serum free controls. 
A arbituary fold cut off of log2(1.6) was applied and data was uploaded into 
various pathway analysis software packages.  
6.2.8 MetacoreTM 
MetacoreTM (GeneGo Inc) is a commercial integrated software suite for 
network and pathway analysis. MetacoreTM allows different data-types to be 
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uploaded, visualised and analysed with the use of its manually curated 
knowledge database of protein- protein interactions, transcription factors, 
drug targets, metabolic pathways and signaling pathways. 
6.2.9 Ingenuity  
Ingenuity is a commercially available integrated software suite for network 
and pathway analysis. The software allows for different data types to be 
uploaded, visualised and also analysed with the use of its knowledge database 
of signaling pathways. Gene lists were uploaded into ingenuity following 
normalisation and processing as described previously. A core analysis 
function was selected to process the data, and pathway, network and 
transcription analyses were generated.  
6.2.10 Genevestigator 
Genevestigator is a software platform that can be used to obtain information 
and insight into expression profiles of specific genes of interest, including; 
identifying cancers, diseases or conditions, which overexpress the target gene.  
The software can also cluster related genes or multiple genes of interest to 
look at co-expression and down-stream targets. To carry out Genevestigator 
analysis, probe database Human Affymetrix HG-U33 Plus was selected and 
uploaded into the software platform.  Genes associated with neoplasms and 
cancer cell lines databases were also accessed and uploaded into the database 
in order to run gene search algorithms and co-expression analysis. Data was 
exported into ImageJ as a heatmap in order to visualise gene expression 
patterns across the datasets.  
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6.2.11 Mitotracker Staining 
Cancer Associated Myofibroblast Cells and Normal Tissue Myofibroblast Cells 
between passages 5 and 10 were cultured on 35mm four chambered glass 
bottomed dishes to reach 80% confluency in DMEM full media. Cell media 
was removed and replaced with DMEM media containing 150nm Mitotracker 
CMXRos dye. Dishes were incubated in the dark at 37oC, 5% Co2 for 25 
minutes before cells were washed three times in 1 xPBS.  Fresh DMEM full 
media was added to the dishes before live cell imaging at 560nm using the 63x 
oil emersion lens on the Multiphoton 2 microscope. Images were taken and 
analysed using ImageJ software. Images were imported into ImageJ software 
and then mitochondria intensity was quantified and recorded, before analysis 
in GraphPad Prism Software. GraphPad software was used to plot the data 
and a one-way ANOVA was carried out to determine statistical significance 
between data sets.  
 
6.2.12 Preparation of Cell Dishes with Cell-Tak 
Cell-Tak was prepared from stock solution, 20μl was added to sodium 
bicarbonate with 10μl of hydrochloric acid (1M).  50μl of Cell-Tak solution was 
then added to each well of the Seahorse XF Flux Analyser 24 well plates and 
left to coat the wells for 20 minutes. The Cell-Tak was then removed and 
200μl of autoclaved water was then used to wash each well, plates were left to 
dry for an houbefore the cells were seeded. 
 
6.2.13 XF Extracellular Flux Analyser  
To investigate glycolytic capacity and oxygen consumption rate in cells, cells 
were split onto 24 well XF Seahorse Flux analyser cell dishes, which had been 
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pre-treated with BD Sciences Cell-Tak. Four wells were left free of cells, to be 
used as the background control for each condition. Ten wells were treated 
with metabolic drugs while control wells were left untreated. For all Seahorse 
experiments, cells were serum starved overnight and the following day media 
was replaced with 450ul of Seahorse Assay media. XF assays require a non-
buffered medium to accurately measure extracellular acidification rate and 
proton production rate of cells growing in culture. The Seahorse Assay media 
is based on the formulation of DMEM, including 2 mM of L-glutamine (as L-
alanyl-glutamine) but without sodium bicarbonate, glucose, or sodium 
pyruvate.  60 minutes prior to running the experiment, the XF24 cell culture 
plate was placed in a 37 ̊C incubator, without CO2 to allow cells to equilibrate 
to the new media. 1.0 ml of Seahorse Bioscience XF24 Calibrant pH 7.4 was 
added to each well of a Seahorse Bioscience 24-well sensor cartridge plate, 
this was stored at 37oC without CO2 overnight. The sensor cartridge plate 
contains wells that have ports that are used to inject the cell media with 
compounds; port A contains 50ul 10mM glucose, port B 55ul oligomycin 
(1ug/ul) and port C 100uM deoxyglucose.  Real-time measurements of OCR 
and ECAR are made by probes isolating a small volume of cell media above 
the cells on the seahorse plate. Cellular oxygen consumption (respiration) and 
proton excretion (glycolysis) cause changes to the concentrations of dissolved 
oxygen and free protons, which are measured at second intervals by the 
probes. Results for each set of measurements were recorded using the 
Seahorse XF Flux Analyser software. Data was imported into Graph pad prism 
software and analysed following normilisation to DNA (see below) data was 
expressed as averages of each substrate injection and one-way ANOVA 
analysis was performed to determine differences between cell subsets and 
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conditions.  
 
6.2.14 DNA Normalisation 
Seahorse results were normalised to DNA concentration to account for any 
potential variability in cell seeding number. To prepare plates for the DNA 
assay all liquid was removed from each well. Quant-iT PicoGreen ds DNA kit 
was used to measure DNA concentration. Cell lysis buffer was prepared; 0.5M 
EDTA, 180 mM NaCl and 0.5 ml of 20x TE lysis buffer, 200ul of RNase A was 
also added to the lysis buffer to remove any RNA contaminates. 50ul of lysis 
buffer was added per well and plates were incubated at room temperature for 
one hour, rocking gently. 40ul of the samples were incubated in a 96 well plate 
and mixed with 40ul Quant-iT PicoGreen dsDNA reagent dye. DNA standards 
were also set up in triplicate from lambda DNA standard stock solution 
ranging from 1ug/ml to 1ng/ml. Samples were excited at 480 nm and the 
fluorescence emission intensity was measured at 520 nm. Fluorescence 
emission intensity was then plotted versus DNA concentration to create a 
standard curve using Graph Pad Prism Software from the DNA standards. 
DNA concentration from the cell samples was extrapolated from the standard 
curve and then used for normalisation. 
6.2.15 Cell Fixation for IF Using Paraformaldehyde 
Cells were grown on glass coverslips in DMEM full media at a density of 1,000 
cells / ml for 24 hours to obtain 80% confluency. Cells were washed three 
times in 1xDPBS before being fixed for 15 minutes in 4% PFA. After fixation, 
cells were washed three times in 1xPBS then quenched in 50mM ammonia 
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chloride for 10 minutes. After further washing with 1xPBS, the cells were then 
permeabilised in 0.2% triton-X for 10 minutes. The coverslips were then 
blocked for one hour in 3% BSA. Following blocking the cells were then 
incubated for one hour in primary antibody [table 20] then washed three 
times in 1xPBS, before being incubated in secondary antibody for one hour 
[table 20] then were washed again three times in 1xPBS.  Coverslips were left 
to air dry on whatman 3mm paper for 10 minutes before being mounted onto 
slides with ProLong Gold plus DAPI.  
6.2.16 Cell Imaging and Analysis 
Fixed coverslips were imaged using the Zeiss fixed cell microscope. Images 
were captured then analysed using ImageJ.   Images were imported into 
ImageJ and then image intensity was quantified.  
6.2.17 RNA Extraction for Real Time PCR  
AGS cells between passages 20 to 25 were grown at in 10cm dishes in 37oC, 5 
% C02, until they reached 60-70 % confluency. AGS cells were then washed 
three times in 1xPBS before 10ml conditioned media from CAMs was added to 
these cells for 24 hours. After 24 hours the cells were washed again three 
times in 1xDPBS before being trypsinised for 5 minutes and then centrifuged 
at 1000 rpm. Cells were then washed again three times in 1xPBS and 
centrifuged at 1000 rpm to remove excess media, then RNA was extracted 
according to the Qiagen RNAeasy Kit manufacturers protocol. RNA 
concentration and purity was measured using the nanodrop 2000.  2μg of 
RNA was used per reverse transcriptase reaction. cDNA reverse transcription 
was carried out using AMV reverse transcriptase, DEPEC treated water, 
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oligo(dT) 15 primer, 10mM deoxynucleotides and recombinant RNasin® 
ribonuclease inhibitor, according to manufacturers instructions. Reverse 
Transcription reactions were aliquoted in 10ul volumes to prevent cDNA 
degradation due to freeze thaw cycles.  
 qPCR primers were designed using Vector NTI software; mRNA sequences 
were imported into the Vector NTI database, and the parameters for primer 
design were set; the melting temperature was established between 55°C and 
65°C, the GC content between 40-60% and the amplicons were set to 70-100 
base pairs. Using these parameters, primer sequences were generated and 
ordered. For all primer sets ordered, primers were optimised first and checked 
for efficiency and for melt curve formation (in case of primer dimers). 
 
 
 
 
 
 
Primers for qPCR 
 
            
 Forward 
 
Reverse 
 
Mct1 
 
5’-CTT-TTG-TTG-ACA-TGG-TAG-CCC-
GAC-3’ 
 
5’-ATT-TGC-ACC-CAT-GTC-TGC-TT-3’ 
 
GLUT1 
 
5’-CGC-TGG-ACC-CAT-GTC-TGG-TT-3’ 
 
5’-CAG-TGC-TTG-GCT-CCC-TGC-AGTT-3’ 
 
GAPDH 
 
5’-CCG-CTT-CGC-TCT-CTG-CTC-CTC-3’  
5’-TGC-TGA-CCA-GGC-GCC-CAA-3’ 
 
CEACAM5 
 
5’-TCA-GCA-GGG-ATG-CAT-TGG-GG-3’ 
 
5’-CGT-TGG-GGG-GAG-AGA-AA-3’ 
 
IGFBP5 
 
5’-CGT-TGG-GGG-GAG-AGA-AA-3’  
5’-TGC-GTT-CCC-TGC-TTG-TCC-CA-3’ 
 
BETA-ACTIN 
 
5’-AGG-CTG-TGC-TAT-CCC-TGT-ACG-
C-3’ 
 
5’-ATG-GGC-ACA-GTG-TGG-GTG-AC-3’ 
 
Table 26. Table to show lists of primers used for qPCR experiments. 
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6.2.18 EdU Proliferation Assay for Flow Cytometry  
AGS cells between passages 20 to 25 were used for flow cytometry 
proliferation assays. Cells seeded at 1,000 cells per ml and were grown for 24 
hours in 10 cm dishes to reach 80% confluency. Cells were serum starved for 
24 hours before being treated with conditioned media from CAM and NTM 
cells for 24 hours. 16 hours prior to cell harvesting, the dishes were treated 
with 10uM of EdU. Cells were washed three times in 1x PBS before being 
trypsinised and spun at 1,000 rpm.  Cell pellets were washed in 3mls of 
1%BSA before spinning again at 1,000 rpm. Click-iT fixative was added to cell 
pellets, and pellets were left for 15 mins in the dark, after washing once with 
3mls of 1% BSA, cells were spun again at 1,000 rpm. Pellets were re-
suspended in 100ul of 1 x click-iT saponin-based permeabilisation and wash 
reagent. The Click-iT® reaction cocktail was prepared according the 
manufacturers instructions. Cells were treated with 500ul of reaction cocktail 
for 30 minutes in the dark before washing in 3mls Click-iT saponin-based 
permeabilisation and wash reagent. Cells were again spun at 1,000 rpm to 
form a pellet, and resuspended in 500ul Click-iT saponin-based 
permeabilisation and wash reagent. Flow cytometric analysis was then 
performed at a low flow rate. 
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6.2.19 EdU Proliferation Assay for Immunoflurescence  
AGS cells between passages 20 to 25 were cultured onto coverslips in 24 well 
plates to reach 80% confluence. Cells were serum starved for 24 hours before 
being treated with conditioned media from myofibroblast cells for 24 hours. 
16 hours prior to cell harvesting, the dishes were treated with 10uM of EdU. 
Following incubation, coverslips were washed three times in 1x PBS before 
being fixed in 4% PFA for 15 minutes at room temperature. Coverslips were 
then washed twice with 1 mL of 3% BSA in PBS.  After removal of BSA 
solution, 1 mL of 0.5% Triton® X-100 in PBS was added to each well for 20 
minutes at room temperature to permeablise the cells. Following 
permeablisation, cells were washed twice with 1 mL of 3% BSA in PBS. The 
Click-iT® reaction cocktail was prepared according the manufacturers 
instructions. 0.5 mL of Click-iT® reaction cocktail was added to each well 
containing a coverslip and coverslips were incubated for 30 minutes at room 
temperature, protected from light, gently rocking to ensure the coverslips 
didn’t dry out. The reaction cocktail was removed and then the cells were 
washed once with 1 mL of 3% BSA in PBS.  Following this, each well was 
washed with 1 mL of PBS then cells were stained with Hoechst 33342 dye.  
Hoechst 33342 was diluted 1:2000 in 1xPBS to obtain a 1X solution of 5 
μg/mL. 1 mL of 1X Hoechst 33342 solution was added per well, and plates 
were then incubated for 30 minutes at room temperature, protected from light 
and gently rocking. The coverslips were washed twice with 1 mL of PBS and 
coverslips were left out to dry on whatman 3mm paper before being mounted 
onto slides using Prolong Gold reagent.  
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6.2.20 Preparation of Cell Lysates 
Cells were washed in 1X PBS then lysed in 1x RIPA buffer containing 1% 
protease and phosphatase inhibitors for 30 minutes on ice, samples were then 
centrifuged for 15 minutes at 13,000 rpm to pellet any debris. BCA assays 
were carried out in 96 well plates according to the manufacturers instructions, 
to determine the protein concentration in each sample. Lysates were mixed 1:1 
with 3x SDS sample buffer [table 22] before boiling at 98 °C for 15 minutes; 
samples were then centrifuged at 13,000 rpm for 5 minutes. For all western 
blots, a final concentration of 20μg of protein was loaded per well.   
 
6.2.21 Western Blotting 
Proteins were resolved by SDS-PAGE using either 10% polyacrylamide gels as 
described in table 22 or 4-12 % pre-cast gels. Samples were heated at 98°C for 
5 minutes before loading onto the gel.  Gels were run for 1 hour 30 minutes, at 
90 volts for 30 minutes, then one hour at 150 volts. Proteins were transferred 
from SDS gels to nitrocellulose membranes by a wet transfer method; 
whatman 3mm paper and nitrocellulose membrane were pre-soaked in 
transfer buffer for 10 minutes before the transfer was set up.  The transfer was 
run for 1 hour at 300 mA and kept on ice.  Membranes were stained with 
Ponceau-S [table 22] for 5 minutes, to check the transfer efficiency and then 
washed with distilled water until all stain was removed. The membranes were 
then incubated in 5% blocking buffer [table 22] to block unoccupied protein 
binding sites for one hour. After blocking, membranes were incubated in 
primary antibody [table 20] diluted in 5% blocking buffer for 1 hour at room 
temperature.  The membrane was then washed three times for ten minutes in 
wash buffer [table 22]. Membranes were incubated with peroxidase-coupled 
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secondary antibody diluted in blocking buffer [table 20] for 1 hour at room 
temperature, then washed three times for ten minutes in wash buffer [table 
22], before a final wash for ten minutes in 1 xPBS. Bound antibodies were 
detected by chemilluminescence using ECL Western blot detection reagents 
for 5 minutes according to manufacturers instructions. Membranes were 
placed protein side face up on cling film before being taped to the inside of an 
X-ray cassette. Kodak X-Omat XAR-5 film was placed over the membrane and 
films were exposed between 2 seconds to 10 minutes before being processed 
in developing reagent for two minutes, and then fixed in reagent for 5 minutes. 
Films were left to dry overnight. Films were scanned and images processed 
using Image J and Adobe Illustrator. 
 
6.2.22 Boydon Chamber Migration Assays  
 
Using an 80% confluent flask of AGS cells, cells were split and counted as 
previously described. Cells were centrifuged at 1,000 rpm for five minutes to 
form a pellet, and then re-suspended in 10 ml of media (9ml serum free 
DMEM media plus 1 ml DMEM plus 10% FBS media) to obtain a final cell 
concentration of 20,000 cells/ml. 10,000 AGS cells were seeded into each top 
insert in a final volume of 500ul serum free medium. In the lower 
compartment of the boydon chamber, 750ul of serum free, CAM and NTM 
conditioned media were added into the wells. The chambers were incubated 
overnight at 37°C, 5% Co2. The following day 24 well plates were prepared 
with quick diff kit solutions according to manufacturers instructions, to stain 
cells which had migrated through the membrane. Briefly, the inserts were 
placed in fixative for 8 minutes to fix cells to the membrane, then red cellular 
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stain for 5 minutes, then finally blue counterstain for 4 minutes. Inserts were 
then washed in distilled water before being left to dry. After drying, the 
membrane was removed from the inserts using a scalpel before being 
mounted onto a coverslip using a drop of immersion oil.  Migrated cells were 
counted in 5 different fields at 10x on a light microscope, and then results 
were expressed as an average.  
 
 
6.2.23 Gene Set Enrichment Analysis and array quality metrics 
report (Dr Helen Jones, Manchester University) 
 
Array quality metrics reports were carried out using Bioconductor in R by Dr 
Helen Jones, Manchester University.  Gene Set Enrichment Analysis was 
carried out using the GSEA software suit by Dr Helen Jones, Manchester 
University. 
6.2.24 Statistical Methods and Analysis 
 
For all immunofluorescence analyses ImageJ software was used to quantify 
intensity of fluorescence before being exported to Microsoft excel. Statistical 
analyses were carried out using Graphpad Prism software. 
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